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A long association has been established between infectious inflammation and 
diseases of the salivary glands (SGs). However, the prompt responses of the 
exocrine tissues to these types of injuries remain unclear. Accordingly, an acute 
inflammation model was developed by the retrograde intraductal injection of a 
double-stranded (ds) RNA analogue; polyinosinic:polycytidylic acid (poly(I:C)), 
into the submandibular glands (SMGs), through Wharton’s duct. The main aim of 
this study was to investigate the early functional and immune events downstream 
of exposure to this viral-like inflammagen. The first part of the current study 
highlighted that the SMGs responded to the locally injected poly (I:C) by a rapid 
decline in saliva secretion, which stopped completely after 24 hours of infection. 
The early loss of function perceived, paralleled the upregulated expression of 
Toll-like receptor-3 (TLR3) and that incited blocking of the receptor in vivo to 
assess its role in the loss of function. The outcome of these experiments 
confirmed that dysfunction of the acutely inflamed glands resulted from ligation 
of TLR3 and initiation and propagation of downstream cytokines. The current 
study revealed for the first time the possibility of using a protease inhibitor to 
restrict TLR3 neo-synthesis, dampen inflammation, fine-tune anti-viral innate 
immune responses and retrieve TLR3-induced loss of SMG function. 
Next, the role played by the acute inflammatory cells which infiltrated the SMGs 
following poly (I:C) infection was examined. Despite successful depletion of these 
cells, the glands’ secretory functions were not retrieved, verifying that TLR3 has 
induced dysfunction independent of the invasive acute cell infiltration.  
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In the last part of this study, it was demonstrated that the TLR3-inhibited, 
functionally-protected SMGs revealed loss of the pro-inflammatory cytokine, 
inducible nitric oxide synthase (iNOS), which displayed extensive acinar 
upregulation in response to poly (I:C) infection. Selective blocking of iNOS by 
aminoguanidine protected the secretory function of the poly (I:C) treated glands 
and specified iNOS as the earliest signal which disrupts the secretory machinery 
after innate immune activation.  
To assess the injurious contributions of iNOS and its rapidly derived cytotoxic 
oxidant peroxynitrite, in the acute SG model, the gland homogenates were 
immunoblotted with the peroxynitrite marker, 3-nitrotyrosine, which revealed 
extensive nitration of a plethora of the gland proteins, including proteins at the 
electrophoretic mobility of the endoplasmic reticulum (ER) SERCA2 channel. 
Immunohistochemistry further revealed the physical co-localization of 
peroxynitrite and the critical regulator of calcium homeostasis, SERCA2. To 
comprehensively investigate the impact of this finding on the cellular calcium 
levels of the infected glands, a novel protocol which allowed assaying of [Ca2+]i  
changes ex vivo was developed, optimized and applied to the aminoguanidine 
treated and non-treated mice. Through this protocol, iNOS-mediated 
dysregulations in resting and stimulated calcium were recorded. The set of 
experiments which followed these findings revealed upregulation of the unfolded 
protein response, global transcriptional downregulation of key water driving 
molecules and altered subcellular localization of these critical membranous 
receptors, water channels and ion transporters. All these changes in response to 
a single poly (I:C) dose, were remarkably reversed when the SMGs were treated 
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1.1 Salivary Glands 
1.1.1 Types and Anatomy of Salivary Glands 
Human and murine SGs can be classified according to size into: (i) three paired 
major glands; parotid (PG), submandibular (SMG) and sublingual (SLG), and (ii) 
numerous glands forming minor packages located in the labial, palatine, buccal, 
lingual and sublingual submucosae (Denny et al., 1997, Amano et al., 2012). 
Based on secretion: saliva from the PG is entirely serous. While the SLGs are 
mucous; the SMGs produce mixed serous and mucous saliva. Major SGs of both 
humans and rodents are essentially similar in their anatomical architecture which 
comprises secretory end pieces (acini) and arborized ductal structures that open 
into the oral cavity. Table 1-1 and Figure 1.1 compare the prominent anatomic 
features of mice and human SGs.  
Table 1-1 Comparison of anatomical features of major SGs in mice and human (Piper M. Treuting, 
2012). 
Feature Mouse Human 
Submandibular • Largest; located in ventral 
cervical region. 
• Duct opens caudal to lower 
incisors (Amano et al., 2012). 
• In digastric triangle, anterior to 
digastric and posterior to stylohyoid 
ligament. 
• SMG Wharton’s duct opens with 
SLG Bartholin’s in the sublingual 
caruncle (Holmberg and Hoffman, 
2014). 
Sublingual • Located in ventral cervical 
subcutaneous region. 
•  Small single lobe. 
•  Close association with 
submandibular; duct opens 
caudal to lower incisors. 
• Smallest major gland. 
•  located above the mylohyoid below 
the mucosa of the middle to anterior 
mouth floor. 
Parotid • Located in ventral cervical 
subcutaneous region. 
•  Diffuse multi-lobed. 
•  Duct opens near lower molars 
 
• Largest gland. 
•  Triangular base at zygomatic arch 
and apex just inferior to the angle of 
the mandible. 
•  Extends posterior to the ear and 
anterior to cover masseter. 
• Stensen’s duct opens in the mouth by 























Figure 1.1 Mouse and human salivary glands. 
A: Mouse regional cervical anatomy and sub-gross histologic section of cervical soft tissues from 
a male mouse. The SMG is the largest in the mouse, whereas the PG is relatively diffuse. B: 
Gross dissection of mouse ventral cervical region. Paired salivary glands are bilaterally located 
and outlined in black. The submandibular (SMG) and sublingual (SLG) glands are encapsulated 
with common fascia (Piper M. Treuting, 2012). C: Human regional cervical anatomy. D: Acini and 

















1.1.2 Histomorphology of The Acinar and Duct Systems of SGs 
A typical SG is surrounded by a fibrous connective tissue capsule, which sends 
remote septae to divide the gland into lobes and lobules. Salivary glands are 
made of three epithelial cell types: acinar, ductal and myoepithelial. The pattern 
of arrangement of these cells is similar in both mice and humans: glandular acini 
connect to intercalated ducts (ID) which drain to intralobular striated ducts (SD) 
and then interlobular ducts that finally merge into excretory ducts (ED) to empty 
into the oral cavity. In addition, the myoepithelial cells usually associate with both 











The acinus, the secretory end piece of salivary glands; produces and secretes 
the primitive saliva into the central lumen. Parotid acini have small pyramidal cells 
with regular nuclei, apical pink staining due to zymogen granules, and basal 
basophilia, when stained with haematoxylin & eosin (H&E).  
Figure 1.2 Basic SG unit.  
Salivary glands are made of three epithelial cell types: acinar, ductal and 
myoepithelial cells. Acinar cells organized into pyramidal acini are connected to a 
network of ducts classified into: intercalated, striated and excretory ducts. 
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Similarly, the SMG acini stain basophilic in histologic sections, with basal nuclei 
and may contain apical cytoplasmic mucin droplets. The sublingual acini are large 
pyramidal mucous-producing cells with abundant pale blue vacuolated cytoplasm 
(Piper M. Treuting, 2012). Figure 1.3 reveals the histologic features and variances 











Like the human SGs, the duct system of rodents is composed of the ID, SD, ED 
and main excretory ducts. The IDs are lined by cuboidal to flattened epithelium in 
mice and cuboidal epithelium in humans. Intralobular SDs are lined by cuboidal 
to low-columnar cells in mice and tall columnar cells with large, apically located 
nuclei in humans. Both species have characteristic eosinophilic striations in the 





P                                  SMG                                          SLG                                         
Figure 1.3 Comparative histology of salivary glands in human and mice.  
Parotid acini (P) in mice (M) and humans (H) are serous-secreting with apical 
cytoplasmic zymogen granules that stain pink with H&E. In both species, the SMG 
serous acini and ducts are numerous and clearly identified. In humans, 
seromucinous and mucous cells are lighter pale-blue staining and more prominent 





These striations are caused by enfolding of the basal plasma membrane. 
Interlobar EDs have cuboidal epithelium. The main excretory ducts in the mouse 
are lined by cuboidal cells that transform to stratified squamous (oral mucosa) at 
the duct opening (Piper M. Treuting, 2012). In addition, mice have a unique ductal 
arrangement in the SMGs, which contain granular convoluted ducts (GCD) 
connecting the intercalated ducts to the striated ducts. This segment of ducts 
within the SMGs has sexual dimorphism in mice, since it is testosterone 
dependent (Chai et al., 1993). In males, cells lining the GCD are large and 
columnar containing bright pink granules. In females, cells are smaller with less 







The GCD produces and secretes a variety of bioactive polypeptides, hormones, 
and cell growth factors including epidermal growth factor (EGF), nerve growth 
factor (NGF) (Gresik, 1994), brain-derived neurotrophic factor (BDNF) (Kondo et 
al., 2010, Tsukinoki et al., 2006), hepatocyte growth factor (HGF) (Amano et al., 
1994, Amano and Iseki, 2001), insulin-like growth factor 1 (IGF-I) (Amano and 
Iseki, 1993, Amano and Iseki, 2001), transforming growth factor (TGF) -α (Wu et 
al., 1993) and -β (Amano et al., 1991, Amano and Iseki, 2001).  
Figure 1.4 Sexual dimorphism in mouse SMGs. 
Tissue sections from female (1) and male (2) SMGs showing the histologic 
dimorphism between each sex. Note the excess GCDs (arrow) in male 
SMGs as well as the intense eosinophilia reflecting abundance of 





1.1.3 Functional and Secretory Pathway Variations in Mouse SG Acinar 
Cells 
In mice, the PG, SMG, and SLG glands secrete 90% of the whole mouth saliva. 
Although all 3 major SGs appear to secrete fluid by a similar molecular 
mechanism, each gland contributes differently to this percentage, which denotes 
that the secretory machinery is functionally inequivalent for each gland. The PG 
secretes approximately 30% more saliva than does the SMG and 6-fold more 
than does the SLG, suggesting that the PG has a more robust secretory 
mechanism. These differences in flow rate are neither entirely dependent on the 
gland weight nor on the acinar volume of each SG (Kondo et al., 2015). To 
appreciate why the PG acini secrete significantly more saliva than do the SMG 
and SLG, the complex process of salivary fluid secretion must be briefly 
demonstrated. In short, Cl- uptake by the basolateral Na-K-Cl cotransporter 1 
(NKCC1) (Haas, 1989, Haas and Forbush, 1998, Haas, 1994) elevates the 
intracellular Cl- concentration above its electrochemical equilibrium. This will 
promote the Ca2+-activated Cl- efflux by the apical channel; Transmembrane 
Protein 16A (TMEM16A) (Yang et al., 2008, Romanenko et al., 2010), once the 
acinar cells are stimulated by the cholinergic agonist; acetylcholine and 
intracellular calcium [Ca2+]i mobilization takes place (Nauntofte, 1992, Ambudkar, 
2014). Consequently, these events comprise the driving force for Na+ and water 
movement through the tight junction complex and apical water channels, 
















According to (Kondo et al., 2015), both TMEM16A protein expression and the 
muscarinic agonist-induced Cl- efflux mediated by this channel were greater in 
the PG acinar cells than in SMG and SLG, which highlighted the essential role 
played by this channel in the mouse salivary acinar cells. In addition to the 
TMEM16A Cl- enhanced expression and activity, they demonstrated that the PG 
and SMG likely secrete greater volumes of fluid than do the SLG because they 
display a larger increase in the [Ca2+]i-stimulated response and more NKCC1 
activity. Interestingly, they showed that the SLG, which exhibits relative deficiency 
in these functional determiners, rely on the basolateral Cl-/HCO3-  anion 
exchanger (Novak and Young, 1986, Melvin and Turner, 1992, Nguyen et al., 
2004) in Cl- uptake to compensate for the absence of NKCC1 activity (Catalan et 
al., 2015).  
    
Figure 1.5 Illustration summary of the saliva 
secretion mechanism in mouse acinar cells.  
Muscarinic agonist-stimulated Ca2+ release, and Cl-   
efflux into the lumen via the apically located TMEM16A 
channel. Towards osmotic balance, Na+ will follow Cl- 
















1.2 Salivary Gland Secretion, Calcium Homeostasis & Dysfunction 
1.2.1 Control of Salivary Secretion 
Parasympathetic and sympathetic arms of the autonomic nervous system interact 
simultaneously on secretory acinar cells to generate a reflex secretion of saliva 
(Proctor and Carpenter, 2007). While the parasympathetic stimulation functions 
to evoke a large volume of saliva, the sympathetic nerves will induce a protein-
rich secretion (Anderson et al., 1995, Asking and Gjorstrup, 1987, Carpenter et 
al., 2000, Matsuo et al., 2000). 
1.2.1.1 Parasympathetic Control: Fluid Secretion and Modification of 
Electrolytes  
Parasympathetic nerves are secretomotor and their stimulation will cause the 
SGs to secrete a large volume of watery fluid that is high in electrolytes and low 
in proteins (Proctor, 1998, Proctor, 2016). In addition, parasympathetic activity 
causes blood vessels to dilate, thereby providing the gland with a source of water 
for secretion (Villa et al., 2016). The parasympathetic nerve supply to the major 
SGs (Khurana, 2009, Hall, 2011) is best summarized as in table 1-2 and figure 
1.6.  
Table 1-2 Summary of parasympathetic nerve supply to the SGs. 
 
 PG SMG/SLG 
Preganglionic 
nerve supply 
Arise from inferior salivary 
nucleus (dorsal nucleus of IXth 
nerve) of medulla. 
Arise from superior salivary 
nucleus (dorsal of the VIIth nerve). 
Preganglionic 
nerve fibres 
Run via the tympanic nerve and 
small superficial petrosal nerve 
to the otic ganglion 
Run in nervous intermedius 
(sensory division of VII nerve), join 
the facial nerve and leave by its 
chorda tympani branch to join the 
lingual nerve. 
Ganglion Otic Submandibular 
Postganglionic 
nerve fibres 
From the Otic ganglion join the 
auriculotemporal nerve to the 
parotid gland 
Arise from the submandibular 
ganglion and supply the glands 











The SG fluid secretion in response to parasympathetic stimulation occurs in two 
phases; acinar secretion of isotonic saliva; which has the same Na+, Cl-, K+ and 
HCO3- concentrations as plasma (Khurana, 2009), followed by duct modification 
phase, which results in the final hypotonic saliva secreted into the mouth. As 
previously illustrated, fluid secretion following the action of the parasympathetic 
postganglionic transmitter; acetylcholine on the acinar M3 muscarinic receptors 
(M3R) (Proctor and Carpenter, 2014), involves increase [Ca2+]i and ion transport. 
The first phase comprises activation of phospholipase Cβ (PLCβ) which cleaves 
phosphatidylinositol 1,4, bisphosphate (PIP2) to produce diacylglycerol (DAG) 
and the soluble signalling molecule inositol 1,4,5, trisphosphate (IP3) (Berridge, 
1993, Melvin et al., 2005). IP3, then activates the endoplasmic reticulum (ER)-
Ca2+ release channels; IP3 receptors (IP3Rs), which induce Ca2+ release from 
the ER stores (Mikoshiba, 2007).  
Tympanic nerve  




Ryanodine receptor 2 (RyR2) is another main intracellular Ca2+ release channel, 
abundantly localized in the basal region of acinar cells (Zhang et al., 1999). 
Positioned as such, it is presumed to play a role in globalization of the Ca2+ signal 
in acinar cells following stimulation, by spreading Ca2+ to sites of the ER where 
IP3Rs are sparse or those at a distance from the site of IP3 generation 
(Ambudkar, 2014). IP3-mediated Ca2+ release via IP3R, and the resultant 
depletion of endoplasmic reticulum calcium  [Ca2+]ER, will then be detected by the 
ER-binding protein sensor STIM1 (Liou et al., 2005, Zhang et al., 2005, Zeng et 
al., 2008, Yuan et al., 2009, Hogan et al., 2010, Cheng et al., 2013, Prakriya, 
2013), which will trigger further influx of extracellular calcium across the 
membranous store-operated calcium channels (SOC) of acinar cells (Putney, 
1990) and will ensure sustained salivary secretion (Melvin et al., 2005, Ambudkar, 











Figure 1.7 Intracellular mechanisms of calcium release in salivary acinar cells.  
The illustrated model describes 2 principal intracellular pathways of calcium 
mobilization. Acetylcholine binding to its cognate M3R (G protein-coupled receptor) 
results in production of inositol 1,4,5-trisphosphate (IP3), which causes ER calcium 
release. Calcium-induced calcium release (CICR) is brought about by calcium 




In the resting acinar cells: NKCC1, Na+/H+ and Cl-/ HCO3- exchanger mediate Cl- 
influx across the basolateral membrane of acinar cells to accumulate chloride 
ions (Cl-), 4–5-fold above electrochemical equilibrium (Foskett, 1990, Zeng et al., 
1997). The use of NKCC inhibitors showed that NKCC activity mediates about 
70% of the Cl− uptake that is secreted across the luminal membrane to drive 
secretory glands fluid secretion (Melvin et al., 2005). The central role of NKCC1 
in salivary glands fluid and electrolyte secretion was further established by 
deletion of the Nkcc1 gene in mice, which resulted in about 70% inhibition of 
salivary secretion (Evans et al., 2000). 
The second phase in stimulated saliva secretion follows the increase in [Ca2+]i 
and starts with activation of the apical Cl- channel; TMEM16A (Arreola et al., 
1996, Hayashi et al., 1996). TMEM16A activation will release Cl- into the central 
acinar lumen, which will be followed by sodium movement by a paracellular 
course through the tight junctions (Zhang et al., 2013). It is important to note that 
the muscarinic Ca2+-dependent fluid secretion was completely abolished in the 
salivary glands of TMEM16A null (Tmem16A−/−) mice, concluding the essential 
role played by this channel in fluid secretion in the adult salivary glands (Catalán 
et al., 2015). 
Typically, the transcellular accumulation of NaCl ions in the acinar lumen will 
result in the obligatory osmotic water flow (Lee et al., 2012b). Although water can 
cross the membrane bilayer, water flow in secretory cells is facilitated by the 
water channels; aquaporins (AQPs). The luminal membrane of acinar cells 
express AQP5, which plays an indispensable role in exocrine glands’ fluid 
secretion by providing highly permeable water channels  (Krane et al., 2001).  
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This was confirmed by the: (i) 60% reduction in secretion observed in the AQP5 
knockout mice (Alper, 2009, Melvin et al., 1988), (ii) aberrant trafficking of AQP5 
in Sjögren’s syndrome patients (Evans et al., 1999, Roussa et al., 1999), (iii) 
markedly decreased labelling intensity of AQP5 in severely damaged irradiated 
SGs (Takagi et al., 2003) and (iv) disrupted trafficking of the water channel in 
Streptozotocin-induced diabetic mice, featuring xerostomia (Ishikawa et al., 
2004). In addition, since AQP5 appears to regulate the water permeability of the 
paracellular pathway, its deletion disrupted integrity of the tight junction and 
reduced the paracellular water permeability (Evans et al., 1999).  
After acinar fluid secretion, saliva enters the duct modification phase, whereby 
salivary ducts secrete K+ and HCO3- and reabsorb Na+ and Cl- (Cook DI, 1994). 
The hypotonicity of secreted saliva indicates that ducts are relatively impermeant 
to water (Melvin et al., 2005). The prevailing model for fluid and electrolyte 
transport in salivary ducts accounts for Na+ and Cl- influx into the duct cell 
luminally, through electroneutral pathways, i.e. a Na+/H+ exchanger (Luo et al., 
2001) a Cl-/HCO3- exchanger (Lee et al., 1998) and through Na+ (Cook et al., 
1998) and Cl- (Zeng et al., 1997) channels. Large amounts of sodium and chloride 
will be transported out of the ductal cell and into the glandular interstitium via the 
basolateral sodium/potassium ATPase (sodium pump) and Cl- channels, 
respectively (Proctor, 2016). Moreover, the HCO3- accumulated in the cytosol via 
the basolateral Na+/H+ exchanger (NHE1) will enter the lumen in exchange for Cl- 
at the apical Cl-/HCO3- exchanger (Cook DI, 1994). Figure 1.8 summarizes the 














Figure 1.8 Model depicting the mechanism of fluid and electrolyte secretion.  
A: Shows the major transporters in the basolateral and luminal membranes of acinar cells. The 
major Cl- loading transporter at the basolateral membrane is NKCC1. TMEM16a/Ano1 is the 
major Ca2+-activated Cl- channel at the luminal membrane. B: Fluid and electrolyte secretion by 
acinar cells is regulated by Ca2+ mobilizing receptors and is a Cl- secretion-driven process. The 
receptor-evoked [Ca2+]i increase is initiated at the apical pole where the Ca2+ signaling 
complexes are located and activates TMEM16a/ Ano1.  The Ca2+-mediated channel activation 
results in luminal Cl- efflux. C: Na+ then follows the Cl- into the acinar lumen through the tight 
junction. D: Model for the modification of primary saliva by ductal secretion. Salivary duct cells 
secrete K+ and HCO3- and reabsorb Na+ and Cl- to produce the final saliva. The salivary duct 
epithelium is tight allowing no water movement, thus resulting in hypotonic saliva (NBCe1-A/B 
electrogenic Na+/HCO3- cotransporters A/B, ENaC epithelial Na+ channel, CFTR cystic fibrosis 
transmembrane conductance regulator). 
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1.2.1.2 Sympathetic Control and Protein Secretion 
The preganglionic sympathetic nerve fibres originate from the lateral horn cells of 
T1 and T2 segments of the spinal cord and enter the paravertebral sympathetic 
chain via ventral roots to synapse with cells in the superior cervical ganglion. 
Subsequently, the postganglionic fibres run along the carotid artery branches and 
supply the major and minor salivary glands by travelling along the blood vessels 








The main sympathetic neurotransmitter is noradrenaline (NA) (BJ Baum, 1999). 
NA released from sympathetic nerve endings binds to β1 adrenoceptors on 
acinar cells and increases G protein-coupled adenylate cyclase activity with the 
generation of increased levels of intracellular messenger; adenosine 30,50-cyclic 
monophosphate (cAMP) (BJ Baum, 1999).  Exocytosis of salivary proteins in 
parotid and submandibular acini is triggered mainly by cAMP and is potentiated 








Figure 1.9 Sympathetic nerve supply to the salivary glands  
(BJ Baum, 1999). 
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1.2.2 Calcium Signalling Homeostasis and Disruption  
1.2.2.1 Key Molecular Determinants of [Ca2+]i Homeostasis 
[Ca2+]i is a critical factor in the regulation of a plethora of physiological functions, 
including muscle contraction, secretion, metabolism, gene expression, cell 
survival and cell death. The key regulator of [Ca2+]i homeostasis is determined by 
a balance between the 'initiating' responses that introduce [Ca2+]i into the 
cytoplasm and the 'terminating' responses through which [Ca2+]i  is removed by 
the combined action of buffers, pumps and exchangers.  
As previously mentioned in the current chapter, introduction of cytosolic Ca2+ 
follows activation of plasma membrane M3R and generation of IP3, which will 
bind to the ER receptor; IP3R, to release [Ca2+]ER (Yule, 2001, Mikoshiba, 2007). 
On the other hand, removal of Ca2+ from the cytoplasm following termination of 
the secretion stimulus, maintains the resting level of Ca2+ at approximately 100 
nM and ensures that the internal stores are kept loaded (Berridge et al., 2003). 
Different pumping mechanisms are activated via the increased [Ca2+]i and are 
responsible for elimination of cytosolic Ca2+: the plasma-membrane Ca2+-
ATPASE (PMCA), the Na+/Ca2+ exchanger (NCX) and the sarco(endo)plasmic 
Ca2+-ATPase (SERCA). Both SERCA and NCX contribute equally to Ca2+ 
clearance, which accounts for approximately 80% of the removal (Schwaller, 
2012). SERCA uses the energy of ATP to drive Ca2+ across the membrane 
against the ion gradient, by forming a high-energy intermediate acyl-phosphate 
(Toyoshima, 2009). Moreover, SERCA plays a major role in Ca2+ homeostasis in 
the cells by controlling the SOCE activity (Bolotina, 2004) and reloading Ca2+ 




Alternatively, NCX is an ion transporter that can rapidly expel calcium ions from 
the cell by utilizing the energy stored in the transmembrane sodium gradient to 
allow influx of three sodium ions and extrusion of one calcium ion (Hilge, 2012, 
Ottolia and Philipson, 2013). Similar to SERCA, PMCA is responsible for fine 
tuning of Ca2+ level in the cell by pumping out Ca2+across the PM at the expense 
of ATP, against a Ca2+ gradient (Niggli et al., 1982).  
Although the ER is accepted as the major organellar Ca2+ buffer, several other 
subcellular organelles are known to eliminate cytosolic Ca2+ and maintain it at 
significantly higher levels than in the cytoplasm, figure 1.10. Golgi apparatus 
secretory-pathway Ca2+ATPases (SPCAs), the mitochondrial uniporter (MCU), 
peroxisomes, and endosomes/lysosomes are all examples of organelles 



































ATP     ADP 
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Figure 1.10 [Ca2+]i Elimination Portals.  
Ca2+ is stored within several different organelles: ER, Golgi 
apparatus, mitochondria, and peroxisomes. A typical Ca2+ 
release pathway ultimately stimulates releasing of Ca2+ from 
the ER lumen. Note that the Golgi apparatus also contains IP3R 
molecules and thus may contribute to Ca2+ release from stores. 
Golgi Ca2+ uptake occurs via SPCA pumps. Ca2+ released from 
the ER has several different fates, including: uptake by 
mitochondrial MCU, or extrusion from the cell via PMCA and 
Na+/Ca2+ exchanger plasma membrane proteins. Orai1 
functions as a plasma membrane Ca2+ channel that allows for 
Ca2+ entry from the extracellular milieu into the cytoplasm, 
where it is taken up by SERCA into the ER lumen. Peroxisomes 
are known to maintain Ca2+ at higher levels than in the 
cytoplasm. Elevated Ca2+ levels in the ER and in the Golgi 
apparatus, will mostly be bound to buffering proteins, as shown 
within these organelles. BiP/GRP78 binding protein/glucose-
regulated protein of 78-kDa; CRT, calreticulin; GRP94, 
glucose-regulated protein of 94-kDa; IP3, inositol 
trisphosphate; IP3R, inositol trisphosphate receptor; NCX, 
Na+/Ca2+ exchanger; P54/NEFA, DNA binding/EF hand/acidic 
amino acid rich region protein; PDI, protein disulfide isomerase; 
SPCA, secretory pathway Ca2+-transport ATPase. Adapted 
from (Prins and Michalak, 2011). 
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1.2.2.2 Calcium and endoplasmic reticulum stress 
Within the ER lumen, Ca2+ is present either in free-form or buffered via ER 
resident chaperones (Michalak and Opas, 2009), namely: Calreticulin, 
Immunoglobulin Binding Protein BiP/GRP78, GRP94, Protein Disulfide 
Isomerase (PDI). One characteristic uniting the ER Ca2+ buffers is their 
multifunctionality. Instead of being limited to serving as a passive sponge for Ca2+ 
within the organelle, Ca2+-buffering proteins are responsible for a variety of 
processes, including chaperoning for post-translational protein modification and 
folding, regulation of apoptosis, and regulating Ca2+ release pathways (Bravo et 
al., 2013).  
The multi-functional nature of the ER enables it to sense and integrate many of 
the incoming cell signals, in particular, the changes in free and bound Ca2+ 
concentrations in and outside of the ER compartment (Krebs et al., 2015). To fulfil 
this critical function, GRP78/BiP; an ER Ca2+-binding protein associates with 
other ER transmembrane proteins; ATF6, IRE1 and PERK. The recruitment of 
Bip to these proteins is stabilized only by high Ca2+ concentrations (Suzuki et al., 
1991). Thus, depleted and un-replenished Ca2+ stores which can lead to 
compromised action of calcium-activated chaperones will result in: (i) rapid 
accumulation of mis-folded proteins, (ii) dissociation of BiP from IRE1, PERK and 
ATF6 and (iii) activation of what’s known by the unfolded protein response (UPR) 












Figure 1.11 The Unfolded Protein Response pathway.  
At a normal [Ca2+]ER: the ER-stress sensors are scaffolded and inactivated by GRP78/BiP. ER-
resident chaperones facilitate the proper folding of the nascent protein and prevent its 
aggregation. Protein trafficking and quality-control mechanisms work normally. In contrast, when 
the [Ca2+]ER is remarkably decreased and not replenished: the function of chaperones 
becomes disturbed and unfolded proteins accumulate and act as a sponge for luminal 
GRP78/BiP. As a consequence, ER-stress sensors are devoid of GRP78/BiP and become 
activated. a- Dissociation of binding immunoglobulin protein (BiP) from inositol-requiring enzyme 
1α (IRE1α), or direct binding of misfolded proteins to IRE1α, activates the endoribonuclease 
domain of IRE1α, which non-conventionally splices an intron from unspliced X-box binding protein 
1 (XBP1u) mRNA to produce XBP1s mRNA that encodes a potent transcriptional activator, 
XBP1s. Among the target genes of XBP1s are genes encoding proteins that increase the protein-
folding capacity of the endoplasmic reticulum (ER) and that assist in the degradation of misfolded 
proteins by ER-associated degradation (ERAD). In addition, the entry of newly synthesized 
proteins into the ER is limited by the degradation of mRNA through regulated IRE1α-dependent 
decay of mRNA (RIDD). b- PKR-like ER kinase (PERK)- dependent phosphorylation of eukaryotic 
translation initiation factor 2α (eIF2α) inhibits ribosome assembly, which causes a translational 
block and allows the cell to manage temporary ER stress. Activating transcription factor 4 (ATF4) 
escapes translation inhibition under ER stress conditions and induces the transcription of genes 
that promote survival, including those involved in compensatory autophagy (see inset box). Once 
ER stress is resolved, eIF2α is dephosphorylated by the GADD34–protein phosphatase 1 (PP1) 
complex to restore protein translation. In addition, the unfolded protein response can activate 
apoptosis, mainly through C/EBP homologous protein (CHOP). c- Upon BiP dissociation from 
ATF6α during ER stress, ATF6α travels to the Golgi compartment where it is processed by the 
Golgi enzymes site 1 protease (S1P) and S2P to produce a cytosolic p50 fragment. ATF6p50 
functions as a transcription factor that activates transcriptional programmes that increase ER 
capacity and protein folding, and that remove misfolded proteins from the ER for degradation 
(ERAD) (Grootjans et al., 2016). 
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An outstanding key task of acinar cells in the exocrine glands is the synthesis and 
packaging of proteins for transport. Accordingly, the ER of these cells is highly 
developed to accommodate the Ca2+ as well as the protein overload that can be 
experienced throughout their secretory role. As a consequence, secretory acinar 
cells may be highly sensitive to environmental conditions that impose ER stress 
like exposure to pathogenic inflammatory stimuli (Bettigole and Glimcher, 2015), 
particularly viral infections (Isler et al., 2005, Pavio et al., 2003, Tardif et al., 
2002).  
1.2.2.3 Disrupted Ca2+ Signalling in Dysfunctional Salivary Glands 
Interestingly, due to the complexity of the signal which induces salivation, the 
integral acinar cell response to muscarinic receptor activation, with temporal and 
spatial [Ca2+]i increase, can be prone to disruption. In fact, both physiologic and 
pathologic conditions can target acinar Ca2+ homeostasis. 
Ageing has always been associated with the depletion of acinar tissue, 
hyperplasia of ducts and fibrosis of connective tissues in the salivary glands 
(Meisel et al., 1988). It is possible that these structural changes result in salivary 
insufficiency and xerostomia in the elderly (Niedermeier et al., 2000). Importantly, 
ageing is associated with signs of damage to many proteins including the Ca2+ 
handling proteins (Puzianowska-Kuznicka and Kuznicki, 2009). Of specific 
interest, studies have clearly demonstrated age-related cytosolic Ca2+ signal 
modulation in the aging parotid glands (Mahay et al., 2004, Salih et al., 1997, 
Maki et al., 1989). These studies suggested impaired or altered IP3-induced Ca2+ 
release from the ER in the aging parotid acinar cells, which in turn declined 
calcium influx machineries (Mahay et al., 2004).  
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Drugs are reported to induce dry mouth (Sreebny and Schwartz, 1997, 
Guggenheimer and Moore, 2003). Furthermore, xerostomia has been considered 
as a side effect of different classes of antihypertensive therapies (Nonzee et al., 
2012). In particular, Hattori et al., suggested that the calcium channel blockers 
which are clinically administered for hypertension, can cause dry mouth by 
inhibiting the non-selective cation and voltage-dependent Ca2+ channels that are 
involved in resting salivation (Hattori and Wang, 2007). 
Reactive oxygen species (ROS) are critical intracellular signalling factors that 
control cellular metabolism. However, high ROS levels exceeding the cellular 
antioxidant capacity cause detrimental effects with pathological consequences 
(Gorlach et al., 2015). ROS can be generated in irradiated salivary glands, that 
can lead to long-term irreversible dysfunction (Ambudkar and Muallem, 2016). In 
response to irradiation, the transient receptor potential melastatin-like 2 
(TRPM2); a Ca2+-permeable non-selective cation channel, is activated by ROS 
metabolites (Di et al., 2012) and contributes to irreversible salivary gland 
dysfunction by enhancing Ca2+ entry in salivary gland cells (Liu et al., 2013). In a 
variety of cell types, Ca2+ entry via TRPM2 has been associated with increased 
cell death and apoptosis (Ambudkar and Muallem, 2016).  
Diabetes: xerostomia and pathological thirst (polydipsia) are two closely related 
complaints among diabetic patients which have been associated with impaired 
functions of the salivary glands (Fedirko et al., 2006). Due to the substantial 
[Ca2+]i changes recorded in different cell types (Biessels et al., 2002, Kruglikov et 
al., 2004, Lagadic-Gossmann et al., 1996) and the altered Ca2+-ATPase activity 
and expression in other tissues (Balasubramanyam et al., 2001, Evcimen et al., 
1999, Vetter et al., 2002, Kim et al., 2001), Ca2+ dysregulation is currently 
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considered a basic pathology associated with diabetes complications. 
Importantly, experimental studies on diabetic rats revealed a marked decrease in 
saliva flow, protein content and amylase activity in response to pilocarpine 
stimulation, which paralleled abnormalities in acinar cell Ca2+ signalling (Fedirko 
et al., 2006, Murai et al., 1996, Watanabe et al., 2001). Furthermore, Fedirko, 
Kruglikov et al. 2006, described dramatic changes in Ca2+ homeostasis and 
signaling in acinar cells of rat submandibular salivary gland after 6–7 weeks of 
Streptozotocin-induced diabetes (Fedirko et al., 2006). Ca2+ alterations in the 
diabetic model comprised: (i) increased sensitivity and Ca2+-mobilizing ability of 
muscarinic receptors, (ii) increased Ca2+ influx across the PM through the G-
protein coupled Ca2+ channel; TRP6 and (iii) elevated resting [Ca2+]i levels. 
Moreover salivary gland acinar cells from the diabetic rats exhibited delayed 
clearance of IP3-induced Ca2+ signals, slower replenishment of [Ca2+]ER and 
diminished endoplasmic reticulum calcium [Ca2+]ER content. These later findings 
were all substantiated to be related to dramatic reduction in the Ca2+ transporting 
abilities of both PMCA and SERCA pumps. 
Sjӧgren’s syndrome (SS) is a chronic autoimmune disease that results in 
lymphocytic infiltration and loss of secretory function in salivary and lacrimal 
glands (Nikolov and Illei, 2009). However, dysfunctional SGs of SS patients 
poorly correlate with inflammation (Shen et al., 2013, Xuan et al., 2013). Early 
studies have shown the upregulated expression of inducible nitric oxide synthase 
(iNOS) in the labial salivary glands of patients with SS when compared to healthy 
controls (Konttinen et al., 1997).  Nitric oxide (NO) production from iNOS is known 
to be long-lasting and at relatively high concentrations when compared to the 
other two isotypes; endothelial (eNOS) and nNOS (Nathan and Xie, 1994).  
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Experiments which investigated the outcome of prolonged exposure of acinar 
cells to nitric oxide reported declined responsiveness of these cells to 
acetylcholine (Dawson et al., 2006), by desensitizing their receptors to stimulation 
(Caulfield et al., 2009). Furthermore, high levels of NO in SS patients (Caulfield 
et al., 2009, Konttinen et al., 1997, Ludviksdottir et al., 1999, Wanchu et al., 2000, 
Pertovaara et al., 2007) have been implicated in NO-mediated s-nitrosylation of 
receptors or other proteins involved in the Ca2+ evoked secretion signal (Caulfield 
et al., 2009). S-nitrosylation is the coupling of NO moiety to a reactive cysteine 
thiol to form an S-nitrosothiol; SNO, which ultimately alters the protein structure 
and function (Stamler et al., 1992a, Stamler et al., 1992b). 
More recently, an important advancement in understanding the signal alteration 
underlying functional loss in SS patients, emerged from data which provided 
definitive evidence that IP3R deficits in acinar cells and subsequent decrease in 
neurotransmitter-stimulated Ca2+ signalling trigger the secretory dysfunction in 









1.3 SG Infections (Sialadenitis) 
1.3.1 General Risk Factors  
Primary mechanisms predisposing to acute infections of the salivary glands 
involve: (i) stasis of flow and (ii) retrograde contamination by bacterial flora from 
the oral cavity (McQuone, 1999). The most prevalent inciting factor in stasis of 
flow is dehydration which is commonly seen: in postoperative patients, in those 
taking particular medications with xerostomia side effects like antihistamines and 
in post-irradiated patients or with certain medical conditions like hepatic and renal 
failures and diabetes mellitus (McQuone, 1999). Interestingly, the reduced 
secretion rate may also be initiated by an autoimmune mechanism (SS) or some 
other process, which is probably either developmental or related to a previous 
virus infection (Banks, 1968). Mechanical obstruction (sialoliths) is another factor 
which precipitates stasis of flow. Sialoliths are more commonly seen in the 
submandibular ductal system (McQuone, 1999), because of the more viscous 
(worsened in a dehydrated state) glycoprotein consistency, upward course of the 
duct, and higher concentrations of calcium carbonate and calcium phosphate 
than are found in the parotid glands (Knepil and Fabbroni, 2008).  
Even with 85% to 90% of sialoliths being found in the submandibular glands, 
sialadenitis remains more prevalent in the parotid glands. This preferential 
predominance is due to the parotid gland fulfilling both risk factors mentioned 
beforehand. First, the relatively long, narrow parotid duct which is adapted to thin 
serous secretions is readily obstructed by small calculi or even by mucus plugs 
formed as a result of change in the content of the saliva, which is known to occur 
in certain circumstances (Patey, 1966).  
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This in addition to the secretory composition variances in both glands; the parotid 
glands secretion which is mostly serous, contain a higher concentration of 
fibronectin, which promotes the adherence of Streptococcus and S aureus 
around the ductal orifice (Mandel and Surattanont, 2002). Alternatively, the 
greater proportion of mucinoid substance in the sublingual and submandibular 
glands contains lysosomes, immunoglobulin A antibodies, and glycoproteins that 
bind epithelial cells and competitively inhibit bacterial attachments (McQuone, 
1999). 
1.3.2 Viral SG Infections 
A long association has been established between viral infections and diseases of 
the salivary gland, which respond by reduced saliva production and/or swelling 
(Jeffers and Webster-Cyriaque, 2011). Although all salivary glands are 
susceptible to viral infection, the parotid and the submandibular glands are most 
prone (Chandak et al., 2012). Furthermore, murine models of viral infection have 
demonstrated that the SG is a unique site in regards to virus–cell interactions. 
Assisted by the abundant capillary supply and extraordinary high rate of blood 
flow (Lu and Jacobson, 2007), viruses can reach the SGs as a consequence of 
secondary viremia, with blood monocytes playing a major role in dissemination 
(Stoddart et al., 1994). Furthermore, in these viral models, the SGs maintained a 
chronic infection, with the infectious virus replicating for months after viral 
clearance from all other organs. Interestingly, the persistent virus was selectively 
sequestered in vacuoles of glandular acinar epithelial cells (Jonjic et al., 1989), 
suggesting that the host immune response to viruses at mucosal sites, like the 
SGs, may be different from systemic immunity; in that clearance is protracted and 
the incidence of reactivation is high (Lu and Jacobson, 2007). 
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1.3.3 Viruses Implicated in SG Pathology 
Mumps is the most common viral SG infection, and the profound xerostomia 
produced by mumps is well recognized  (Banks, 1968). It is caused by a single 
stranded RNA virus belonging to the genus Rubula virus and the family 
Paramyxoviridae. In humans, mumps is the most common cause of non-
suppurative acute sialadenitis; 85% of cases occur in children younger than 15 
years (McQuone, 1999).  
It has no animal reservoir and is therefore purely a human disease (Senanayake, 
2008). The disease is highly contagious and spreads by airborne droplets from 
salivary, nasal, and urinary secretions. There is a primary viral infection of the 
oral cavity, after which the virus replicates within the upper respiratory tract and 
local reticuloendothelial and lymphoid systems. Subsequently, there is a period 
of 7–10 days of viremia, during which other organs can become infected (Singh 
et al., 2006).  Symptoms include acute onset of unilateral or bilateral tender, self-
limited swelling of the parotid gland, lasting two or more days without other 
apparent cause. In 10% of cases, other salivary glands may also be involved 
(Senanayake, 2008).  
Discovered in cultured Burkitt's lymphoma cells (Epstein et al., 1964), Epstein-
Barr virus (EBV) is an enveloped DNA herpesvirus that is transmitted by saliva 
and is shed even in apparently healthy subjects (Gerber et al., 1972). 
Identification of EBV in chronic nonspecific sialadenitis, Warthin's tumour and 
lymphoepithelial carcinoma, is highly suggestive of its role in these lesions (Kim 
et al., 1999). EBV infects the oropharyngeal epithelium and replicates there. Then 
it infects the surrounding B lymphocytes in a form of latent infection. The infected 
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B lymphocytes then re-infect the epithelial cells of other tissues via circulation in 
the blood (Hatton et al., 2014).  
In addition to the large percentage of Human Immunodeficiency Virus (HIV)-
infected patients which have been reported with SS-like conditions and dry mouth 
(Ulirsch and Jaffe, 1987), Human immunodeficiency virus-associated salivary 
gland disease (HIV/SGD) is another oral manifestation of HIV infection (Schiodt 
et al., 1989).  A low, unstimulated, whole-saliva flow rate has been associated 
with HIV/SGD (Grimoud et al., 1998, Flaitz et al., 1998). In addition, quantitative 
changes have been detected in saliva of HIV/SGD patients; such as lower 
secretory rates of sodium, calcium chloride, cystatin, lysozyme, and total anti-
oxidant capacity, which affect the homeostasis of the oral cavity and account for 
significant morbidity during the progression of HIV disease (Lin et al., 2003). 
Histologically, HIV/SGD is characterized by hyperplastic, intra-parotid lymph 
nodes and/ or predominant CD8+ T-cells peri-ductal lymphatic infiltrates. 
Histochemical analysis has revealed acinar atrophy, ductal dilation, and mild to 
moderate fibrosis with collagen deposition (McArthur et al., 2003).  
Several DNA, RNA and retroviruses have been considered important co-factors 
in the development of SS. In fact, two mechanisms have been reported to 
correlate viral infections to development of SG autoimmunity. Viral proteins 
exhibiting structural or functional molecular mimicry with host components can 
result in production of autoantibodies in SS patients (Navone et al., 2005). 
Moreover, activation of the innate immune responses upon viral recognition, 
results in a prolonged inflammatory response that may lead to chronic 
inflammation with activation of adaptive immune responses (Francis and Perl, 
2010). Whereas the DNA viruses that have been studied in association with SS 
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are cytomegalovirus (CMV) and EBV (Saito et al., 1989, Mariette et al., 1991, 
Maitland et al., 1995), the RNA viruses detected within the salivary glands of SS 
patients are hepatitis C (HCV) and Coxsackie virus (Triantafyllopoulou et al., 
2004, Carrozzo, 2008). Table 1-3 lists the viruses which are related to salivary 
gland diseases (Jeffers and Webster-Cyriaque, 2011). 
 
Table 1-3 Viruses Detected in SGs (Jeffers and Webster-Cyriaque, 2011) 
Virus Associated Disease(s) 
BK virus (polyomavirus family) HIV-SGD 
Paramyxovirus Mumps 
Human immunodeficiency virus 
(HIV) 
HIV-SGD, SS 
Epstein-Barr virus (EBV) Benign Lymphoepithelial Cysts (BLC), salivary gland 
tumors, SS 
Cytomegalovirus (CMV) Sialadenitis 
Coxsackie virus SS 
Human T-lymphotropic virus 
(HTLV) 
SS 
Human herpes virus 6 (HHV-6) Parotitis 
Human herpes virus 7 (HHV-7) Parotitis 
Kaposi sarcoma virus (KSHV) Warthin’s tumor, SS-associated parotid MALT 
lymphomas 
Influenza Parotitis 
Parainfluenza virus (PIV) Parotitis 
Guinea pig CMV Guinea pig CMV infection 
Hepatitis C SS 
Mouse CMV (MCMV) Acute and chronic SGD 
Mouse polyomavirus (PyV) Mouse parotid tumor 







1.3.4 Double Stranded (ds) RNA 
Invading pathogens are recognized by several innate receptors, termed pattern 
recognition receptors (PRRs), which are located both at the cell surface and intra-
cytosolic. These sensors function to generate immune responses against 
conserved structures on microorganisms, known as pathogen-associated 
molecular patterns (PAMPs) (Melchjorsen, 2013).  Albeit the diversity of viral 
PAMPs; which include: surface structures, genomic material, and capsids, the 
intermediates generated during the replication cycle can also constitute PAMPs. 
In fact, the dsRNA produced during the replication of many RNA and DNA viruses 
(Kawai and Akira, 2007) is considered a hallmark PAMP and the most potent viral 
trigger of innate immune signalling (Nellimarla and Mossman, 2014). 
1.3.4.1 Origin of dsRNA 
It has been commonly assumed that the major source of cellular dsRNA is viral 
infections (Wang and Carmichael, 2004). Viruses possess unique long stretches 
of dsRNA (Brencicova and Diebold, 2013), the origin of which is diverse. RNA 
viruses with double-stranded genomes induce the innate immune response 
through their genome itself. This property, however, is not exclusive to these 
viruses, and as mentioned beforehand, it is generally accepted that most viruses 
also produce dsRNAs when replicating (Jacobs and Langland, 1996). While it 
was suggested that the electronegative properties of dsRNA would limit its ability 
to disseminate (Majde, 2000), studies reported travel of dsRNA between cells 
and tissues in plants and nematodes (Obbard et al., 2009). Similarly, in 
Drosophila, studies have reported that viral dsRNA travels from the site of 
infection and induces antiviral responses in neighbouring or uninfected cells 
(Saleh et al., 2009). 
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As opposed to viral dsRNAs, which are often much longer, endogenous (self) 
dsRNAs are commonly found in short stretches (<20bp) (Kato et al., 2008). Self 
dsRNA can arise from microRNAs (miRNAs) which are constantly synthesized 
by the cell (Gantier and Williams, 2007). Micro-RNAs represent an abundant and 
important class of noncoding RNA species, which can enter the sequence-
specific RNA interference (RNAi) pathway, where they mediate the destruction of 
targeted mRNAs (Rana, 2007). In addition to microRNA, necrosis in the absence 
of infection also releases self dsRNA, leading to inflammatory and autoimmune 
responses (Nellimarla and Mossman, 2014). 
In the laboratory, most studies utilize dsRNA substitutes to look at the dsRNA-
mediated-IFN antiviral response in a reproducible manner (DeWitte-Orr and 
Mossman, 2010). Synthetic poly(I:C), which consists of stretches of inosine and 
cytidine forming dsRNA-like motifs (Michelson et al., 1967), has been extensively 
used since its discovery, half a century ago, to mimic viral dsRNA. Both animals 
and humans develop an acute phase response characteristic of viral infections 
following treatment with poly (I:C) (Caskey et al., 2011). Moreover, studies have 
demonstrated that a single local administration of poly (I:C) induces inflammatory 
responses in the lungs of mice similar to that observed in the lungs of patients 
with chronic obstructive pulmonary disease (Harris et al., 2013). Also, poly (I:C) 
was shown to play a significant role in disruption of self-tolerance and 
establishment of an autoimmune response as seen in poly (I:C) induced 




1.3.4.2 Uptake of dsRNA 
Poly (I:C) internalization is the best studied model of dsRNA uptake in both in 
vitro and in vivo studies. Poly (I:C) is internalized into cells through clathrin-
mediated endocytosis and delivered to endosomal TLR3 and to cytoplasmic 
MDA5 (melanoma differentiation-associated gene 5) (Kato et al., 2008). Previous 
studies confirmed that the cytoplasmic lipid raft protein; raftlin, is essential for poly 
(I:C) cellular uptake in human myeloid DCs and epithelial cells. In raftlin 
knockdown cells, poly (I:C) neither enters the cell nor activates TLR3 and MDA5, 
further indicating that cellular uptake is a prerequisite for dsRNA-induced cellular 
responses. Upon poly (I:C) stimulation, raftlin migrates from the cytoplasm to the 
cell surface, where it associates with the clathrin–AP-2 (clathrin associated 







Figure 1.12 Extracellular poly (I:C) uptake. 
Poly (I:C) is recognized by cell surface uptake receptor and 
delivered to the TLR3-resident endosomes through Rarftlin- and 
clathrin-dependent endocytosis. Upon ligand recognition, TLR3 
activates IRF3 and NF-κB via TICAM-1, leading to production of 
type I IFN and inflammatory cytokines, respectively. Adapted from 
(Misako Matsumoto, 2016)  
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Furthermore, studies have shown that class A scavenger receptor (SR-As); a cell 
surface pattern recognition receptor (PRR), is critical for poly (I:C) induction of 
inflammatory responses (Limmon et al., 2008). In fact, the ubiquitously expressed 
SR-As mediate dsRNA entry via clathrin-mediated endocytosis, delivering them 
to intracellular dsRNA-binding proteins and inducing antiviral responses both in 
vitro and in vivo (DeWitte-Orr et al., 2010). The role played by scavenger 
receptors was further confirmed by studies which showed that downregulation of 
these critical sensors inhibited dsRNA uptake (Rocha et al., 2011). 
Other different mechanisms of dsRNA uptake have been reported: while uptake 
by B cells is mediated through their B-cell receptor (BCR) (Leadbetter et al., 
2002), bone marrow derived macrophages (BMDMs) depend on CD14 for dsRNA 
internalization (Lee et al., 2006). Finally, CD11b has also been found to 
essentially facilitate the internalization of poly (I:C) in peritoneal macrophages 




1.3.4.3 Innate Sensing of dsRNA  
It has been known for many years that introduction of synthetic or naturally 
occurring dsRNAs into the cytoplasm can trigger nonspecific and global immune 
responses in animals (Cunnington and Naysmith, 1975). Since dsRNA is the 
most potent trigger of the innate immune system, it is not surprising that cells 









1.3.4.3.1 Toll-like receptor (TLR) 
TLRs were the first PRRs to be identified and have been most thoroughly studied 
(Lester and Li, 2014). First acknowledged in Drosophila, the Toll receptor was 
shown to be important for host defence against fungal infection (Lemaitre et al., 
1996). Subsequently, 15 subfamilies of TLRs have been identified in vertebrates 
(Takeda et al., 2003b). These transmembrane receptors, which localize to both 
the PM and endolysosomal compartments (figure 1.14), play key roles in 
development, homeostasis and injury repair (Ramnath et al., 2016). 
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Each TLR is specialized in recognition of distinct PAMPs among which TLR3, 7, 
8 and 9 recognize foreign nucleic acids (Blasius and Beutler, 2010). TLR7 and 
TLR8 recognize virus-derived ssRNA (Diebold et al., 2004, Heil et al., 2004, Lund 
et al., 2004), while TLR9 recognizes microbial non-methylated CpG-containing 
DNA (Hemmi et al., 2000). TLR3 is the only TLR that recognizes virus-derived 
dsRNA and its synthetic analogue, poly (I:C) (Alexopoulou et al., 2001), as well 





Figure 1.14 TLRs  
TLRs are membrane-bound receptors localized at the cellular or 
endosomal membranes, recognizing PAMPs via the leucine-rich 
repeats (LRR) domain and transducing signals to the intracellular 




1.3.4.3.1.1 TLR3 Structure and Ligand Binding 
TLR3 is a type I integral transmembrane glycoprotein. Similar to all TLRs, TLR3 
possess an extracellular domain or ectodomain (ECD) comprising 19–25 tandem 
copies of leucine-rich repeats (LRRs), a transmembrane domain, and an 
intracellular Toll/IL-1 receptor (TIR) domain (Akira and Takeda, 2004) (figure 
1.17). The crystal structure of the TLR3 ectodomain resembles a long solenoid 
bent into the shape of a horseshoe, of which one face is largely masked by 
carbohydrate, whereas the other is unglycosylated. Each turn of the solenoid 
corresponds to a single LRR sequence from a total of 23 leucine-rich repeats 
(Bell et al., 2005). Binding of dsRNA to TLR3 induces the receptor to 
homodimerize (Liu et al., 2008), causing a structural rearrangement where the 
TIR domains come into close contact and provide a “platform” for the adaptor 
protein TIR domain-containing adapter protein inducing IFNβ (TRIF) (O'Neill and 
Bowie, 2007), figure 1.15. This structural re-organization is essential for ligand 









Figure 1.15 TLR3 Structure and Dimerization.  
TLR3 consists of an ECD containing: 23 LRRs and the N (N-terminal) and C (C-
terminal) regions, the transmembrane domain, the cytoplasmic linker region and the 
TIR (Toll–IL-1 receptor) domain. The TIR domain is critical in signalling of TLR3 
through interaction with downstream signal adaptor molecules. dsRNA interacts with 
both an N- and a C-terminal-binding site of each TLR3 ECD (Liu et al., 2008). The two 
LRR-CT regions come together, which is essential for stable receptor–ligand complex 








Several studies using different lengths of the preferential TLR3 ligand; poly(I:C), 
indicated that longer duplexes of at least 40-50 bp are prerequisites to induce 
TLR3 signalling (de Bouteiller et al., 2005, Okahira et al., 2005). This length 
requirement would help avoid inappropriate recognition of cellular ssRNAs with 
short hairpin structures or mature siRNAs or miRNAs (Peisley and Hur, 2013). 
 
1.3.4.3.1.2 TLR3 Intracellular Trafficking and Maturation  
Endosomal TLR maturation is tightly regulated through a combination of receptor-
specific intracellular trafficking and proteolysis. The concept of TLR signalling 
being functionally intertwined with the cellular membrane trafficking machinery 
has received much attention in recent years (Barton and Kagan, 2009). However, 
despite great progress in the identification of the molecular components of TLR 
signalling pathways, still little is known about whether and how regulators of the 
endosomal/phagosomal trafficking system affect TLR signalling and function, 
particularly under inflammatory in vivo conditions. TLR9 resides predominantly in 
the ER in resting cells (Leifer et al., 2004) and reaches the acidic endolysosomal 
compartments after stimulation by dsDNA (Barton et al., 2006, Tabeta et al., 
2006). In contrast, TLR3 is continuously exported to the Golgi and accumulates 
in the endolysosomal compartments, where it undergoes a single cleavage by 
cathepsins and the two fragments remain associated without disruption even 




















Monoclonal antibodies generated against the TLR3 ectodomain revealed that at 
steady state, there exists three forms of TLR3: a full length, 130 kDa highly 
glycosylated TLR3, a C-terminal fragment observed after cathepsin cleavage and 
another isoform which is predicted to represent the N-terminal fragment of 
cleaved TLR3 (Garcia-Cattaneo et al., 2012, Toscano et al., 2013, Murakami et 
al., 2014). Furthermore, immunoblotting analysis revealed the increased 
expression levels of the cleaved C-terminal fragment of TLR3 following exposure 
to poly (I:C).  
Figure 1.16 Proposed model of TLR3 trafficking and maturation.  
(1) TLR3 is neosynthesized and N-glycosylated in the ER. (2) it crosses the Golgi apparatus 
where it is fully glycosylated to become EndoH resistant. TLR3 exits the Golgi to enter the 
endosome membrane where it is cleaved by cathepsins (3). The two proteolytic fragments remain 
associated to fully signal (4) (Toscano et al., 2013). Interestingly, acidified endosomes are 
required not only for cleavage of TLR3 but also for activation of cleaved TLR3, likely by inducing 
a conformational change required for signalling. The strongest response to dsRNA is achieved 
between pH 5.7 and 6.7 (de Bouteiller et al., 2005), which corresponds to endosomal pH range 
(Cain et al., 1989). As with other endosomal TLRs, TLR3 trafficking and subsequent cleavage 
and signalling, depend on the transporter protein UNC93B1 (an ER chaperone with 12 
membrane-spanning domains). It interacts with transmembrane segments of TLR3 (Tabeta et al., 
2006). Beside its role in TLR3 trafficking, Unc93b1 is also important for TLR3 cleavage and 
stability by protection from ubiquitination and degradation (Qi et al., 2012). 
 













Importantly, it is the cleaved form of TLR3 that signals from endosomes upon 
ligand recognition in nonimmune (epithelial) and immune (MDDC) cells (Garcia-
Cattaneo et al., 2012). Based on the TLR3 3D structure, the predicted TLR3 
cleavage site has been localized within the region which encompasses the 
LRR12 flexible loop that protrudes from the lateral face of the ectodomain, hence 
it is potentially well exposed to proteases (Choe et al., 2005, Park et al., 2008) 










In epithelial cells, TLR3 cleavage depends on cysteine protease cathepsins B 
and H, as poly (I:C)-dependent TLR3 signalling is inhibited and cleavage is 
reduced in cells exposed to the cathepsin inhibitor; z-FA-fmk or silenced for both 




Figure 1.17 TLR3 cleavage.  
It occurs at the LRR 12 loop facilitated by its 
structural protrusion from the helix and exposure 
to the endolysosomal cysteine proteases. 
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1.3.4.3.1.3 TLR3-Mediated Innate Immune Responses  
As formerly mentioned, TLR3 is assembled in the endoplasmic reticulum, from 
where it is recruited to endosomes by the transmembrane protein UNC93B1 (Kim 
et al., 2008). Although TLR3 signals exclusively via the TRIF pathway, all other 
TLRs use the adaptor MyD88. The alanine residue present in the TLR3 TIR 
domain plays a major role in this uniqueness, as evidenced by mutation of TLR3 
Ala795 into a proline; present in other TLR TIR domains, which resulted in 
MyD88-biased signalling (Verstak et al., 2013). The cascade of events triggered 
upon TLR3 engagement by its ligands; example poly (I:C), commences by the 
receptor homodimerization and recruitment of TRIF (Kaisho and Akira, 2006, 
O'Neill and Bowie, 2007), after which TLR3 signalling diverges into several 












Figure 1.18 TLR3 Signalling Pathway 
(Ramnath et al., 2017) 
61 
 
TRIF activates the serine/threonine tank binding kinase-1 (TBK-1), which directly 
binds to and phosphorylates IRF3 (Sato et al., 2003). Phosphorylated IRF3 
(pIRF3) dimerizes and translocates to the nucleus and leads to the transcription 
of IFN-β (Honda and Taniguchi, 2006, O'Neill and Bowie, 2007). IFN-β signals in 
an autocrine fashion to activate the transcription factors signal transducer and 
activator of transcription (STAT) 1 and 2, resulting in the activation of type I IFN 
stimulated genes (ISGs) and subsequent anti-viral responses (Platanias, 2005).  
In addition, the transcription factor NF-κB is induced through TLR3 stimulation 
(Kaisho and Akira, 2006, Gauzzi et al., 2010, Sen and Sarkar, 2005, O'Neill and 
Bowie, 2007, Matsumoto et al., 2011). The C-terminal region of TRIF contains a 
receptor-interacting protein homotypic interaction motif (RHIM), which is essential 
for its interaction with the serine/threonine kinase receptor-interacting protein 
kinase (RIPK)1 (Meylan et al., 2004). RIPK1 interacts with TRAF6 which 
polyubiquitinates transforming growth factor β activated kinase 1 (TAK1) and IκB 
kinase-related kinase γ (IKKγ) (Jensen and Thomsen, 2012). IKKγ directly 
associates with IKKα and IKKβ, while TAK1 forms a complex with TAK1 binding 
proteins 1, 2, and 3 (TAB1, 2, and 3) and then phosphorylates IKKβ (Brown et 
al., 2011). The activated IKK complex then phosphorylates IκBα facilitating its 
ubiquitination and degradation, and the release and activation of NF-κB (Jensen 
and Thomsen, 2012, Gauzzi et al., 2010, Mathes et al., 2008). The TRIF-RIPK1 
axis is a central control point in cell survival/death pathways, since RIPK1 also 
associates with Fas-associated death domain (FADD), via a death domain 
interaction (Kaiser and Offermann, 2005). This subsequently leads to the 
assembly of a death-inducing signalling complex that contains caspase-8.  
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Homodimerized caspase-8 undergoes autocatalytic processing and activation, 
leading to RIPK1 cleavage and inactivation, followed by apoptotic cell death. 
However, if caspase-8 heterodimerizes with a non-catalytically active homologue 
of caspase-8, FLICE-like inhibitory protein, it is partially activated. This complex 
is not able to cleave RIPK1 adequately to cause apoptosis, and therefore 
mediates cell survival (Kaiser and Offermann, 2005). Furthermore, if caspase-8 
activity is compromised, RIPK1 cleavage is completely prevented, thereby 
allowing it to interact with RIPK3 to form a necrosome, leading to necroptotic cell 
death (Kaiser et al., 2011, Oberst et al., 2011). Thus, RIPK1 acts as a central 
signalling hub in dictating whether TLR3 signalling promotes survival, apoptotic 
cell death or necroptotic cell death. Importantly, TLR-3 induced apoptotic cells 
discharged into the extracellular space, will release endogenous death 
associated molecular patterns (DAMPs), exposing molecular hydrophobic 
portions that were normally hidden in a healthy living cell. DAMPs are a rapidly 
growing class of potent inflammatory stimuli. They act in an autocrine manner, 
alerting the host of damage, but can also amplify inflammation leading to further 
tissue damage (Prince et al., 2011).  
  
1.3.4.3.2 RIG-I-Like Receptors, RLRs 
The RLR family is another cytosolic dsRNA sensor comprising 3 closely related 
members of RNA helicases, RIG-I, MDA-5, and LGP2, which can detect 
cytoplasmic dsRNA, generated during replication of RNA viruses (Kawai and 
Akira, 2008, Loo and Gale, 2011, Dixit and Kagan, 2013). All 3 members contain 
centrally located RNA helicase domains, whereas RIG-I and MDA5, but not 






The helicase domain is responsible for the recognition of RNA, whereas the 
CARD domains are required for downstream signalling. LGP2, which lacks the 
CARD domains, cooperates with RIG-I and MDA-5 and enhances their functions 
(Moresco and Beutler, 2010, Satoh et al., 2010, Childs et al., 2013). Studies have 
shown that the length of dsRNA is a determinant for the recognition by specific 
RLRs; RIG-I and MDA-5 can preferentially detect short and long dsRNA species, 
respectively (Kato et al., 2008).  Since poly (I:C) is a mixture of various lengths of 
RNA species, it can be recognized by both RIG-I and MDA-5 (Chattopadhyay 
and Sen, 2014). Upon activation by cytoplasmic dsRNA, RIG-I and MDA-5 
activate downstream signalling via the CARD containing adaptor protein IPS-1, 
which binds to them through CARD–CARD interaction (Bruno Miguel Neves, 




Figure 1.19 RLR structural domains  















1.3.4.3.3 dsRNA-activated protein kinase (PKR) 
PKR is a central player in the cytoplasmic response to dsRNA. PKR is an 
interferon-inducible, dsRNA-activated Ser/Thr protein kinase (Clemens, 1997, 
Proud, 1995). This enzyme is normally present only at low levels in cells and 
exists in an unphosphorylated, inactive form (Hovanessian, 1989, Samuel, 1991). 
When dsRNA binds to PKR, this induces its dimerization, auto-phosphorylation 
and activation (Wang and Carmichael, 2004). Consequently, pPKR 
phosphorylates a number of substrates, the most important of which is the 
eukaryotic initiation factor 2 (eIF-2α) (Samuel, 1979), which results in global 
cellular inhibition of protein synthesis (Samuel, 1993).  
Figure 1.20 RLR signalling.  
RIG-I and MDA5 function as cytosolic sensors of short and long 
dsRNAs, respectively. Binding of dsRNAs to these receptors 
activates signalling through the adaptor protein IPS-1, located in 
the outer mitochondrial membrane or on peroxisomes. 
Mitochondrial IPS-1 leads to activation of NF-κB and IRF3/IRF7 
through the IKK complex and TBK1/IKKi, respectively, which 
results in the production of inflammatory cytokines, type I 
interferons and interferon-stimulating genes (ISGs). In turn, 
peroxisomal IPS-1 induces early expression of ISGs via 
transcription factor IRF1 (Bruno Miguel Neves, 2012).  
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The activation of PKR is independent of the sequence of dsRNAs but depends 
on both their concentration and on their length. PKR is activated by low 
concentrations of dsRNAs but inhibited by higher concentrations (Samuel 1993). 
Activated PKR can mediate signal transduction in response to dsRNAs (Proud, 
1995), figure 1.21. In addition, there is evidence that dsRNAs can trigger 
apoptosis through PKR (Gil and Esteban, 2000) by activation of the Fas-
associated death domain/caspase 8 pathways (Balachandran et al., 1998) or of 












Figure 1.21 dsRNAs can bind to and activate PKR.  
Activated PKR phosphorylates a number of targets, including 
the translation factor eIF2, leading to translation inhibition.  It can 
phosphorylate IκB, releasing it from the transcription factor NF-
κB, which can now be translocated to the nucleus, where it 
activates the expression of genes having NF-κB binding sites. 
These genes include beta interferon (Thanos and Maniatis, 
1995), Fas (Donze et al., 1999), p53 (Cuddihy et al., 1999), Bax 
(Gil and Esteban, 2000), and others (Williams, 2001).  
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1.3.4.3.4 2’,5’-AS/RNase L. 
In addition to the PKR pathway, the 2’,5’-oligoadenylate synthetase (2’,5’-
AS)/RNase L pathway responds to dsRNA. IFN signalling leads to the induction 
of oligoadenylate synthetases (OAS1), which following activation by long double 
stranded RNA (dsRNA), generates 2’-5’-linked oligoadenylates (2-5A) 
(Hovanessian, 2007). 2-5A then binds to RNase-L, leading to its dimerization and 
enabling its nuclease activity (Tanaka et al., 2004). RNase L, which is a widely 
expressed cytoplasmic endoribonuclease, catalyses the degradation of viral and 
cellular RNAs (Li et al., 1998), including mRNAs, thus inhibiting protein synthesis 














Figure 1.22 2',5'-oligoadenylate synthetase 1 (OAS1)  
OAS1 is expressed at low constitutive levels and is upregulated by type I interferons (IFNs). OAS1 
protein accumulates in the cell cytoplasm as an inactive monomer. Following activation by 
dsRNA, the enzyme oligomerizes to form a tetramer that synthesizes 2',5'-oligoadenylates (using 
ATP as a substrate) that, in turn, activates the constitutively expressed inactive ribonuclease L 
(RNaseL). RNase L then forms a crossed dimer and degrades RNA that is of both cellular and 
viral origin, leading to the inhibition of viral propagation (Hornung et al., 2014). 
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1.4 Aims of The Study 
A long association has been established between viral infections and diseases of 
the salivary gland. However, the mechanism(s) by which primary viral infections 
can induce glandular injury and compromise the secretory machinery are not well 
understood. Previous studies demonstrated that multiple systemic injections of 
poly (I:C) in SS prone NZB/WF1 mice, resulted in loss of glandular function 
(Nandula et al., 2013, Deshmukh et al., 2009). These studies hypothesized the 
involvement of cumulative effects of type I IFN production and other inflammatory 
cytokines in the perceived glandular hypofunction (Deshmukh et al., 2009).  
The aims of this study were: 
1-To develop a viral mimic model based on direct injection of poly (I:C) into the 
SMGs and activation of local exocrine innate immunity, ruling out any possible 
extraneous impacts arising either from systemic delivery responses or 
autoimmune susceptibility of mice.   
2- To utilize the SG model to verify the initial impact of these types of infections 
on the functional responses of the glands. 
3- To comprehensively characterize the early molecular events and innate 
immune signalling pathways that can be triggered by viruses and potentially 
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2.1 Viral Mimic Model Development 
Female C57BL/6 mice, weighing 18-21 grams (Harlan Labs Ltd., Loughborough, 
UK), were aged between 10-12 weeks at the start of the experiments. They were 
housed in a temperature-controlled environment under a 12 h light–dark cycle 
with free access to food and water. All procedures were approved by the local 
ethics committee, and performed in accordance with the Home Office license. 
Female mice were chosen due to studies suggesting that they possess the 
combined capacity of: (1) heightened sensitivity to infectious and injurious stimuli 
(in the form of increased number of tissue macrophage with a greater density of 
pathogen/injury-sensing TLRs), (2) more efficient phagocytosis and NADPH 
oxidase-mediated killing by resident macrophage that eliminate pathogens faster 
than in males and (3) increased population of resident anti-inflammatory T-
lymphocytes that selectively prevent excessive macrophage-derived cytokine 
production without affecting phagocytosis. Based on these findings, the 
mechanisms that regulate leukocyte function in females are more efficient to that 
in males as rapid detection and elimination of pathogens increases the threshold 
for pathogen-induced tissue injury in females (Scotland et al., 2011). In addition, 
relative rarity of the granular convoluted tubules in the female submandibular 
glands, which were used in this study, render them histologically and functionally 
more comparable to the human glands.   
To develop the mouse model, we cannulated the mouse SMGs as previously 
performed in rats (Correia et al., 2010) and mice (Bombardieri et al., 2012). 
Submandibular glands were used in this study for ease of cannulation, in addition 
to the gland encapsulation, lacking in the mouse parotid glands, which makes it 
much easier to identify and excise all infiltrated and inflamed tissues. 
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Initially, a glass cannula (Supelco, 25715, PA- USA) was stretched over a flame 
(figure 2.1 A) and fitted into a polyethylene tube with 0.28 mm inner diammeter. 
Polyinosinic–polycytidylic acid sodium salt (P1530-25MG, Sigma-Aldrich) was 
then diluted in 0.9% saline solution to a final concentration of 4mg/ml. Towards 
consistent, visualised and flawless submandibular gland (SMG) injection, poly I:C 
was pre-mixed with Trypan blue (T8154-100ML-Sigma- Aldrich) prior to injection. 
Eighty micrograms of poly (I:C) in 20 µls were loaded in a 0.3 ml syringe (613-
4900, VWR International). Finally, the glass cannula, polyethylene tube and 









For recovery experiments, mice were anaesthetised intraperitoneally (i.p) with 0.1 
ml of combined 5 mg Ketamine/1 mg Xylazine. Under a stereomicroscope, the 
glass cannula was inserted into Wharton’s duct and poly (I:C) was injected slowly 
and constantly into the left SMG (Correia et al., 2010) (figures 2.3 A, B and C). 
The same volume of the vehicle (0.9% saline and Trypan blue) was delivered to 
the right SMG as a contralateral negative control. 
 
Figure 2.1 Pre-injection Set-up.  













Prior to tracheal exposure and endotracheal intubation, the animal was i.p 
anaesthetized with 150 µl of Pentobarbital Sodium (Euthatal, Merial) 1 mg/ml. A 
minor tracheal cut was performed and a polyethylene tube was inserted gently 
into the trachea to avoid asphyxia caused by accumulation of lung fluids during 
pilocarpine induced functional assessment. Skin incision over the mylohyhoid 
muscle was made and followed by gentle maceration of the posterior and medial 
fibres to form an oval shaped tissue slit over the submandibular and sublingual 
ducts. Through these surgical breaches, the submandibular ducts on both sides 
were medially and partially cut to avoid cutting of the laterally adjacent sublingual 
gland (SLG) ducts.  
Polyethylene tubes were fitted into the needles of two insulin syringes and a 
pilocarpine stock solution (Sigma Ltd) of 10 mg/ml was diluted in saline to 0.1 
mg/ml from which 0.1 ml was injected i.p. to stimulate salivation. The tissue slits 
were flushed briefly with saline and local anaesthetic to avoid contamination of 
the streamed saliva with any blood or tissue fluids.  
Figure 2.2 SMG Retrograde Ductal Injection.  
A: Microscopic depiction of pre-fabricated glass cannula inserted into Wharton 
Duct for poly (I:C) delivery B:  Left SMG with clear Trypan blue-poly (I:C) 
injection. C: Excised SMG showing specific retrograde SMG injection. 





After approximately 5-7 min post pilocarpine injection, saliva started flowing from 
the duct incisions and accumulating into the primed myelohoid cavities. Pooled 
saliva was drawn with the insulin syringes for 5 minutes and collected into pre-
weighed Eppendorf tubes (figures 2.3 A and B). The volume of collected saliva 
calculated (1mg = 1μl saliva) was used to assess the flow rate expressed as μl 
saliva/min. for different experiments in the present research, saliva was collected 






The SMGs were carefully excised and dissected from the SLGs, then weighed 
on a sensitive balance and sectioned. Tissues for histopathologic examination 
and immunohistochemistry were fixed in 10% neutral buffered formalin [50 ml 
37% formaldehyde, 450 ml distilled water, 3.25 gm sodium phosphate, dibasic 
(Na2HPO4), 2 gm sodium phosphate, monobasic (NaH2PO4)]. Other tissue pieces 
were stored in RNAlater® (R0901-100ml, Sigma-Aldrich) in -20°C freezer for 
future analyses (RTqPCR and protein analysis).  For calcium signalling and flow 
cytometry experiments, tissues were flushed with Dulbecco’s phosphate buffered 
saline (PBS) (D8537-100ml, Sigma-Aldrich) to eliminate hair and blood then 
preserved in Hanks’ Balanced Salt solution (H9394-100ML, Sigma-Aldrich) until 
reaching the appropriate facility where the experiments were conducted on the 
same day. 
Figure 2.3 Extraoral saliva collection.  
A: Myelohoid muscle slits enclosing the accumulated saliva. B: 




2.2 Histopathologic Examination 
Following formalin fixation, salivary gland tissues were briefly washed in distilled 
water, enclosed in uniquely numbered/labelled cassettes, rinsed in distilled water, 
drained and held in 70% alcohol while setting up the processing machine (Leica 
TP1020). Once the tissue processing was completed, cassettes were transferred 
into the embedding station (Leica TP1020) and salivary gland tissues were 
embedded and allowed to cool on the cold plate. After 30 mins, the blocks were 
removed from their base moulds and 5 µm sections cut with a microtome, 
mounted on glass slides and placed on a hot plate for a minimum of 1 hour. 
Paraffin is hydrophobic and impervious to aqueous solutions, so removal of the 
wax was done by immersing tissue sections in three changes of xylene (a 
hydrocarbon solvent), then hydrating them in three changes of absolute alcohol 
followed by thorough rinsing in water. Sections were stained in Mayer 
hematoxylin for 1 minute, blued in a weakly alkaline ammonia solution and 
submerged in aqueous eosin. Following eosin staining, slides were rinsed and 
passed through several changes of alcohol to remove all traces of water, then 
dipped in several baths of xylene to clear the tissues and render them completely 
transparent. A thin layer of DPX mounting medium was applied on each tissue 
section followed by a glass cover slip. Mounted tissue sections were ready to 
examine under light microscope attached to a digital camera, to capture 
significant histopathologic and morphologic changes following poly (I:C) and 





Three µm tissue sections were microtome cut and mounted on Superfrost™ Plus 
adhesive glass slides (10149870-Fisher Scientific Ltd) and placed on a hot plate 
for 1 hour. In order to standardize immunohistochemistry, increase staining 
intensity and reduce non-specific background staining, Trilogy™ (Cell Marque, 
Rocklin, CA-920P-06) was used for deparaffinization, rehydration, and 
unmasking (Chang et al., 2013) .  Slides were placed in a plastic rack and in a 
staining pot filled with approx. 800 ml of Trilogy™. Since this product performs its 
purpose only when boiled under pressure, the pot with slide rack was placed in 
an autoclave adjusted to boil at 121°C and chamber pressure approximately 15 
psi for 10 minutes. After the autoclave run came to an end, slides were retrieved 
from the Trilogy™ solution and washed thoroughly for 5 minutes with 1X TBS 
immunobuffer wash. Then slides were drained very briefly on absorbent tissue 
(all efforts should be made hence after to avoid tissue dryness and later on false 
positive results). To block endogenous peroxidase activity and avoid non-specific 
background reactions, sections were incubated in 3% hydrogen peroxide solution 
for 20-30 minutes. Slides were washed for 5 minutes in 1X TBS buffer and ringed 
using a delimiting ‘PAP’ pen (S2002-dako). To block non-specific epitopes on the 
tissue samples, sections were incubated with 1% BSA in 1X TBS and azide, 
pH7.6 for 5 minutes. The blocking buffer was flicked off and the primary antibody 
(see each relevant chapter) was applied at the appropriate working dilution 
overnight at 4°C. On the following day, slides were rinsed in 1X TBS and 
washed for 10 mins in 500ml 1X TBS. Excess solution was flicked off and 
sections were incubated for 60 mins at room temperature with a secondary 
antibody raised against the appropriate primary antibody host. Slides were then 
rinsed in 1X TBS and washed once for 10 mins in the 500ml 1X TBS.  
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Colour was developed for 5-10 mins in DAB solution (34002-Pierce™) and slides 
were washed under running tap water for 5 mins. Counterstaining was performed 
by dipping slides for 2 mins in Mayer haematoxylin and washing under a running 
tap until clear. Blue colour was developed with ammonia solution, and optimal 
intensity of nuclear staining under was checked light microscope. Slides were 
dehydrated by rinsing thoroughly in three changes of absolute alcohol, and 
cleared by dipping in 2 changes of xylene, 5 mins each. Slides were DPX-
mounted and left to set before thorough examination under the light microscope. 
2.4 Gland homogenization, Protein extraction and Western Blotting 
Tissues stored in RNAlater® were retrieved and weighed on a sensitive balance 
and placed in 2 ml lysing matrix tubes (Lysing Matrix D, 6913-100-MP 
Biomedicals) with cell lysis buffer (AA-LYS-10 ml- RayBiotech, Inc., Norcross, 
GA) and protease inhibitor cocktail (1:10 dilution, Calbiochem, UK). Tubes were 
fitted in FastPrep™ tissue homogenizer (MP Biomedicals Santa Ana, CA) 
carousel which was adjusted to allow sample disruption with the lysing beads in 
60 seconds (20 seconds X 3 intervals). Samples were briefly centrifuged at 4°C, 
this was followed by incubation on ice on a gentle rocker for 30 mins. 
Subsequently, protein homogenates were retrieved from the lysing matrix tubes 
and transferred to labelled Eppendorf tubes which were then sonicated on ice for 
5 minutes. Homogenized samples were centrifuged at 10,000 g for 20 mins at 
4°C and supernatants were collected without disrupting the pellet, aliquoted and 
stored at -80°C for later use. For accurate measurement of the extracted protein 
concentration, Qubit® 3.0 Fluorometer (Q33216, Invitrogen™, UK) was used. 
Three assay tubes for the standards and one for each sample were setup. 200 
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μL of Qubit® working solution was prepared by diluting the Qubit® reagent 1:200 









Homogenates were diluted 1:5 with distilled water and prepared for SDS-PAGE 
by mixing with DTT 1:10 and LDS 1:4. Tubes were centrifuged, vortexed and 
boiled at 100°C for 3 mins, during which running buffer (NP0002, Novex™) was 
prepared at 1:20. Samples were then electrophoresed on precast 4-2% SDS-
PAGE gel (NuPAGE® Novex™ Bis-Tris Gels, Invitrogen™ UK) at 200V and 
200mA for 35 mins. During this period, 0.2 µm pore–size nitrocellulose 
membrane (1620112, Bio-Rad, UK) were cut and soaked in buffer: 25 ml transfer 
buffer (BT00061, Novex™), 50 ml methanol and 375 ml distilled water, together 
with sponge pads and filter papers. Electro-transfer of proteins was done for 1 
hour according to standard protocol (Invitrogen, UK, Paisley) at 30V and 200mA.  
 
 
Figure 2.4 Outline for protein concentration measurement using Qubit® kit. 
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Following protein transfer, membranes were blocked with 5% bovine serum 
albumin (BSA) in TBS-T (20 mM TRIS, 150 mM NaCl, 0.1% Tween-20, PH 7.6), 
washed three times (5 minutes each) in TBS-T and incubated at 4°C overnight 
with the appropriate working dilutions of primary antibodies (will be mentioned in 
each relatable chapter) in blocking buffer. On the next day, the membrane was 
incubated with the recommended dilution of conjugated secondary antibody in 
blocking buffer at room temperature for 1 h followed by three washes of TBS-T, 
5 min each. For signal development, an Enhanced Chemioluminescence 
substrate (ECL, GE Healthcare, UK) was prepared following the kit 
manufacturer's recommendations and applied over the membranes. Excess 
reagent was flicked and positive and negative protein expression was assessed 
and captured using ChemiDoc™ MP System (Bio-Rad, UK).  
 
2.5 RTqPCR Analysis 
RNAlater® -stored SMGs were weighed and 5-15 mg of tissues were placed in 2 
ml lysing matrix tubes with 20X RNA-Bee™ and homogenized with FastPrep™ 
tissue homogenizer (MP Biomedicals Santa Ana, CA) for 60 seconds (20 
seconds X 3 intervals). RNeasy® Micro Kit (74004, Qiagen) was used for total 
RNA extraction according to the manufacturer’s protocol. RNA concentration as 
well as the A260/280 and A260/230 ratios were then measured with the NanoDrop ND-
1000 Spectrophotometer (Thermo Fischer Scientific, Nottingham UK).  iScript™ 
cDNA Synthesis kit (170-8890, Bio-Rad) was used to reverse transcribe 100 ng 
of extracted RNA. 20 µl of reverse transcription (RT) reaction was incubated as 
follows: 5 minutes at 25°C, 30 minutes at 42 °C, 5 minutes at 85 °C and the 
reaction was terminated by transferring the tubes to ice (4 °C).  
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qPCR reactions (10 µl) were prepared by adding all required components 
according to table 2-1 and scaled according to the number of samples. 
 
Table 2-1 RTqPCR Reaction Mix 




SsoAdvanced ™ Universal SYBR Green Supermix 
(172-5271, Bio-Rad) 
5 1X 
Primers (PrimerDesign™, Ltd.) 
(will be mentioned in each relevant chapter) 
2 600 nM 
cDNA template 3 __ 
 
The main steps of RTqPCR is depicted in figure 2.5. the three main steps 
comprising the RTqPCR protocol are repeated 40 times or cycles. In first cycle, 
the double stranded template DNA strand is first denatured into 2 single strands 
by heating to above 90°C, so that the region to be specifically amplified can be 
made accessible. The temperature is then cooled to between 40-60°C and the 
annealing step starts by primers bind to the complementary sequence, and serve 
to “prime” the DNA synthesis reaction. The third step, DNA synthesis or 
extension is carried out by a thermo stable DNA polymerase which catalyzes the 







Figure 2.5 Stages of PCR: denaturation, annealing and elongation. 
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Thermal cycling was performed using Corbett RotorGene 6000 System (Qiagen, 
UK) following the protocol in table 2-2.  
 
Table 2-2 Corbett RotorGene Setting 
Setting/Mode Polymerase 
Activation and DNA 
Denaturation 
Amplification Melt Curve 
Analysis 
Denaturation Annealing Cycles 
Fast 
 






In all RTqPCR experiments, relative gene quantification was assessed according 
to the "Delta Delta CT" (ΔΔCT) (Winer et al., 1999), where ΔΔCT= [Ct GOI Exp – 
Ct HKG Exp]-[Ct GOI Cal – Ct HKG Cal]: Ct: cycle threshold, GOI: gene of interest, 
Exp: poly (I:C)-injected glands, HKG: housekeeping gene showing the highest 
stability within each experiment condition, Cal: control glands injected by the 
vehicle. 
2.6 Statistical Analysis 
Results were shown as mean ± SEM (standard error of means). Statistical 
significance between individual comparisons was determined using Student t-
test. For multiple comparisons, one-way ANOVA with Sidak’s (selected pairs) 
pairwise test were used. The calculations were performed with the statistical 
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TLR3 Mediated SMG 
Dysfunction Independent of 











The dsRNA is the most potent viral stimulant of the innate arm of the immune 
system, and is largely believed to be an intermediate replication by-product 
generated by most viruses (Jacobs and Langland, 1996). The synthetic dsRNA; 
poly (I:C) has been extensively studied for its capability to induce the 
characteristic innate immune responses, closely mimicking those associated with 
viral infections; such as: loss of epithelial integrity, inflammatory cytokine 
production and declined functions (Lever et al., 2015).  
TLR3 is a dsRNA sensor found in mammals and is activated by viral dsRNA or 
poly (I:C). Traditionally, newly synthesized endogenous TLR3 is transported 
through the ER and Golgi apparatus to endosomes, aided by the multi-pass 
transmembrane protein UNC93B1 (Kim et al., 2008). Within the endosomes, 
TLR3 is rapidly processed by cathepsins to generate a short fragment which 
corresponds to the C-terminal, functional form of the receptor. Once ligated by 
poly (I:C), TLR3 protein expression is up-regulated, leading to the accumulation 
of this cleaved terminus (Garcia-Cattaneo et al., 2012). 
At the signalling level, poly (I:C) binding to TLR3 will be followed by recruitment 
of the adaptor molecule; TRIF, and initiation of a signalling cascade, leading to 
upregulation of type I IFN and inflammatory cytokines, via activation of IRF3 and 
NF-κB, respectively (Kawasaki and Kawai, 2014). Previous data demonstrated 
the combined contribution of type I IFNs and IL-6 in inducing salivary gland 
hypofunction (Nandula et al., 2013). Moreover, in various viral models, poly (I:C) 
prompted an acute inflammatory response, featuring the migration and activation 
of innate immune cells, principally neutrophils and monocytes (Clarke et al., 2014, 
Kanaya et al., 2014, De Alba et al., 2015).  
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Beside efficiency of these cells in combating viral infections (Gabriel et al., 2013), 
tissue damage can be collaterally mediated by: ROS, superoxides, inflammatory 
cytokines and NETs (Hemmers et al., 2011, Drescher and Bai, 2013). This, in 
addition to their destructive potential via a number of inherent proteases; namely: 
neutrophil elastase (NE), cathepsin G and myeloperoxidase (MPO) (Kanaya et 
al., 2014).  In particular, MPO which is predominantly stored in lysosomes of 
monocytes as well as azurophilic granules of PMNs (Klebanoff, 2005), is one of 
the most abundant enzymes released on neutrophil activation and predominantly 
involved in tissue damage (Nagra et al., 1997, Eiserich et al., 2002, Malle et al., 
2003). It has been implicated in downregulation of aquaporins at the gene level 
(Sakai et al., 2014), in addition to disruption of plasma membrane ion transport 
channels (N.S. MacCallum, 2007) and epithelial tight junction proteins (Kucharzik 
et al., 2001).  
Despite the thoroughly documented injurious consequences of all the formerly 
mentioned molecular events, the sequelae of acute exposure of the SGs to viral 
infections have never been comprehensively investigated. In this chapter, we 
developed a novel acute SG model via intraductal retrograde infusion of the 
synthetic viral analogue; poly (I:C), into the C57/B6 mouse SMGs. The developed 
model is unique in rapidly and reliably demonstrating the functional and immune 
consequences prompted by the exocrine SGs, upon local exposure to the potent 




3.2 Materials and Methods 
3.2.1 Surgical Procedure and Saliva Collection 
Chapter 2, paragraph 2.1 details the surgical procedures, the method of saliva 
collection and calculation of flow rates.  
3.2.2 TLR3 Inhibition and LY6G/LY6C Depletion Models 
Table 3-1 summarizes the drugs and doses used in the experiments of the current 
chapter.  
Table 3-1 Drugs used in in vivo injections 























tala et al., 
2015) 
i.p injection at the 








eBioscience 16-5931 i.p. 200 
µg/mouse 
(Daley et al., 
2008)  
24 hrs prior to poly 
(I:C) local injection 
 
In the TLR3-inhibitor model, the contralateral SMGs received the vehicle (saline 
and trypan blue) in addition to the TLR3/dsRNA inhibitor drug dose given in 





3.2.3 Immunohistochemical Analysis 
Paraffin-embedded SMG sections were deparaffinised, rehydrated and antigen 
retrieved by autoclaving with Trilogy™ as detailed in chapter 2, paragraph 2.3. 
Subsequently, slides were incubated in hydrogen peroxide to block endogenous 
peroxidase activity and protein block to inhibit non-specific background reaction. 
After incubation with the specific primary antibodies (table 3-2), the detection was 
completed using the compatible host HRP-conjugated secondary antibodies. 
Nuclear and counterstaining was done with Mayer’s haematoxylin or 
VECTASHIELD Antifade Mounting Medium with DAPI (vector laboratories, H-
1200) in case of fluorescence imaging. 









J2 anti-dsRNA SCICONS Budapest, 
Hungary, J2-1511 
Mouse 1:1500 
TLR-3 Abcam, Ltd, ab62566 Rabbit 1:10000 
MDA 5 Abcam, Ltd, ab69983 Rabbit 1:450 
RIG I Bioss Inc., bs-0993R Rabbit 1:700 
Cox2 Abcam, Ltd, ab133466 Rabbit 1:400 
iNOS Novus Biologicals, USA, 
NB300-605 
Rabbit 1:650 








Cleaved caspase 3 R&D Systems, MAB835 Rabbit 1:280 
Myeloperoxidase BosterBio, USA, 
PB9057 
Rabbit 1:1000 
Goat anti-Mouse IgG (H+L) Secondary 
Antibody, Alexa Fluor® 594 conjugate 
Thermo Fisher 
Scientific, A-11005   
Goat 1:1000 
Polyclonal Goat Anti-Rabbit 
Immunoglobulins-HRP 
Dako, P0448 Goat 1:200 
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3.2.4 Western Blotting 
SMG protein extracts were electrophoresed on precast 4-2% SDS-PAGE gel and 
transferred to nitrocellulose membrane as detailed in chapter 2, Paragraph 2.4. 
Membranes were incubated with primary antibody, followed by 1 hr incubation 
with the appropriate secondary antibody (table 3-3). Subsequently, signal 
development and exposure with Enhanced Chemioluminescence and 
ChemiDoc™ MP System were performed. 
Table 3-3 List of Antibodies Used in Western Blots 
 
3.2.5 RTqPCR  
Total RNAs isolated from SMG tissues (stored in RNAlater®) were extracted 
using RNeasy® Micro Kit (Qiagen) and 100 ng of extracted RNAs were reverse-
transcribed in a 20 μL reaction using the iScript™ cDNA Synthesis kit. 
Quantitative real time PCR (qRT-PCR) was carried out as detailed in chapter 2, 
Paragraph 2.5. All mouse primers were synthesized by PrimerDesign™, Ltd and 










TLR-3 Abcam, Ltd, ab62566 Rabbit 1:10000 
Myeloperoxidase BosterBio, USA, PB9057 Rabbit 1:1000 
Β-actin Sigma, A2228 Mouse 1 μg/mL 
Polyclonal Goat Anti-Rabbit 
Immunoglobulins-HRP 
Dako, P0448 Goat 1:2000 
Polyclonal Goat Anti-Mouse 
Immunoglobulins- HRP 
Dako, P0447 Goat 1:1000 
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          Table 3-4 List of Primers used 
Gene Accession 
NO 
MX-1 (MX dynamin-like GTPase 1) NM_010846 
ISG-15 (ISG15 ubiquitin-like modifier) NM_015783 
OAS1a (2'-5' oligoadenylate synthetase 1A (Oas1a) NM_145211 
PKR  NM_011163 
IL 6 NM_031168 
IL 1β NM_008361 
TNF NM_013693 
TLR3 (Toll-like receptor 3) NM_126166 
MDA5 (Interferon induced with helicase C domain 1 (Ifih1),  NM_027835 
RIG1 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (Ddx58) NM_172689 
Chemokine (C-X-C motif) ligand 1 (Cxcl1), KC NM_008176 
Chemokine (C-X-C motif) ligand 2 (Cxcl2), MIP2-a NM_009140 
Chemokine (C-X-C motif) ligand 5 (Cxcl5), LIX NM_009141 
Chemokine (C-X-C motif) ligand 15 (Cxcl15), IL-8 NM_011339 
Chemokine (C-C motif) ligand 2 (Ccl2), MCP-1 NM_011333 
HPRT (Hypoxanthine guanine phosphoribosyl transferase) NM_013556 
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) NM_008084 
 
3.2.6 Histologic Examination 
As described in chapter 2, paragraph 2.2, following gland excision and formalin 
fixation of tissues, samples were processed, embedded in paraffin, microtome 
sectioned, stained with H&E and examined under a light microscope. 
3.2.7 Flow Cytometric Analysis 
Excised glands were rinsed with PBS, minced and transferred through a 100 µm 
cell strainer mesh (352369, Corning Life Sciences, DL) using a syringe plunger 
into a 50 ml Falcon tube.  The mesh was washed 3 times with Dulbecco’s 
phosphate buffered saline and the tube was centrifuged at 600 g for 10 minutes. 
The supernatant was discarded and 3 ml fresh PBS was pipetted up and down 
several times to further dissociate any cell clumps.  
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The tube was centrifuged again at 600 g for another 10 minutes after which the 
supernatant was discarded. 3 ml cell staining buffer (420201, Biolegend, UK) was 
applied on top of the cells and pipetted up and down before the whole volume 
was passed through a 35µm nylon mesh of a cell strainer cap fitted to 5mL 
Falcon® tube with round bottom (352235, Corning). Twenty microliters of this 
preparation were pipetted in a 0.5 ml tube for cell counting, whereas the whole 
cell suspension was transferred to a 15 ml Falcon tube and centrifuged at 600 g 
for 10 minutes. According to the number of cells in the cell suspension, the 
volume of the blocking antibody; TruStain fcX™ anti-mouse CD16/32 (101319, 
Biolegend) was calculated and cells were incubated at 1.0 µg per 106 cells for 5-
10 minutes on ice prior to immunostaining. After 10 minutes, the Falcon tube with 
TruStain fcX™-blocked cells was centrifuged at 600 g for 10 minutes and the 
supernatant was discarded. Immunostaining with the fluorochrome-conjugated 
antibodies followed directly without an intermediate washing step. The anti-
mouse antibodies used and their isotype controls (Biolegend, UK) are shown in 
table 3-5.  
 




Cells: Neutrophils, Macrophages, Monocytes 
Fluorochromes FITC PE PE/CY7 APC APC/CY7 
Antibody Panel F4/80 CD45 CD11b LY6G LY6C 
Catalogue Number 123107 103207 101215 127613 128025 
Isotype Control  Rat IgG 2a Rat IgG 2b Rat IgG 2b Rat IgG 2a Rat IgG 2c 
Catalogue Number 400505 400607   400617   400511   400719   
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Supernatant over centrifuged cells was discarded and cells were re-suspended 
in 300 µl cell staining buffer. All antibodies were diluted 1:100 in the cell staining 
buffer and in a 96-well plate with rounded bottom, 50 µl of the cell suspension 
was mixed with 50 µl of each panel and incubated for 2 hrs in the dark at 4 °C. 
Compensations for spillover and spectral overlap were established by labelling 6 
tubes for each of the 5 fluorochromes used and 1 for a fluorochrome-free tube as 
an unstained sample.  
Twenty microliters of OneComp eBeads® (01-1111-41, eBioscience, Ltd, UK) 
was mixed with 0.5 µl of each fluorochrome and 80 µl of the cell staining buffer 
and incubated in the same 96-well plate holding the cell suspensions, antibodies 
and isotype controls. An automated compensation algorithm in BD™ FACSDiva 
6.1 software (BD Biosciences) was used to read the spectral overlap values from 
single-color compensation controls in sequential acquisitions. Spectral overlap 
values were automatically calculated by the software and applied to the 
experiment.   
After 2 hrs, the 96-well plate was retrieved from the fridge and 100 µl cell staining 
buffer was dispensed on each stained sample and pipetted up and down several 
times. The plate was then centrifuged at 600 g at 4°C for 10 minutes. After plate 
centrifugation, cells were seen precipitated at the well bottoms, vigorous 
propelling of the supernatants was done and 150 µl cell staining buffer was 
applied to each well. Precipitated cells were thoroughly mixed with the dispensed 
cell staining buffer and the content of each well was re-transferred through a 
35µm nylon mesh of a cell strainer cap fitted to a 5mL Falcon® tube to finally and 
completely dissociate any cell that may have clustered and to prevent clogging 
of the machine fluidic system. 
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All samples were analysed using a 3-laser (405, 488 and 630 nm) 5-color BD 
FACS Canto II flowcytometer (BD Bioscience). Thresholds on Forward Scatter 
(FSC) and Side Scatter (SSC) were set to: 505 V for FSC and 571 V for SSC and 
the positive population was gated and recorded. The flow rate of the cytometer 
was set to medium while acquiring and recording 100,000 events for each 
sample. Data for each sample was stored as an FCS 3.0 file and subsequently 
analysed by Flowing Software 2.5.1. Mean fluorescence intensity (MFI) of isotype 
controls was subtracted from the MFI measured for specific markers to control 
for background auto-fluorescence and non-specific fluorescence. The gating 





3.3  Results 
3.3.1 Establishment of the acute viral mimic model: Poly (I:C) 
Internalization and Induction of an Antiviral State in the SMGs  
Despite the extensive use of poly(I:C) in diverse experimental models, very little 
is known about its uptake and intracellular fate. Accordingly, it was mandatory to 
validate internalization of the poly (I:C), since the well-characterized dsRNA-
binding proteins are intracellular (Saunders and Barber, 2003). To achieve this 
objective, dsRNA monoclonal antibody was used to immunolabel poly (I:C) and 
track its fate, 6hrs and 24 hrs post retrograde duct injection. The vehicle-injected 
SMGs did not show any dsRNA-positive signal. Conversely, the ducts and acini 
of the poly (I:C)-injected SMGs showed retention of poly (I:C) up till 24 hrs 













Figure 3.1 Immunolabelling of poly (I:C) with the monoclonal dsRNA J2 antibody.  
A: Control vehicle-injected SMG. B: 6hrs post poly (I:C) injection, dsRNA was 
immunolocalized in duct cells (yellow arrows) as well as acinar cells (blue arrows). C: 24 hrs 
post poly (I:C) injection, more dispersed and less immunostaining intensity of poly (I:C) in duct 
cells (yellow arrows) as well as acinar cells (blue arrows). Original magnification= 40x. 
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To ensure the reliability of a single local poly (I:C) dose in the induction of an 
antiviral condition in the SMGs, we examined the expression of the best 
characterized antiviral genes including MX1, ISG15, OAS1 and PKR. Real-time 
qRT-PCR results showed that poly (I:C) prompted a significant upregulation in 
these gene, 6hrs post its local introduction (Figure 3.2). The interferon-inducible 
MX1 antiviral gene showed the highest expression relative to HPRT 
housekeeping gene and the vehicle injected control glands, followed by ISG15, 

















Figure 3.2 mRNA expression of MX1, ISG15, OAS1 and PKR antiviral genes. 
Upregulation of all antiviral genes in the SMGs, 6 hrs post poly (I:C) injection (6h 
P-PIC) compared to the vehicle injected control glands (V-C). Data represent 






















Unpaired Two Tailed t test 
 
MX1 ISG15 OAS1 PKR 
P value <0.0001 <0.0001 0.001 0.0002 












































































































































































3.3.2 Poly (I:C) Induced SMG Hypofunction 
To explore the functional response of the SMGs to poly (I:C), the mean flow rates 
of pilocarpine-stimulated saliva was measured from control and infected glands 
for 5 minutes: 6hrs, 9hrs and 24 hrs following poly (I:C) retrograde injection. For 
simplicity of analysis, all vehicle-injected control SMGs showing approximately 
equal flow rates at different time points were assembled in one group, to which 
the experimental flow rates following poly (I:C) injection were compared. The poly 
(I:C) injected glands exhibited progressive and rapid loss of function, which 
started 6 hrs post its retrograde injection and was further deteriorated by 9 hrs, 
until the glands ceased secretion completely after 24 hrs of poly (I:C) 
innoculation. No difference in mean flow rates was recorded between the vehicle 











One Way ANOVA 
P value <0.0001 
P value summary **** 
Dunnett's test Summary P Value 
V-C vs. C-UN ns 0.1927 
V-C vs. 6H **** 0.0001 
V-C vs. 9H **** 0.0001 
V-C vs. 24H **** 0.0001 
Figure 3.3 Salivary Flow rates in Control and Poly (I:C)-Injected SMGs. 
Scatter plot analysis of the mean ± SD SMG flow rates after 6h, 9h and 24h of poly (I:C) 
intraductal injection, all compared to the vehicle injected glands (V-C). Non-injected SMGs (C-
UN) were compared to the vehicle injected ones to assess the impact of retrograde injection 
on the gland functional capabilities, and a non-significant change was seen between the two 
groups. Conversely, poly (I:C) induced an extremely significant reduction in mean flow rates 
as early as 6 hrs of its infusion and ultimately lead to complete impairment of the SMG function 
after 24 hrs. ****: P<0.0001, ns: non-significant. 


























3.3.3   Loss of SMG Secretion in Response to The Viral Mimic is TLR3 
Mediated 
3.3.3.1 Characterization of the dsRNA Sensors in the SMG. 
To assess receptors that sense dsRNA in the SMGs, we examined the 
expression of TLR3 and the cytoplasmic RLR receptors; MDA5 and RIG-I at the 
mRNA as well as their subcellular protein expression pattern. qRT-PCR revealed 
that poly (I:C) significantly upregulated all dsRNA sensors in the SMGs, after 6 
hrs of poly (I:C) intraductal infusion, figure 3.4. Since these results indicated that 
SMGs are equipped to upregulate functional endosomal and cytoplasmic dsRNA 
sensors, immunohistochemical staining was performed consequently to identify 
cell phenotypes expressing these receptors.  
Basal expression level was first determined for the three dsRNA receptors, TLR3 
showed intense membranous and cytoplasmic immunostaining in intercalated 
ducts. Conversely, the cytosolic dsRNA receptors; MDA5 and RIG-I were 
immunolocalized almost exclusively in resident peri-ductal immune cells. 
Following poly (I:C) introduction, TLR3 showed immunopositivity in the 
basolateral membranes of acinar and duct cells with increased numbers of 
intensely stained intercalated ducts. On the other hand, the glands which 
received poly (I:C) revealed intense MDA5 and moderate RIG-I immunostaining, 
exclusively limited to infiltrating immune cells which embraced ducts and acini. 
Frequently, MDA5 and RIG-I positive immune cells were seen extruded into duct 
lumena, figure 3.4. 
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Figure 3.3.4 Expression of dsRNA sensors; TLR3, MDA5 and RIG-I. 
Right: Transcriptional upregulation of all dsRNA sensors in the SMGs, 6 hrs post 
poly (I:C) injection (6h P-PIC). Data represent means ± SEM (n=3). ****p≤0.0001. 
V-C: vehicle injected control, HPRT: Hypoxanthine guanine phosphoribosyl 
transferase (housekeeping gene). Left: Immunoexpression of the dsRNA sensors.  
A- basal TLR3 expression in intercalated duct cells B- poly (I:C) injection induced 
intense membranous and cytoplasmic positivity of intercalated ducts (arrow) as well 
as moderate basolateral staining of the acinar and duct cells. C- MDA5 expression 
in resident immune cells of the saline injected control SMGs. D- MDA5 positive 
immunostaining following poly (I:C) injection was exclusively detected in peri-ductal 
and peri-acinar infiltrating immune cells, MDA5 positive cells was commonly seen 
extruded in duct lumen (arrows). E- RIG-I labelling the resident immune cells in the 
control SMG (arrow). F-  poly (I:C) injected glands showing moderate 
immunostaining of infiltrating inflammatory cells. Note the extrusion of RIG-I 












Unpaired Two Tailed t test 
 
TLR3 MDA5 RIG1 
P value <0.0001 <0.0001 <0.0001 
P value summary **** **** **** 
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3.3.3.2 TLR3/dsRNA complex inhibition 
Expression of TLR3 in the ducts of the control SMGs, as well as its intense 
epithelial immunolocalization post poly (I:C) injection, incited the priority to assess 
its role in the perceived SMG injury. A TLR3/dsRNA competitive inhibitor was 
used to competitively disrupt poly (I:C) binding to TLR3. Previous studies 
documented that poly (I:C) exposure increased the expression of the cathepsin-
cleaved C-terminus form of TLR3 which directly correlates to its signalling 
capacity (Garcia-Cattaneo et al., 2012). The outcome of TLR3 blocking was 
investigated initially by analysing the expression levels of neo-generated, TLR3 
C-terminal, using a polyclonal antibody raised against 15 amino acids near the 
carboxy terminus of TLR3. Immunohistochemistry and western blotting were 
conducted on the control as well as the poly (I:C)-injected glands, treated and 
non-treated with the TLR3/dsRNA complex inhibitor.  Results revealed that the 
TLR3/dsRNA inhibitor, caused an extremely significant downregulation of the 
TLR3 C-terminus in the poly (I:C)-injected glands, compared to its widely-





























P value <0.0001 
P value summary **** 
Sidak's multiple comparisons test Summary P Value 
V-C vs. TLR-I+PIC ** 0.0015 
PIC vs. TLR-I+PIC **** <0.0001 
Figure 3.5 TLR3 C-terminal expression in the SMGs following competitive inhibition by 
dsRNA/TLR3 complex molecule.  
LEFT: The basal intercalated duct-positive immunoexpression of TLR3 C-terminal (arrows) was 
extensively upregulated 9 hrs post poly (I:C) injection (9h-PPIC), TLR3 was seen immunolabelling 
all ducts and acinar cells. Following administration of the dsRNA/TLR3 complex (TLR-I) which 
competes with poly (I:C) over TLR3 binding, the TLR3 C-terminal was remarkably downregulated 
and positive TLR3 immunostain was exclusively seen in intercalated ducts (arrows) in a pattern 
comparable to the vehicle injected control glands (V-C). Original magnification=25x. RIGHT: 
Similar results were seen in the representative western blots of the tested groups, TLR3 
expression was calculated as TLR3/β-actin ratio fold change from control saline injected glands. 
ANOVA showed an extremely significant reduction in the receptor in dsRNA/TLR3-treated glands, 
9 hrs post poly (I:C) exposure. Additionally, the level of TLR3 C-terminus even revealed a very 
significant decrease below the basal level seen in the vehicle injected control glands. Data 
represent mean ± SD of three independent experiments for each tested group. **p≤0.01, **** 
p<0.0001 
Β-actin 
TLR3         
C-
terminal 
~ 52 KDa  
V-C                 9h P-PIC       TLR-I+9h P-
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To detect the TLR3 signal which prompted the perceived loss of function, mRNA 
and protein levels of cytokines and inflammatory mediators downstream TLR3 
inhibition were investigated using qRT-PCR and immunohistochemistry, 
respectively. Figure 3.6 reveals the extremely significant transcriptional reduction 
of pro-inflammatory cytokines in the glands which received the TLR3 inhibitor in 
conjunction with the poly (I:C), versus those which didn’t receive it, normalized to 
the relevant, vehicle injected control glands and GAPDH housekeeping gene (in 
the TLR-inhibited glands) and HPRT (in the glands which received poly (I:C) only 
















Figure 3.6 mRNA Expression of pro-inflammatory cytokines; IL6, IL1β and TNF-α. 
The TLR3/dsRNA complex inhibitor significantly reduced the transcriptionally upregulated pro-
inflammatory cytokines, 9 hrs post poly (I:C) injection (9h P-PIC). Data represents means ± SEM 
(n=3). *P≤0.05, **p<0.01 ****p<0.0001, NS: non-significant, TLR-I: TLR3/dsRNA inhibitor 






















ANOVA IL-6 IL-1β TNF-α 
P-value <0.0001 <0.0001 0.0009 
 
**** **** *** 








V-C vs. 9h P-PIC **** <0.0001 **** <0.0001 ** 0.0012 
9h P-PIC vs. TLR-I+9h P-PIC **** <0.0001 **** <0.0001 * 0.0112 
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Next, immunohistochemistry was performed to explore the: (i) expression of other 
pro-inflammatory cytokines, (ii) induction of apoptosis and the (iii) acute 
inflammatory cellular infiltrate, downstream TLR3 ligation and following its 
inhibition. Histologic sections from mouse SMGs treated with the vehicle, poly 
(I:C) or poly (I:C) along with TLR3-inhibitor were stained with H&E and 
immunolabelled with antibodies against IFN-γ, Cox2, NF-κB, iNOS and cleaved 
caspase-3 (csp-3). Figure 3.7 reveals that the TLR3/dsRNA inhibitor has 
successfully interfered with NF-κB nuclear translocation in response to poly (I:C) 
stimulation and declined the parenchymal expression of the assessed antibodies. 
Moreover, H&E staining of these tissue sections revealed efficient elimination of 
the acute inflammatory cells which infiltrated the tissues in response to poly (I:C) 

































Figure 3.7 Immunohistochemical representation of IFN-γ, Cox2, NF-κB, iNOS and 
cleaved csp-3 markers as well as H&E histology. 
Analysis of the vehicle injected control (V-C) glands and 9 hrs post poly (I:C) local 
administration in glands treated and non-treated with the TLR3/dsRNA inhibitor (TLR-I) 
revealed the remarkable reduction in expression of the tested proteins in response toTLR3 
inhibition. H&E sections of TLR3/dsRNA blocker treated and non-treated SMGs showed 
the efficient depletion of the infiltrating immune cells in response to TLR3 competitive 














3.3.3.3 TLR3 Inhibition Protected the SMG from Secretory Dysfunction.   
At the functional level, inhibition of: (i) poly (I:C) binding to TLR3, (ii) TLR3 C-
terminal neo-synthesis and (iii) subsequent downstream immune signals, 
protected the SMG secretory functions. The mean flow rates of the glands which 
received the TLR3 inhibitor in conjunction with poly (I:C) was similar to the 












Two-tailed Paired t test 
P value 0.8169 
P value summary ns 
Two-tailed Unpaired t test 
P value 0.0026 
P value summary ** 
A                                                         B 
Figure 3.8 Functional analysis of the SMGs in response to TLR3 inhibition.  
Data represent mean ± SD of the TLR3 inhibited glands (TLR3/dsRNA inhibitor + 
poly (I:C) & TLR3/dsRNA inhibitor + Vehicle). A: Inhibition of TLR3 in the current 
model sustained a constant salivary flow rate even after 9hrs of poly (I:C) exposure. 
B: The lost saliva secretion, 9 hrs post poly (I:C) injection was very significantly 
preserved upon combining the TLR3 competitive inhibitor to the viral mimic. N=3 





































































3.3.4 TLR3 Mediated SMG Dysfunction Independent of Acute Inflammatory 
Infiltrate    
3.3.4.1 Poly (I:C)-Mediated Transcriptional Upregulation of Neutrophil and 
Monocyte Chemo-attractants   
In various viral models, poly (I:C) induced migration and activation of acute 
inflammatory cells, principally neutrophils and monocytes. qRT-PCR was 
performed to explore the mRNA expression of chemokines that organize 
trafficking of these acute inflammatory leukocytes. Results showed that 
retrograde duct injection of a single poly (I:C) dose induced an extremely 
significant up-regulation of four genes encoding neutrophil chemoattractants: 
keratinocyte-derived chemokine (KC)/CXCL1, macrophage-inflammatory 
protein-2 (MIP-2)/CXCL2, lipopolysaccharide-induced chemokine (LIX)/CXCL5, 
and CXCL15/lungkine (mouse IL-8) which exhibited the highest mRNA 
expression. In addition, the monocyte chemoattractant protein-1 (MCP-1)/CCL2 
revealed very significant upregulation in response to poly (I:C).  mRNA 
expression of the tested chemokines was calculated relative to HPRT internal 





























Unpaired t test 
 
CXCL1 CXCL2 CXCL5 CXCL15 CCL2 
P value <0.0001 <0.0001 <0.0001 <0.0001 0.0016 

























































































































































































































Figure 3.9 mRNA Expression of pro-inflammatory chemokines; CXCL1, CXCL2, CXCL5, 
CXCL15 and CCL2. 
Extremely significant upregulation of all neutrophil chemo-attractants and very significant 
increase in the monocyte chemokine; CCL2, 6hrs post poly (I:C) introduction (6h P-PIC). Data 





3.3.4.2 Invasive Infiltration of Immune Cells Showing High MPO-Positivity  
The former PCR findings, in addition to the results seen in figure 3.7 which 
indicated a highly positive, TLR-3-driven inflammatory signal, incited us to 
explore the intensity and pattern of immune cell distribution in the SMGs. 
Accordingly, sections from the control and poly (I:C)-injected glands, at various 
experimental time points, were stained with H&E. Besides, based on the 
transcriptional overexpression of the neutrophil and monocyte chemo-attractants, 
we verified the predominance of these immune cell subsets in the SMG tissues 
using MPO, which is expressed in lysosomes of monocytes as well as azurophilic 
granules of neutrophils.  
The H&E stained sections revealed that the SMGs which were injected and non-
injected with the vehicle showed normal histology in the form a compact lobular 
structure with packed acini having pale basophilic cytoplasm and basal nuclei. 
The ductal system was patent and included intercalated, striated and secretory 
ducts with supporting connective tissues, all exhibiting normal appearance. Six 
hours post poly (I:C) inoculation, the SMG vasculature exhibited margination and 
transmigration of acute inflammatory cells. The infected glands displayed an 
apparently normal histomorphologic feature with oedema and pervasive 
inflammatory cells that were sometimes seen extruded into duct lumens. 
Surprisingly, the inflammatory cells were seen invading the duct lining from the 
blood vessels direction, pushing and flattening the native duct epithelial cells. 
Similarly, inflammatory cells were frequently seen invading and occupying acinar 
cells adjacent to blood vessels. By 9hrs, widespread infiltration of immune cells 
was displayed in extended stromal spaces, obscuring interlobular ducts and 
invading inter-acinar tissues.  
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Likewise, SMG morphology was still well-maintained after 24 hours of poly (I:C) 
injection, some infrequent vacuolar degeneration and interlobular oedema 
transformed some parts of the gland into an island-like appearance. Diffuse 
inflammatory cell infiltrate was seen throughout the whole glandular tissues, with 
the predominant cells exhibiting the multilobulated, doughnut-shaped nucleus 
which characterizes active neutrophils. Immunolabelling the SMG tissues with 
MPO revealed that after 6 hrs of introducing the viral mimetic, MPO-positive cells 
were seen clustering perivascularly and peri-ductally. Nonetheless, obvious 
migration of these cells to more distant and widespread inter-acinar orientations 
was detected at this early time point.  
By 9 hrs, more extensive MPO positivity was perceived and the immune cells 
were seen within the gland acini and ducts. 24 hrs post poly (I:C) infusion, MPO 
positive cells were ubiquitously detected in interlobular, inter-acinar and more 
interestingly intra-acinar locations, analogous to the H&E intrusive patterns. 
Remarkably, the peri-ductal infiltrating cells at 6hrs displayed a confined 
homogenous cytoplasmic MPO positivity, whereas a spattered-like 
immunostaining pattern was seen in the inter-acinar and more pronounced in the 
intra-acinar MPO positive cells at 9hrs and 24 hrs post poly (I:C) introduction, 



























Figure 3.10 H&E and MPO Immunostain of control and poly (I:C)-injected SMGs.  
A: histomorphology of normal un-injected SMG and B: vehicle injected control SMG. 
C: Negative MPO expression in the vehicle injected control SMG. D: 6 hrs post poly 
(I:C) showing apparently preserved histomorphology, with inflammatory cells extruded 
into duct lumens. E: higher magnification of D revealing margination and transmigration 
(arrow) of inflammatory cells. F: the peri-ductal and sporadic inter-acinar cells are MPO-
positive. G: Another higher magnification photomicrograph showing invasion of the 
infiltrating inflammatory cells into the SMG duct lining from all directions where blood 
vessels are sited, note the apparent replacement of native duct epithelial cells (now 
pushed and flattened, (arrows)) by the plethora of infiltrating cells. H: Extensive 
infiltration of stromal acute inflammatory cells, 9 hrs after poly (I:C) injection. I: MPO-
positive cells invading ducts and interlobular spaces, 9 hrs after poly (I:C). J: 24 hrs 
following poly (I:C): edema and widening of the interlobular and inter-acinar spaces 
transforming the gland architecture into island-like morphology, with diffuse 
inflammatory cell infiltrate broadly occupying the expanded spaces. K: cells exhibiting 
the histologic features of neutrophils (doughnut-shaped /multilobulated nuclei) can be 
seen interlobular, inter-acinar and intra-cinar (arrow). L: intra-acinar (red arrow) and 
intra-ductal (black arrow) MPO-positive cells, 24 hrs after poly (I:C). Original 
Magnification A, B, J =16X. C, D, F, H, L=25X. E, G, I, K, =40X 
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3.3.4.3 Ly6G/Ly6C Depletion in the Acute SG Dysfunction Model 
Repressed MPO-Positive Cells 
Immunohistochemistry substantiated abundant MPO-positive cellular infiltrate in 
response to the viral mimetic. Accordingly, we hypothesized that these cells may 
be major contributors in the poly (I:C)-mediated SMG injury and hypofunction. To 
validate our theory, we used the RB6-8C5 monoclonal antibody which binds to 
neutrophils (Hickey, 2012) and monocytes (Jutila et al., 1988). 200 µg of the 
depletion antibody; RB6-8C5 was administered intraperitoneally into the mice, 24 
hrs before poly (I:C) local injection, and saliva was collected 24hrs after 
introduction of the viral mimic. Successful depletion of the acute inflammatory cell 
infiltrate was reflected in the flow cytometry results, which showed that the CD45+ 
fraction was declined from 21.47% in the poly (I:C) injected SMGs, to 8.62% in 
the viral mimic-infected SMG from mice primed with the depletion antibody. 
Moreover, gating the CD45+ cells within the F4/80- CD11b+ channel, revealed that 






























CD45+: 7.05% CD45+21.47% CD45+: 8.62% CD45+: 8.07% 
V-C                                    24h P-PIC                           Rb6-8C5+24h P-PIC                    Rb6-8C5+V 
Figure 3.11 Representative flow cytometry analysis images of RB6-8C5 treated and non-
treated glands. 
Cell suspensions of SMGs from mice which received the viral mimic versus animals which were 
primed with the granulocyte depletion drug, 24hrs before receiving the poly (I:C). For neutrophil 
discrimination, cells were serially gated in the CD45+F4/80-CD11b+LY6C+LY6G+ channels. 
Obvious decline in the percentage of CD45+ cells was perceived in the depleted animals. Note 
the absence of distinct immune cell populations in the SMGs from mice which were exposed to 
the depletion drug in contrast to the very characteristic CD45+F4/80-CD11b+LY6C+LY6G 
populations seen 24 hrs post poly (I:C) injection. 
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3.3.4.4 Depletion of LY6C/LY6G Eliminated the MPO Positive Cells. 
To explore if RB6-8C5 had efficiently depleted the MPO-positive immune cell 
populations in the SMGs, immunohistochemistry and western blot analysis were 
conducted which showed that the Rb6-8C5 antibody successfully repressed 

















     24hrs P-Poly (I:C)          Rb6-8C5+24hrs P-Poly (I:C) 
A B 
C D 
    V-C      24hrs P-PIC   Rb6-8C5+P-PIC   
 MPO 62 KDa 
Β-actin 
Figure 3.12 RB6-8C5 depleted MPO positive cells.  
(A&C) Photomicrograph of SMG tissue sections injected only with poly (I:C) and (B&D) with the 
Rb6-8C5 depletion antibody followed by the viral mimic after 24 hrs. Original magnification: A, 
B=10X, C, D=25X. Representative western blot confirming reduction in MPO protein expression 
in response to Rb6-8C5 depletion drug, 24 hrs post poly (I:C) retrograde injection (P-PIC). 
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3.3.4.5 SMG Functional Capacity in Response to Immune Cell Depletion 
Depletion of LY6G+/LY6C+ inflammatory cells, 24 hrs prior to poly (I:C) retrograde 
duct injection did not induce any recovery in the SMG function, 24 hrs following 
exposure to the viral mimic. A significant reduction in mean flow rates of the 
SMGs which received the viral mimic was perceived independent of immune cell 















Two-tailed Paired t test 
P value 0.0422 
P value summary * 
Figure 3.13 SMG flow rates 48 hrs following the RB6-8C5 
administration and 24 hrs post poly (I:C) retrograde injection.  
Data represents mean ± SD from three independent mice 
experiments and shows persistent loss of secretion of the SMGs 








































In the current study, we demonstrated the development of an acute viral SG 
dysfunction model based on the retrograde ductal injection of a synthetic dsRNA; 
poly (I:C), into the SMGs. By developing this model, we aimed at mimicking and 
characterizing the acute functional, tissue and signalling changes sequential to 
primary exposure of the SMGs to a viral mimetic.  
Poly (I:C) is a viral analogue, it has been consistently used in vitro and in vivo to 
study IFN-based pathways in a reproducible manner (DeWitte-Orr and Mossman, 
2010). Studies reported that poly (I:C) is internalized into cells via clathrin-and 
raftlin- mediated endocytosis where it co-localizes with endosomal TLR3 (Kato et 
al., 2008). However, despite of the extensive poly (I:C) use in diverse 
experimental models, its uptake and intracellular fate have been rarely 
demonstrated (Nellimarla and Mossman, 2014). Therefore, to verify the 
consistent and reliable parenchymal infectivity of poly (I:C) in the present model, 
initial experiments aimed at visualizing its internalization and retention in the SMG 
ducts and acini. The J2 monoclonal antibody is the gold standard in dsRNA 
detection and an extremely useful tool for the recognition of acute, and potentially 
persistent viral infection in formalin-fixed, paraffin-embedded tissue samples 
(Richardson et al., 2010). Vehicle injected control glands were negatively stained 
with the dsRNA monoclonal antibody, suggesting that it does not detect 
endogenous species of dsRNA that might be present in the cells (such as 
microRNAs or transferRNAs). This is in accordance with the fact that these 
endogenous dsRNA species are usually less than 50 bp in length and the 
antibody reportedly recognises only those dsRNA species which exceed 50 bp in 
length (Schonborn et al., 1991).  
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On the contrary, the dsRNA monoclonal J2 antibody positively stained acinar and 
duct cells which internalized the poly (I:C) as early as 6 hrs post its retrograde 
infusion. Immunofluorescent staining of the SMG tissues further disclosed the 
ability of the gland epithelial cells to hold the viral mimic for 24 hrs post its 
inoculation, which may be reflect the role played by the exocrine tissues in 
retaining viruses during infection periods. Given the role played by viruses in 
triggering SG disease and dysfunction, the detection of dsRNA 
immunohistochemically might provide a straightforward approach to substantiate 
infection or even tropism. In addition, this provides an efficient method for  
following up therapeutic interventions, prior to embarking on other time and 
money consuming methods example viral microarrays (Weller et al., 2016), or in-
situ hybridization (Hilton et al., 1992).  
Importantly, the SGs in the current model displayed a rapidly progressive 
functional decline, which started after 6 hrs of poly (I:C) infusion and nearly 
peeked after 9 hrs, until the SMGs ceased secretion completely after 24 hrs. 
Previous studies demonstrated that multiple, systemic injections of poly (I:C) in 
SS prone NZB/WF1 mice, resulted in loss of glandular function (Deshmukh et al., 
2009, Nandula et al., 2013). The model represented herein is unique in 
demonstrating the direct influence of innate immune activation on the SG 
functional responses, ruling out possible extraneous impacts arising either from 






In the current model, loss of SMG functions upon local exposure to poly (I:C) 
paralleled upregulation of the dsRNA sensors; TLR3, MDA5 and RIG-I. 
Nonetheless, the parenchymal immunoexpression of TLR3 in the control and poly 
(I:C)-stimulated glands raised the postulation that TLR3 is the most likely receptor 
which may have responded to poly (I:C) by interfering with saliva secretion. In 
contrast, since MDA5 and RIG-I exclusively immunolabelled the infiltrating 
immune cells, these cytosolic receptors were theoretically considered as one of 
the TLR3 acute responses in the viral mimic model, rather than active contributors 
in the perceived loss of function. To verify our hypothesis, experiments were 
planned to selectively inhibit TLR3 in vivo and assess its exclusive role in the poly 
(I:C)-driven secretory dysfunction. 
Previous studies have revealed that in the absence of stimuli; TLR3 is found as 
both a full-length 130 kDa protein corresponding to the highly-glycosylated 
receptor and a shorter form which corresponds to the C-terminal fragment that 
accumulates in the cells after cleavage by cathepsin (Garcia-Cattaneo et al., 
2012). In addition, exposure to poly (I:C) has been shown to upregulate the TLR3 
C-terminal, which was correlated to the signalling capacity of the receptor 
(Garcia-Cattaneo et al., 2012). Initially, we depicted the endogenous expression 
of the TLR3 C-terminus in the SMGs using an antibody against 15 amino acids 
in this fragment. Immunohistochemistry clearly demonstrated that the positive 
signal was exclusively seen in the intercalated ducts in the normal SMGs.  This 
novel illustration may reflect the readily defensive property of these ducts in 
confronting viral infections via expressing the functional form of the receptor 
(Garcia-Cattaneo et al., 2012).  
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Furthermore, immunohistochemistry and western blot analysis revealed the 
significant increase in the TLR3 C-terminus, following poly (I:C) introduction, this 
phenomenon was previously illustrated and indicates a positive feedback loop 
that regulates the constant expression of TLR3 in epithelial cells, to maintain an 
antiviral response throughout the duration of infection (Garcia-Cattaneo et al., 
2012).  
To analyse the role played by the TLR3 C-terminal in the acute SMG dysfunction, 
we used a TLR3/dsRNA complex inhibitor to competitively interfere with poly (I:C) 
binding to TLR3.  Expectedly, the SMGs which received a TLR3 inhibitor that 
competes with poly (I:C) over the receptor binding, did not show any upregulation 
of the C-terminus. Our results show for the first time the importance of ligand 
binding in vivo for the neo-synthesis of this fragment. More distinctively, these 
experiments revealed that the in vivo inhibition of TLR3 C-terminus accumulation, 
paralleled effective rescue of the poly (I:C)-mediated loss of secretion.  
Interestingly, experiments conducted to validate the efficiency of the drug 
complex in inhibition of TLR3 showed partial mRNA downregulation of the poly 
(I:C)-induced pro-inflammatory cytokines; IL6, IL-1β and TNF-α as well as 
incomplete inhibition of IFN-γ and Cox2 protein expression, all of which, may be 
attributed to the signalling contribution of the cytoplasmic dsRNA sensors; MDA5 
and RIG-I. Conversely, TLR3 blocking in the infected SMGs, proficiently inhibited: 
(i) acute inflammatory cell infiltration, (ii) cleaved caspase-3 positive acinar cells, 
(iii) nuclear translocation of NF-κB and (iv) upregulated expression of the pro-
inflammatory mediator; iNOS. Based on these findings, the potential role played 
by each of the efficiently inhibited signals downstream TLR3/dsRNA blocking 
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were chosen for successive investigation to identify the early, acute, TLR-3- 
mediated event which interfered with saliva secretion.        
TLR3 inhibition in the current model, interfered with infiltration of immune cells 
into the poly (I:C)-injected glands. These findings are in accordance with previous 
studies which revealed that in absence of TLR3, skin wounds displayed defective 
recruitment of neutrophils and macrophages, in association with decreased 
expression of the chemokines; MIP-2/CXCL2, MIP-1α/CCL3, and MCP-1/CCL2, 
(Lin et al., 2011). To investigate the role played by the infiltrating immune cells in 
the TLR3-mediated loss of function, we started by characterizing the immune cell 
chemo-attractants that were upregulated upon exposure to the viral mimic. qRT-
PCR was conducted on the control and poly (I:C)-injected SMGs, which 
highlighted the immediate induction of the neutrophils’ chemoattractants; CXC: 
KC/CXCL1, MIP-2/CXCL2, LIX/CXCL5 and CXCL15 (DeVries et al., 2003), in 
addition to expression of CC-chemokine (MCP-1/CCL2) encoding monocytes. 
These results initially indicated the phenotype of immune cells which may have 
infiltrated the SMGs sequential to poly (I:C) infection.  
The former PCR results were followed up by microscopic examination of the SMG 
tissue sections, which revealed that poly (I:C) induced widespread infiltration of 
inflammatory cells having the histologic features of active neutrophils (bilobed 
nucleus).  Surprisingly, a unique pattern of intra-acinar and intra-ductal invasive 
distribution was displayed by these cells. They were frequently seen dislocating 
and flattening the resident duct nuclei, in addition to being commonly extruded 
into the lumens. Interestingly, duct cells (Ogawa et al., 2002), as well as acinar 
cells (Dios, 2010) have demonstrated ability to respond to inflammatory signals 
by the production of chemokines.  
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Accordingly, the inherent ability of the salivary gland epithelial cells to produce 
these low molecular weight chemo-attractants may have guided the infiltrating 
immune cells to the perceived intra-epithelial invasive positions.  
Next, immunolabelling the SMG tissues with a polyclonal antibody against MPO 
revealed that the robustly recruited immune cells, tethering, transmigrating and 
invading into ducts and acini were MPO positive, which emphasized their 
neutrophil/monocyte identity (Klebanoff, 2005), and directed towards using RB6-
8C5 as the appropriate method for their specific depletion. The discovery that 
high doses of RB6-8C5 are very effective at removing neutrophils from the 
circulation, gave researchers a convenient and reproducible approach for 
assessing the contribution of neutrophils to experimental models of inflammation. 
RB6-8C5 binds to 2 members of the Ly6 family of leukocyte-expressed markers; 
Ly6C and Ly6G (Hickey, 2012). The mechanism by which RB6-8C5 can deplete 
immune cells is based on the demonstrated inability of neutrophils to respond to 
chemotactic stimuli, in the presence of this monoclonal antibody. Furthermore, 
the recruitment capabilities of neutrophils were significantly compromised upon 
Ly6G ligation, this is due to diminished surface levels and function of crucial 

















In addition, RB6-8C5 was shown to bind to Ly6C which is not only expressed on 
neutrophils, but also on dendritic cells (DCs), and subsets of monocytes, 
macrophages, and lymphocytes (Jutila et al., 1988, Hestdal et al., 1991, Kung et 
al., 1991, Jutila et al., 1994). Thus, in the present study, RB6-8C5 antibody was 
used to dually deplete neutrophils and monocytes and investigate their injurious 
role in the acute virally-mediated loss of function. Histopathology, flow cytometry, 
immunohistochemistry and western blot showed that priming of the mice with 
RB6-8C5 markedly attenuated immune cell invasion into the SMGs, after 24hrs 
of poly (I:C) treatment.  
 
Figure 3.14 Ly6G. 
A GPI-linked protein, is present at high levels on 
the neutrophil surface, although its function is 
unknown. Wang et al (Wang et al., 2012) showed 
that Ly6G is co-localized with β2 integrins, and 
that antibody ligation of Ly6G reduces β2 integrin 
expression and inhibits neutrophil recruitment. 




Surprisingly, treatment of mice with the anti-Ly6G/Ly6C which efficiently 
restrained tissue inflammation and eliminated the MPO-positive immune cells, 
did not induce functional recovery. These experiments verified that TLR3 
interfered with the secretory ability of the SMGs independent of the invasive 
immune cell signal. Findings from the current experiments, combined to other 
neutrophil-independent injury models (Raeburn et al., 2002, de Vries et al., 2003) 
and studies which frequently demonstrate irrelevance between secretory 
hypofunction and immune cellular infiltration (Shen et al., 2009, Shen et al., 
2013), strongly implicate alternative impairment mechanisms by which the SG 
epithelial cells endogenously respond to injury and suggest a bystander role of 
the early acute and later lymphocytic infiltrations in exocrine dysfunction.  
In conclusion, results presented in the current chapter identified the exclusive role 
played by TLR3, in the poly (I:C)-mediated loss of secretion. Our findings 
highlighted for the first time the basal and stimulated expression of the functional 
form of TLR3; the C-terminal fragment and suggested its blockade as a promising 
therapeutic strategy for the treatment of SG diseases with viral implications. 
Moreover, the results demonstrated herein undoubtedly excluded the invasively 
infiltrating neutrophils; one of the robustly induced and fundamentally damaging 
signals, from the contribution to the acute TLR3-mediated secretory dysfunction. 
Experiments in the upcoming chapters will verify alternative injurious signals 
downstream of TLR3 activation and correlate their induction to the loss of function 





Chapter 4                                        
Pan Caspase Inhibitor; z-VAD-
fmk Protected the SMG From 






Evidence has accumulated over the years that poly (I:C) can directly trigger 
apoptosis in many types of cells by activating TLR3. Moreover, studies have 
indicated that adaptor proteins involved in TLR3 signalling pathways play crucial 
roles in initiating apoptosis (Zhao et al., 2012). Specifically, the key adaptor of 
TLR3 signalling pathway; TRIF, was shown to be indispensable for apoptotic cell 
death (Yamamoto et al., 2002).  
Apoptosis has been considered as one of the main factors which may be related 
to loss of SG secretory function (Hayashi, 2011). In fact, death of ductal and 
acinar cells are considered major mechanisms for salivary gland dysfunction of 
patients with SS (Horai et al., 2016) and following irradiation of salivary glands 
(Acauan et al., 2015).  
We reported in the previous chapter that TLR3 has triggered an apoptotic signal 
in the poly (I:C)-infused glands, marked by the increased expression of cleaved 
caspase-3-positive cells. Caspase family members function as important signals 
in the last step of several apoptosis signalling pathways (Vaux and Strasser, 
1996). The cell permeable pan- caspase inhibitor; z-Val-Ala-Asp (Ome) fluoro-
methyl-ketone (z-VAD-fmk), was reported to have a strong antiapoptotic effect in 
vivo (Li et al., 2000), via irreversibly binding to the catalytic site of caspase 
proteases (Gregoli and Bondurant, 1999). Therefore, we hypothesized that by 
systemic administration of this caspase inhibitor, we can protect the SMG 
parenchymal cells from apoptosis, rescue the compromised secretory machinery 
and identify induction of apoptosis as the injury signal which induced dysfunction 
in the current model.  
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Unexpectedly, the conducted experiments unravelled novel, off-target properties 
of z-VAD-fmk which culminated in recovery of the TLR3-induced loss of function, 




4.2 Materials and Methods 
4.2.1 z-VAD-fmk Mouse Model 
Table 4-1 summarizes the z-VAD-fmk dose and administration protocol used in 
the current chapter. 
Table 4-1 In vivo inhibition dose and protocol of the z-VAD-fmk model 










(Equils et al., 
2009) 
i.p. 30 min prior to Poly 
(I:C) local injection 
 
4.2.2 Immunohistochemical Analysis 
Paraffin-embedded SMG sections were deparaffinised, rehydrated and antigen 
retrieved by autoclaving with Trilogy™ as detailed in chapter 2, paragraph 2.3. 
Subsequently, slides were incubated in hydrogen peroxide to block endogenous 
peroxidase activity and protein block to inhibit nonspecific background reaction. 
After incubation with the specific primary antibodies (table 4-2), the detection was 
completed using the compatible host HRP-conjugated secondary antibodies. 
Nuclear and counterstaining was done with Mayer’s haematoxylin, then slides 










Table 4-2 Primary Antibodies Used 
 
4.2.3 Western Blotting 
SMG protein extracts were electrophoresed on precast 4-2% SDS-PAGE gel and 
transferred to nitrocellulose membrane as detailed in chapter 2, Paragraph 2.4. 
Membranes were incubated with the primary antibody, followed by 1 hr incubation 
with the appropriate secondary antibody (table 4-3). Subsequently, signal 
development and exposure with enhanced chemiluminescence and ChemiDoc™ 
MP System were performed. 
Table 4-3 List of Antibodies Used in Western Blots 
 
Antibody 
Source & Catalogue Number Host 
Working 
Dilution 
Cleaved caspase 3 R&D Systems, MAB835 Rabbit 1:280 
TLR-3 Abcam, Ltd, ab62566 Rabbit 1:10000 
Myeloperoxidase BosterBio, USA, PB9057 Rabbit 1:1000 
IFN-beta Bioss USA, bs-0784R Rabbit 1:1100 
Cox2 Abcam, Ltd, ab133466 Rabbit 1:400 
Interferon-gamma (IFN-γ) Proteintech Europe,15365-1-AP Rabbit 1:2500 
Phospho-NF-κB (p50) 
Santa Cruz Biotechnology, sc-
271908 
Mouse 1:450 
iNOS Novus Biologicals, USA, NB300-
605 
Rabbit 1:650 
Polyclonal Goat Anti-Rabbit 
Immunoglobulins-HRP 
Dako, P0448 Goat 1:200 
Antibody 





Cleaved Caspase 3 Novus Bio, NB100-56113 Rabbit 1:5000 
TLR-3 Abcam, Ltd, ab62566 Rabbit 1:10000 
Β-actin Sigma, A2228 Mouse 1 μg/mL 
Polyclonal Goat Anti-Rabbit 
Immunoglobulins-HRP 
Dako, P0448 Goat 1:2000 
Polyclonal Goat Anti-Mouse 
Immunoglobulins- HRP 
Dako, P0447 Goat 1:1000 
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4.2.4 RTqPCR  
Total RNAs isolated from SMG tissues (stored in RNAlater®) were extracted 
using RNeasy® Micro Kit (Qiagen) and 100 ng of extracted RNAs were reverse-
transcribed in a 20 μL reaction using the iScript™ cDNA Synthesis kit. 
Quantitative real time PCR (qRT-PCR) was carried out as detailed in chapter 2, 
Paragraph 2.5. All mouse primers were synthesized by PrimerDesign™, Ltd and 
are listed in Table 4-4. All experiments were performed in triplicate. 




MX-1 (MX dynamin-like GTPase 1) NM_010846 
ISG-15 (ISG15 ubiquitin-like modifier) NM_015783 
IL 6 NM_031168 
IL 1β NM_008361 
 Interferon gamma (Ifng) NM_008337 
TLR3 (Toll-like receptor 3) NM_126166 
MDA5 (Interferon induced with helicase C domain 1 (Ifih1), 
transcript variant 1) 
NM_027835 
HPRT (Hypoxanthine guanine phosphoribosyl 
transferase) 
NM_013556 
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) NM_008084 
 
4.2.5 Histologic Examination 
As described in chapter 2, paragraph 2.2, following gland excision and formalin 
fixation of tissues, samples were processed, embedded in paraffin, microtome 






4.2.6 PCR Array of Mouse Toll-Like Receptor Signaling Pathway 
The Mouse RT² Profiler Toll-Like Receptor (TLR) signaling pathway array 
(Qiagen, PAMM-018Z) profiles the expression of 84 genes central to TLR-
mediated signal transduction and innate immunity, including members of the TLR 
signaling family as well as adaptor and effector proteins, members of the NFκB, 
JNK/p38, IRF and JAK/STAT signaling pathways downstream of TLR activation. 
RNA for the control and poly (I:C) injected glands were extracted as detailed in 
chapter 2 Paragraph 2.6. Genomic DNA elimination and reverse transcription 
were performed on 800 ng of extracted RNA, using the RT2 First Strand Kit 
(330401, Qiagen), according to the manufacturer’s protocol. 20 µl of the PCR 
reaction mix (table 4-5) was added to individual wells of the RT2 Profiler PCR 
array format R (PAMM-018ZR, Qiagen) and the thermal cycler was set according 
to http://www.SABiosciences.com/pcrarrayprotocolfiles.php.  
 
               Table 4-5 PCR Components Mix 
2x RT2 SYBR Green ROX FAST Mastermix (330520, Qiagen) 1150 µl 
cDNA synthesis reaction 102 µl 
RNase-free water 1048 µl 
Total Volume 2300 µl 
 
A threshold value above the background signal was chosen and the CT values 
for the run samples were extracted to an excel sheet and analysed using the web-
based PCR Array Data Analysis Software available at 
www.SABiosciences.com/pcrarraydataanalysis.php. Table 4-6 lists the TLR- 





Table 4-6 Gene table: RT² Profiler PCR Array 
Gene Table  
Position Unigene GeneBank Symbol Description Gene Name 
A01  Mm.4475 NM_013482 Btk Bruton agammaglobulinemia 
tyrosine kinase 
AI528679, xid 
A02  Mm.336851 NM_009812 Casp8 Caspase 8 CASP-8, FLICE, MACH, 
Mch5 
A03  Mm.290320 NM_011333 Ccl2 Chemokine (C-C motif) ligand 
2 
AI323594, HC11, JE, 
MCAF, MCP-1, MCP1, 
SMC-CF, Scya2, Sigje 
A04  Mm.3460 NM_009841 Cd14 CD14 antigen - 
A05  Mm.89474 NM_009855 Cd80 CD80 antigen B71, Cd28l, Ly-53, Ly53, 
MIC17, TSA1 
A06  Mm.1452 NM_019388 Cd86 CD86 antigen B7, B7-2, B7.2, B70, CLS1, 
Cd28l2, ETC-1, Ly-58, 
Ly58, MB7, MB7-2, TS, A-2 
A07  Mm.439656 NM_009883 Cebpb CCAAT/enhancer binding 
protein (C/EBP), beta 
C, EBPbeta, CRP2, IL-
6DBP, LAP, LIP, NF-IL6, 
NF-M, Nfil6 
A08  Mm.3996 NM_007700 Chuk Conserved helix-loop-helix 
ubiquitous kinase 
AI256658, Chuk1, Fbx24, 
Fbxo24, IKBKA, IKK1, Ikka, 
NFKBIKA 
A09  Mm.248327 NM_019948 Clec4e C-type lectin domain family 4, 
member e 
C86253, Clecsf9, Mincle 
A10  Mm.4922 NM_009969 Csf2 Colony stimulating factor 2 
(granulocyte-macrophage) 
Csfgm, GMCSF, Gm-CSf, 
MGI-IGM 
A11  Mm.1238 NM_009971 Csf3 Colony stimulating factor 3 
(granulocyte) 
Csfg, G-CSF, MGI-IG 
A12  Mm.877 NM_021274 Cxcl10 Chemokine (C-X-C motif) 
ligand 10 
C7, CRG-2, INP10, IP-10, 
IP10, Ifi10, Scyb10, gIP-10, 
mob-1 
B01  Mm.490895 NM_007922 Elk1 ELK1, member of ETS 
oncogene family 
Elk-1 
B02  Mm.5126 NM_010175 Fadd Fas (TNFRSF6)-associated 
via death domain 
Mort1, FADD 
B03  Mm.246513 NM_010234 Fos FBJ osteosarcoma oncogene D12Rfj1, c-fos, cFos 
B04  Mm.207047 NM_010439 Hmgb1 High mobility group box 1 DEF, HMG-1, Hmg1, SBP-
1, amphoterin, p30 
B05  Mm.334313 NM_008284 Hras1 Harvey rat sarcoma virus 
oncogene 1 
H-ras, Ha-ras, Harvey-ras, 
Hras-1, Kras2, c-H-ras, c-
Ha-ras, c-rasHa, ras 




B07  Mm.6388 NM_010479 Hspa1a Heat shock protein 1A Hsp70-3, Hsp70.3, Hsp72, 
hsp68, hsp70A1 
B08  Mm.1777 NM_010477 Hspd1 Heat shock protein 1 
(chaperonin) 
60kDa, Hsp60 
B09  Mm.1245 NM_010510 Ifnb1 Interferon beta 1, fibroblast IFN-beta, IFNB, Ifb 
B10  Mm.240327 NM_008337 Ifng Interferon gamma IFN-g, Ifg 
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B11  Mm.277886 NM_010546 Ikbkb Inhibitor of kappaB kinase 
beta 
AI132552, IKK-2, IKK-beta, 
IKK2, IKK[b], IKKbeta 
B12  Mm.874 NM_010548 Il10 Interleukin 10 CSIF, Il-10 
C01  Mm.103783 NM_008351 Il12a Interleukin 12A IL-12p35, Il-12a, Ll12a, p35 
C02  Mm.15534 NM_010554 Il1a Interleukin 1 alpha Il-1a 
C03  Mm.222830 NM_008361 Il1b Interleukin 1 beta IL-1beta, Il-1b 
C04  Mm.896 NM_008362 Il1r1 Interleukin 1 receptor, type I CD121a, CD121b, IL-iR, 
Il1r-1 
C05  Mm.14190 NM_008366 Il2 Interleukin 2 Il-2 
C06  Mm.1019 NM_031168 Il6 Interleukin 6 Il-6 
C07  Mm.2856 NM_010559 Il6ra Interleukin 6 receptor, alpha CD126, IL-6R, Il6r 
C08  Mm.38241 NM_008363 Irak1 Interleukin-1 receptor-
associated kinase 1 
AA408924, IRAK, IRAK-1, 
IRAK1-S, Il1rak, Plpk, 
mPLK 
C09  Mm.152142 NM_172161 Irak2 Interleukin-1 receptor-
associated kinase 2 
6330415L08Rik, AI649099, 
IRAK-2 
C10  Mm.105218 NM_008390 Irf1 Interferon regulatory factor 1 AU020929, Irf-1 
C11  Mm.489648 NM_016849 Irf3 Interferon regulatory factor 3 C920001K05Rik, IRF-3 
C12  Mm.275071 NM_010591 Jun Jun oncogene AP-1, Junc, c-jun 
D01  Mm.87787 NM_010735 Lta Lymphotoxin A LT, LT-[a], LT-alpha, LT[a], 
LTalpha, Ltx, TNF-beta, 
TNFSF1, Tnfb, Tnfsf1b, 
hlb382 
D02  Mm.3177 NM_010739 Muc13 Mucin 13, epithelial 
transmembrane 
114, A10, 14, A10, 
AI159736, Lrrp, Ly64, NJ-1 
D03  Mm.2639 NM_010745 Ly86 Lymphocyte antigen 86 MD-1, MD1 
D04  Mm.116844 NM_016923 Ly96 Lymphocyte antigen 96 ESOP-1, MD-2, MD2 
D05  Mm.18494 NM_008928 Map2k3 Mitogen-activated protein 
kinase kinase 3 
AW212142, MEK3, MKK3, 
Prkmk3, mMKK3b 
D06  Mm.412922 NM_009157 Map2k4 Mitogen-activated protein 
kinase kinase 4 
JNKK1, MEK4, MKK4, 
PRKMK4, Sek1, Serk1 
D07  Mm.15918 NM_011945 Map3k1 Mitogen-activated protein 
kinase kinase kinase 1 
MAPKKK1, MEKK1, Mekk 
D08  Mm.258589 NM_172688 Map3k7 Mitogen-activated protein 
kinase kinase kinase 7 
B430101B05, C87327, 
Tak1 
D09  Mm.21495 NM_016700 Mapk8 Mitogen-activated protein 
kinase 8 
AI849689, JNK, JNK1, 
Prkm8, SAPK1 
D10  Mm.43081 NM_013931 Mapk8ip3 Mitogen-activated protein 
kinase 8 interacting protein 3 
BB120594, D17Wsu15e, 
JIP-3, JSAP1, JSAP1a, 
JSAP1b, JSAP1c, JSAP1d, 
Jip3, Syd2, mKIAA1066 
D11  Mm.68933 NM_016961 Mapk9 Mitogen-activated protein 
kinase 9 
AI851083, JNK2, Prkm9, 
p54aSAPK 
D12  Mm.213003 NM_010851 Myd88 Myeloid differentiation 
primary response gene 88 
- 
E01  Mm.256765 NM_008689 Nfkb1 Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells 1, p105 
NF-KB1, NF-kappaB, NF-




E02  Mm.102365 NM_019408 Nfkb2 Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells 2, p49/p100 
NF-kappaB2, lyt, p49, p49, 
p100, p50B, p52 
E03  Mm.170515 NM_010907 Nfkbia Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells inhibitor, alpha 
AI462015, Nfkbi 
E04  Mm.220333 NM_010908 Nfkbib Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells inhibitor, beta 
IKB-beta, IKappaBbeta, 
IkB, IkBb 
E05  Mm.300795 NM_010909 Nfkbil1 Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells inhibitor-like 1 
Def-7, IKBL 
E06  Mm.238146 NM_172766 Nfrkb Nuclear factor related to 
kappa B binding protein 
A530090G11Rik 
E07  Mm.87062 NM_011630 Nr2c2 Nuclear receptor subfamily 2, 
group C, member 2 
TAK1, Tr4, mKIAA4145 




E09  Mm.21855 NM_009402 Pglyrp1 Peptidoglycan recognition 
protein 1 
PGRP, PGRP-S, Pglyrp, 
Tag7, Tasg7, Tnfsf3l 
E10  Mm.212789 NM_011144 Ppara Peroxisome proliferator 
activated receptor alpha 
4933429D07Rik, 
AW742785, Nr1c1, PPAR-
alpha, PPARalpha, Ppar 
E11  Mm.378990 NM_011163 Eif2ak2 Eukaryotic translation 




AI467567, AI747578, Pkr, 
Prkr, Tik 
E12  Mm.292547 NM_011198 Ptgs2 Prostaglandin-endoperoxide 
synthase 2 
COX2, Cox-2, PGHS-2, 
PHS-2, Pghs2, TIS10 
F01  Mm.4869 NM_009044 Rel Reticuloendotheliosis 
oncogene 
c-Rel 
F02  Mm.249966 NM_009045 Rela V-rel reticuloendotheliosis 
viral oncogene homolog A 
(avian) 
p65 





D4Bwg0615e, RICK, RIP2 
F04  Mm.34580 NM_019786 Tbk1 TANK-binding kinase 1 1200008B05Rik, AI462036, 
AW048562 




F06  Mm.149280 NM_173394 Ticam2 Toll-like receptor adaptor 
molecule 2 
B430113A10, TICAM-2, 
TRAM, Tirp, Trif 






F08  Mm.273024 NM_030682 Tlr1 Toll-like receptor 1 - 
F09  Mm.87596 NM_011905 Tlr2 Toll-like receptor 2 Ly105 
F10  Mm.33874 NM_126166 Tlr3 Toll-like receptor 3 AI957183 




F12  Mm.116894 NM_016928 Tlr5 Toll-like receptor 5 - 
G01  Mm.42146 NM_011604 Tlr6 Toll-like receptor 6 - 
G02  Mm.489377 NM_133211 Tlr7 Toll-like receptor 7 - 
G03  Mm.196676 NM_133212 Tlr8 Toll-like receptor 8 - 
G04  Mm.44889 NM_031178 Tlr9 Toll-like receptor 9 - 
G05  Mm.1293 NM_013693 Tnf Tumor necrosis factor DIF, TNF-a, TNF-alpha, 
TNFSF2, TNFalpha, Tnfa, 
Tnfsf1a 
G06  Mm.116683 NM_009397 Tnfaip3 Tumor necrosis factor, alpha-
induced protein 3 
A20, Tnfip3 
G07  Mm.474976 NM_011609 Tnfrsf1a Tumor necrosis factor 
receptor superfamily, 
member 1a 
CD120a, FPF, TNF-R, 
TNF-R-I, TNF-R1, TNF-
R55, TNF-alphaR1, 
TNFAR, TNFR60, TNFRI, 
TNFRp55, TNFalpha-R1, 
Tnfr-2, Tnfr1, p55, p55-R 
G08  Mm.103551 NM_023764 Tollip Toll interacting protein 4930403G24Rik, 
4931428G15Rik 













G12  Mm.360108 NM_023230 Ube2v1 Ubiquitin-conjugating enzyme 




H01  Mm.3317 NM_010368 Gusb Glucuronidase, beta AI747421, Gur, Gus, Gus-r, 
Gus-s, Gus-t, Gus-u, Gut, 
asd, g 
H02  Mm.299381 NM_013556 Hprt Hypoxanthine guanine 
phosphoribosyl transferase 
C81579, HPGRT, Hprt1 
H03  Mm.2180 NM_008302 Hsp90ab1 Heat shock protein 90 alpha 
(cytosolic), class B member 1 
90kDa, AL022974, 
C81438, Hsp84, Hsp84-1, 
Hsp90, Hspcb 
H04  Mm.304088 NM_008084 Gapdh Glyceraldehyde-3-phosphate 
dehydrogenase 
Gapd 
H05  Mm.391967 NM_007393 Actb Actin, beta Actx, E430023M04Rik, 
beta-actin 
H06  N/A SA_00106 MGDC Mouse Genomic DNA 
Contamination 
MIGX1B 
H07  N/A SA_00104 RTC Reverse Transcription 
Control 
RTC 
H08  N/A SA_00104 RTC Reverse Transcription 
Control 
RTC 
H09  N/A SA_00104 RTC Reverse Transcription 
Control 
RTC 
H10  N/A SA_00103 PPC Positive PCR Control PPC 
H11  N/A SA_00103 PPC Positive PCR Control PPC 






4.3.1 Investigating the Role of Apoptosis in TLR3-Mediated SMG 
Dysfunction 
Intraperitoneal priming of mice with the pan caspase inhibitor; z-VAD-fmk was 
undertaken to inhibit apoptosis and assess the role of TLR-3 mediated cell death 
in the SMG hypofunction perceived. The SMG flow rates from the z-VAD-treated 
mice showed an extremely significant recovery compared to the approximate loss 
of secretion perceived in the non-treated animals, 9hrs post poly (I:C) 







   
  
 
Unpaired t test 
P value 0.0007 
P value summary *** 
Paired t test 
P value 0.4587 
P value summary ns 
Figure 4.1 SMG flow rates in response to z-VAD-fmk treatment.  
Data represent the mean ± SD SMG flow rates of the control (V-C: trypan blue and saline) and 
poly (I:C) (PIC)-injected glands from mice treated and non-treated with z-VAD-fmk, 9 hrs post 
poly (I:C). An extremely significant recovery was perceived in the SMGs from mice which received 































































Western blot analysis and immunohistochemistry were performed to validate the 
efficient inhibition of apoptosis by z-VAD-fmk and correlate this to the preserved 
SMG functions. Surprisingly results obtained from these experiments revealed 
the incomplete elimination of the cleaved csp-3 immunolabelled apoptotic cells in 
the SMGs, despite priming the mice with the pan caspase inhibitor, figure 4.2. 
 













-  -           +           + 
-  +           -           + 
+       +         -         - 
Figure 4.2 Caspase-3 expression in the SMGs from z-VAD-fmk treated and non-treated 
mice.  
A: Western blot analysis demonstrated that the control vehicle-injected SMG tissue extracts 
revealed the 32 KD pro-caspase 3 only and lack of its proteolytic cleavage.  Poly (I:C) injection 
induced apoptosis in the SMGs and the pro and cleaved bands were clearly seen. The glands 
from mice primed with z-VAD-fmk prior to poly (I:C) injection exhibited incomplete inhibition of 
apoptosis which was demonstrated by expression of the cleaved csp-3 positive band. B: 
Immunohistochemically, cleaved caspase-3 immunolabelled cells were still clearly depicted in the 
in acini of SMG tissue sections from z-VAD-primed mice. Original magnification= 25x. 
 
Vehicle   
Pro-CSP-32 KDa 
Cleaved CSP-3 14-21 KDa 
Cleaved CSP-3 10 KDa 







4.3.2 Investigating Off-Target Effects of z-VAD-fmk 
These unexpected results prompted us to broadly investigate the likely off-target 
therapeutic effect of the pan caspase inhibitor, z-VAD-fmk, which protected the 
viral mimic-infected SMGs. To provisionally assess the histomorphology of the 
tissues, H&E sections from SMGs of the z-VAD-treated and non-treated mice 
were microscopically examined. Surprisingly, the viral mimic-infected glands from 
the z-VAD treated mice were inflammation- and edema-free; two hallmark 
features which were widely observed in the poly (I:C) injected glands lacking 
priming with the caspase inhibitor, figure 4.3. Although we have previously shown 
that loss of function in the current model is independent of neutrophil infiltration, 
we aimed at confirming the unpredictable anti-inflammatory effect which z-VAD 
conferred on the viral mimic-infected glands by labelling these tissues with MPO 
and comparing the results to those perceived in the dsRNA/TLR3 inhibition 
model. Immunohistochemistry similarly confirmed the H&E results, whereby the 
SMGs from the z-VAD-treated mice displayed broad MPO negative 































































































































































































































Based on these finding, we hypothesized that z-VAD which can efficiently inhibit 
cathepsin activity (Schotte et al., 1999, Rozman-Pungercar et al., 2003), might 
have protected the viral mimic induced SMG dysfunction via interfering with the 
cathepsin-mediated proteolytic processing of TLR3 (Garcia-Cattaneo et al., 
2012) and subsequent generation of the C-terminal cleaved isoform.  
A straightforward verification of our hypothesis came from probing gland 
homogenates from mice pre-treated with z-VAD with the TLR3 C-terminal 
antibody and comparing the results with the glands which received the viral mimic 
only. Figure 4.4 illustrates the extremely significant, declined expression of the 
cleaved form of the receptor in the glands of the z-VAD-treated group, in contrast 
to its upregulated expression in the non-treated mice which received poly (I:C) 































Sidak's multiple comparisons test Summary P Value 
V-C vs. z-VAD+PIC ns 0.4280 
PIC vs. z-VAD+PIC *** 0.0002 
ANOVA summary 
P value 0.0002 
P value summary *** 
Figure 4.4 TLR3 C-terminal immunohistochemistry and western blots following z-VAD-fmk 
treatment. 
A: Excessive tissue upregulation of TLR3 C-terminal in the ducts and acini following poly (I:C) 
exposure, and its remarkable retraction when mice were pre-treated with z-VAD-fmk. B: TLR3 
expression was calculated as TLR3/β-actin ratio fold change from control saline injected glands. 
ANOVA showed an extremely significant reduction of the receptor C-terminal isoform in the z-
VAD treated group following poly (I:C) exposure, which was retracted to a level non-significant 
from that expressed in the control vehicle glands. Data are representative of three independent 





















































Vehicle                                
Poly (I:C)                                                                         
z-VAD-fmk                     -         -                   + 
-         +                  + 
TLR3 C-terminal ~ 52 KDa 
Β-actin 
B 




4.3.3 Mapping Poly (I:C)-Induced Innate Immune Signals Following z-VAD-
fmk  
Mouse RT2 Profiler™ TLR PCR array was used to provide wide-ranging analysis 
of TLR-related, innate immune adaptor and effector genes and downstream 
signalling pathways. We analysed a total of 84 genes in the SMGs, 6 hrs post 
vehicle and poly (I:C) injection, in the z-VAD-fmk treated and non-treated mice. 
Unpredictably, z-VAD-fmk damped the expression level of all TLR-related genes, 
compared to the extensive transcriptional upregulation seen in the SMGs which 




































                 6h P-PIC                                z-VAD-fmk + 6h P-PIC 
z-VAD- + 6 hrs P-PIC 
 
Figure 4.5 Heat map of TLR PCR array. 
Differential expression of 84 genes in SMGs stimulated with poly (I:C), normalized to the control 
contralateral glands and GUSB housekeeping gene in case of z-VAD non-treated and β-actin in 
z-VAD treated mice. The fluorescence range from high (red) to low (green) is indicated by the 
coloured bar and reflects the degree of fluorescence intensity/gene expression. Note the overall 
decline in the SMG innate immune-related genes following priming the mice with z-VAD-fmk and 
interference with neo-generation of the TLR3 C-terminal.   
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Next, to confirm this novel, off-target role played by z-VAD-fmk in controlling 
innate immunity following SMG infection with a viral mimic, qRT-PCR was carried 
out to further analyse the mRNA expression levels of dsRNA-response genes 
and pro-inflammatory cytokines in the SMGs of z-VAD-fmk treated mice. Bar 
charts in figure 4.6 and 4.7 clearly demonstrate the overall significant decline in 
tested genes in the z-VAD-fmk group, compared to the poly (I:C)-upregulated 
responses seen in the glands from non-treated mice, all normalized to the 
‘relevant’ vehicle injected control glands and GAPDH housekeeping gene (for the 
glands from z-VAD-fmk treated mice) and HPRT (in the glands which received 









































ANOVA ISG15 MX1 TLR3 MDA5 
P value <0.0001 <0.0001 <0.0001 <0.0001 
P value summary **** **** **** **** 








V-C vs. 6h P-PIC **** <0.0001 **** <0.0001 **** <0.0001 **** <0.0001 
6h P-PIC vs. z-VAD+PIC **** <0.0001 **** <0.0001 **** <0.0001 **** <0.0001 
























































































































































































































* * * * * * * * *
Figure 4.6 mRNA Expression of dsRNA response genes: antiviral genes; MX1 and ISG15 
as well as the dsRNA sensors; TLR3 and MDA5.  
SMGs from z-VAD-fmk-treated animals showed either non-significant (TLR3 and MX1) or mild 
activation (MDA5 and ISG15) of the dsRNA response genes compared to the extremely 
significant upregulation of these genes, 6hrs following poly (I:C) (6h P-PIC) in the glands from z-






























ANOVA  IL-1B IL-6 IFN-G 
P value <0.0001 <0.0001 <0.0001 
P value summary **** **** **** 








V-C vs. 6h P-PIC **** <0.0001 **** <0.0001 **** <0.0001 
6h P-PIC vs. z-VAD+PIC **** <0.0001 **** <0.0001 **** <0.0001 

































































































































































* * * * * * * * * * * *
Figure 4.7 mRNA Expression of genes encoding pro-inflammatory cytokines; 
IL-1β, IL-6 and IFN-γ.  
z-VAD-fmk remarkably downregulated the pro-inflammatory cytokine response 
perceived 6 hrs following poly (I:C) (6h-P-PIC) injection. Data represents means ± 
SEM (n=3). **P≤0.01, ****p≤0.0001 
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To confirm the PCR outcome which identified a novel non-specific immune 
regulatory role of the cysteine protease inhibitor; z-VAD-fmk, tissue sections were 
immunolabelled with cytokines, which have been prominently upregulated in 
response to local poly (I:C) injection. Figure 4.8 clearly demonstrates an overall 
reduction in the immunhohistochemical expression of tested cytokines in tissues 
from mice primed with z-VAD-fmk in contrast to the non-primed ones. 
Interestingly, in the SMGs from z-VAD-treated mice, traces of IFN-β, Cox2 and 
IFN-γ cytokines were perceived in the glandular parenchymal tissues, which 
parallels their minimal transcriptional activation recorded by the RT2 profiler 
arrays (figure 4.5). Conversely, NF-κB nuclear translocation and iNOS 
immunoexpression were completely inhibited in the protected SMGs from mice 







































Figure 4.8 Immunohistochemical analysis of pro-inflammatory cytokines 
expression in the control-vehicle and poly (I:C) injected SMGs of the z-VAD-fmk 
treated and non-treated mice.  
Note the remarkably reduced protein expression of IFN-β, Cox2 and IFN-γ in response 
to z-VAD priming. On the contrary, NF-κB nuclear translocation which was abundantly 
seen 9h post poly (I:C) (insets) and extensive iNOS immunoexpression, were 
completely inhibited to levels comparable to the control glands. Original 































In the current chapter, a novel mechanism was reported, whereby the pan 
caspase inhibitor z-VAD-fmk: (i) restricted TLR3 C-terminal neo-generation, (ii) 
limited the innate immune responses and (iii) guarded against the TLR3-induced 
loss of SMG function. Initial experiments to investigate the role of apoptosis in the 
current dysfunction model, revealed two contradictory results: priming mice with 
the pan caspase inhibitor efficiently preserved saliva secretion, despite of the 
incomplete elimination of cleaved caspase 3-positive signal.  
Key players involved in apoptosis are the eight cysteine aspartyl proteases 
caspase- 2, -3, -6, -7, -8, -9, -10, -12 (Earnshaw et al., 1999). Typically, the 
extrinsic apoptotic signalling pathway mediated by caspase 8 (Donepudi et al., 
2003) as well as the intrinsic pathway mediated by caspase 9 (Wang, 2001), 
converge into cleavage of caspase 3, which then triggers the appearance of the 
apoptotic morphology, particularly DNA/nuclear fragmentation (Krammer, 2000). 
In the current model, the persistent cleaved caspase 3 positive signal in the 
presence of z-VAD-fmk, can be attributed to the dose of the pan caspase 
inhibitor, which at many instances turn out to be highly unspecific at the 
concentrations widely used to test programmed cell death (Schotte et al., 1999). 
Also, previous studies have suggested non-caspase, serine proteases, which 
might be active under cellular stress conditions, as upstream prerequisites to 
caspase-3 processing as well as cytochrome c release and apoptosis, even in 
the presence of z-VAD-fmk (Egger et al., 2003). Finally, Marsden et al., proposed 
that a yet unknown z-VAD-fmk -insensitive caspase acting aside or upstream of 
mitochondria was responsible for intrinsic cell death, in the presence of z-VAD-
fmk (Marsden et al., 2002). 
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Attempts to broadly investigate the unexpected rescuing effect of z-VAD-fmk, 
revealed depletion of MPO positive cells in the poly (I:C) injected glands, similar 
to what was demonstrated in the TLR3/dsRNA inhibition model. The overlapping 
of these findings, suggested that the pan caspase inhibitor has unexpectedly 
targeted TLR3 activation and inhibited its downstream inflammatory response. 
Cathepsin B has already been considered an essential component in TLR3 
signalling, by proteolytically processing TLR3 to generate the functional C-
terminal form of the receptor, crucial for signalling (Garcia-Cattaneo et al., 2012, 
Murakami et al., 2014, Toscano et al., 2013). Indeed, it has been shown that z-
VAD-fmk concentrations that are commonly used to reveal a role of caspases, 
can potently bind and inhibit cysteine proteases of the cathepsin family, mainly 
Cathepsin B (Schotte et al., 1999). The reason for this non-specific binding is 
unclear, given that the structures and catalytic sites of caspases do not resemble 
those of cathepsin B (Chou et al., 1997, Podobnik et al., 1997). However, 
cathepsins possess broad substrate specificity that can explain its proposed 
inhibition by z-VAD-fmk (Turk et al., 2001). By considering the previously 
documented z-VAD-fmk ‘off-target’ effects (Satoh et al., 2013, Rozman-
Pungercar et al., 2003, Wu et al., 2011, Schotte et al., 1999) and its non-specific 
inhibition of cathepsins (Schotte et al., 1999), we hypothesized that z-VAD-fmk 
may have inhibited TLR3-driven immune responses and subsequent SMG 
dysfunction by interfering with cathepsin-mediated TLR3 cleavage in acidic 













Cysteine cathepsins constitute the largest cathepsin family, including 11 
members; cathepsins B, C, F, H, K, L, O, S, W, V and X (Rawlings et al., 2012). 
They are synthesized as inactive precursors that are normally activated in the 
acidic environment of lysosomes. Although, cathepsin B inhibition by z-VAD-fmk 
has not been comprehensively verified in the current model, immunoblotting of 
the SMG homogenates from the z-VAD-fmk treated group revealed that the pan 
caspase inhibitor had efficiently inhibited the neo-synthesis of TLR3 C-terminal 
fragment and accounted for a novel anti-viral, regulatory role of this drug.  
To overcome the constrains of large-scale experimental analysis of the complex 
innate immune responses to TLR3, and in the meantime broadly investigate the 
novel z-VAD-fmk immune regulatory role, we used an array of 84 genes encoding 
TLR-related adaptor and effector molecules. Six hrs post its infusion, poly (I:C) 
predictably upregulated TLR3 expression, as well as IFN-β and acute pro-
inflammatory cytokine genes; IL-1α, IL-1β, IL-6, TNF-α and IFN-γ.  
 
TLR3/dsRNA 
inhibitor  z-VAD-fmk 
MPO 
+ Cells 
TLR3 Competitively inhibit 




Figure 4.9 Hypothesis to explain z-VAD-fmk therapeutic and anti-
inflammatory effects in the acute viral SMG dysfunction model. 
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In addition, we identified CXCL10 (interferon gamma-induced protein 10, IP-10), 
a chemokine that promotes leukocyte trafficking (Muller et al., 2010) and directly 
contributes to the pathogenesis of excessive neutrophil-mediated inflammation 
(Ichikawa et al., 2013). Alongside its protective role during viral infections, 
CXCL10 may enhance the severity of these types of infections and cause 
apoptosis (Sui et al., 2004) as well as calcium dysregulation (Sui et al., 2006). 
Other several interesting groups of genes showed remarkable upregulation in the 
TLR array, example the CD14 which has been shown to bind poly (I:C) at the cell 
surface (Lee et al., 2006). In addition, HMGB1 and the Hspa1a genes were 
upregulated in the current model in response to poly (I:C), possibly due to DAMPs 
released subsequent to TLR-3 induced apoptosis and necroptosis (Cunningham 
et al., 2004, Wang and Carmichael, 2004, Leadbetter et al., 2002). Finally, 
previous studies reported that components of the TLR2 and NOD2 signalling 
cascade had been significantly upregulated upon monocytes recruitment into 
acutely inflamed tissues (Zigmond et al., 2012), which may justify the 
upregulation of the TLR2-MyD88-NOD2-RIPK2 signalling axis in the current 
acute viral mimic model.  
The pattern of innate, TLR-related gene transcription in the SMGs following poly 
(I:C) injection shifted towards baseline and declined levels when mice were 
primed with z-VAD-fmk. Besides, the immunohistochemical analysis, revealed 
that the poly (I:C)-induced NF-κB nuclear translocation and extensive protein 
expression of IFN-β, IFN-G, Cox2 and iNOS, were retracted or completely 
inhibited in response to priming with z-VAD-fmk. These results clearly signify the 




In this regard, it is worth noting that that protease inhibitors have been used 
successfully to dampen inflammation during HIV and HCV infections (Equils et 
al., 2004). Their therapeutic ability was shown to rely on the interaction with the 
proteasome, which is important for degradation of inhibitor κB, restricting NF-κB 
nuclear translocation, hence, its activation.  
Although much has been learned on the biochemical and cell biological 
characteristics of TLRs, the integration of their signalling pathways into the 
trafficking network, under inflammatory conditions, remains to be defined.  
Endosomal cathepsins have been documented to cleave TLR9, as a prerequisite 
to its activation (Ewald et al., 2008, Park et al., 2008, Sepulveda et al., 2009). 
However, newly synthesized TLR9 is retained in the ER at steady state until 
exposed to CpG DNA ligand, which promotes its trafficking to endosomes (Fukui 
et al., 2009), where it is subjected to cathepsin-mediated proteolytic processing 
to initiate signalling (Ewald et al., 2011, Park et al., 2008). In contrast, in vitro 
experiments have shown that: in the absence of ligand, TLR3 is transported to 
the endosome via a classical-secretion pathway, where cleavage occurs and a 
pool of cleaved C-terminal fragment accumulates there, ready to signal (Garcia-
Cattaneo et al., 2012). Since the antibody against the TLR3 C-terminus has 
detected minimal expression of this fragment in the SMGs of the z-VAD treated 
group, this residual positivity may probably correspond to the control cellular 
pools of the basally-cleaved TLR3.  
In the current study, incomplete inhibition of the innate immune signals has been 
observed in the SMGs from mice primed with z-VAD-fmk. These signals can be 
attributed either to the cytosolic RLRs or the initial innate immune signals which 
took place following ligation of basal TLR3.  
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Also, these detected signals may have been truncated by z-VAD-fmk, which 
interrupted TLR-3 neo-synthesis and propagation of its downstream responses. 
Our results undoubtedly highlight, the possibility of fine-tuning innate immune 
responses using z-VAD-fmk or similar protease inhibitor drugs in vivo, which can 
provide promising clues into developing therapeutic approaches against SG viral 
infections.  
Finally, functional analysis of the z-VAD-fmk treated SMGs revealed the 
therapeutic effects that can be achieved by z-VAD-fmk in acute SG dysfunctions. 
Based on cytokine profiling of the protected glands following TLR3 inhibition and 
z-VAD-fmk treatment, we observed that functional rescue in both models 
paralleled complete blocking of the potent pro-inflammatory cytokine, iNOS. 
Given this recurrent finding and the injurious role played by iNOS in salivary gland 
injury and dysfunction (de la Cal et al., 2006, Takeda et al., 2003a, Hanaue et al., 
2007, Konttinen et al., 1997), we hypothesized the potential involvement of this 
innate immune cytokine in the TLR-3 mediated loss of function. Therefore, in the 
next chapter, iNOS expression and its potential injurious effects in the acute viral 





Chapter 5                                 
Injurious Contribution of 
Inducible Nitric Oxide Synthase 
in the Acute SMG Dysfunction 





In a previous chapter of this thesis, the synthetic dsRNA analogue has induced 
SMG injury and loss of function, in TLR3-dependent manner. In addition, it was 
demonstrated that the functionally-preserved, TLR3-inhibited SMGs (in the 
dsRNA/TLR3 and z-VAD-fmk models) revealed loss of the extensively 
upregulated pro-inflammatory cytokine; iNOS. Nitric oxide synthase (NOS) is the 
enzyme responsible for converting L-arginine into nitric oxide in the presence of 
O2. Three isoforms of NOS are known in mammals: two constitutive isoforms 
(NOS1 or nNOS, produced by neurons; NOS3 or eNOS, produced by endothelial 
cells) and one inducible isoform (iNOS or NOS2) (Knowles and Moncada, 1994). 
In contrast to constitutive NOS isoforms which produce nitric oxide (NO) within 
seconds, with direct and short acting activities, inducible NOS produces very 
large, toxic amounts of NO in a sustained manner (Salvemini et al., 2003), which 
plays regulatory roles at nearly each phase of the inflammatory response (Guzik 
et al., 2003).  
iNOS expression can be induced by a wide range of stimuli, such as microbial 
products and cytokines. Signal transduction via MyD88 or TRIF converge in the 
activation of the transcription factor NF-κB, which upregulates iNOS transcription. 
Cytokines such as IL-1β, which also activates the signalling pathway of MyD88 
and IRAK and TNF-α also induces the production of iNOS by activating NF-κB 
(Uehara et al., 2015). Additional participating transcription factors include AP-1, 













A very likely event during the inflammatory response is the side by side 
generation of large amounts of iNOS-driven NO and superoxide anion (O2-), 
where the reaction of these unstable molecules will yield a more stable and more 
potent cytotoxic peroxynitrite (ONOO-) (Channon and Guzik, 2002, Guzik et al., 
2002) (figure 5.2). No enzyme is required to form peroxynitrite because no 
enzyme can possibly catalyze any reaction as fast. Consequently, the kinetics of 
the reaction of superoxide with NO make the formation of peroxynitrite inevitable 
in vivo (Pacher et al., 2007).  
 
 
Figure 5.1 Overview of iNOS induction by TLR 
agonists and cytokines.  
iNOS expression can be induced and/or potentiated by 
PAMPs, DAMPs, and cytokines. TLR, IL-1R, and TNFR 
signalling induce the activation of AP-1 and NF-kB, the 
main transcription factor involved in iNOS expression. 
Further, IFN-R activates STAT1, which in turn can 
directly promote iNOS transcription and alternatively 
promote the synthesis of interferon regulatory factor 1 
(IRF1), another transcription factor that positively 
regulates iNOS transcription. In turn, TGF-β inhibits NF-
κB activation thus suppressing iNOS expression (Uehara 












Peroxynitrite accompanies various inflammatory responses, and has been 
proposed to play an important role in mediating NO-related cellular injury (Szabo, 
2003). Previous studies have suggested peroxynitrite-promoted modulations of 
cell signalling, induction of oxidative injury (Pacher et al., 2007), release of matrix 
metalloproteinases (MMPs) (Ichikawa et al., 2014) and nitration of tyrosine 
residues (Ischiropoulos, 1998). Alongside its contribution to multiple pathways of 
cytotoxicity (Szabo, 2003), peroxynitrite has been shown to inhibit a variety of ion 
pumps including calcium pumps (Klebl et al., 1998), calcium-activated potassium 
channels and also membrane Na+/K+ ATP-ase activity (Muriel and Sandoval, 
2000). Another major aspect of peroxynitrite-dependent cytotoxicity relies on its 
ability to trigger lipid peroxidation in membranes (Radi et al., 1991), causing 
membrane permeability and fluidity changes with significant biological 
consequences (Richter, 1987).  
 
Figure 5.2 Scheme of Nitric oxide, superoxide 
and the product of their reaction peroxynitrite 
formation.  
iNOS catalyses the oxidation of L-arginine to L-
citrulline, producing NO, which combined with 
superoxides to yield peroxynitrite, nitrites and 
nitrates (Salvemini et al., 2003). 
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The implication of iNOS (Konttinen et al., 1997) with accumulated damage from 
NO (Konttinen et al., 1997, Kimura-Shimmyo et al., 2002, Takeda et al., 2003a, 
Dawson et al., 2006) and peroxynitrite (Hanaue et al., 2007) in the loss of saliva 
production, have been previously reported. Experiments which investigated the 
effect of NO on the SG secretory function, validated desensitization of the SMG 
acinar cells after prolonged exposure to NO (Caulfield et al., 2009). In addition, 
NO has been shown to mediate Ca2+ disruption, either via tyrosine nitration of 
SERCA-ATPase (Xu et al., 1999, Viner et al., 1999) and inhibition of Ca2+ uptake 
from cytosol or S-nitrosylation of RyR (Xu et al., 1998) and excessive Ca2+ 
release to cytosol. Based on this, it has been reported that through its ability to 
disturb ER Ca2+ homeostasis (Oyadomari et al., 2002), NO can initiate the ER 
stress pathway (Oyadomari et al., 2001, Xu et al., 2004). Since the salivary 
glands’ ER is involved in extensive folding, processing and trafficking of newly 
synthesised secretory and membrane proteins, these exocrine tissues are 
exceptionally sensitive to ER stress and its inhibitory impact on integral formation 
of key receptors, channels and transporters.  
The aim of the present chapter was to determine the temporal expression and 
possible injurious contributions of the pro-inflammatory mediator; iNOS and its 









5.2 Materials & Methods 
5.2.1 iNOS Inhibition Model 
To investigate the possible injurious effect of iNOS on the SMG functions, we 
used the selective iNOS inhibitor, aminoguanidine (AG). Table 5.1 summarizes 
the AG doses used in the experiments of the current chapter. 








Sigma, 396494 For short term inhibition:  100mg/kg i.p. AG 
(Tunctan et al., 1998) and 0.1 mg AG combined with 
poly (I:C): tissue and saliva collection after 9 hrs of 
poly (I:C). 
For long term inhibition (MacFarlane et al., 1999): 
2.5% AG in drinking water for 7 days. Poly (I:C) local 
injection in conjunction with 0.1 mg AG: tissue and 
saliva collection after 24 hrs of poly (I:C). 
 
The vehicle injected control gland received: trypan blue, saline, and 0.1 mg 
aminoguanidine. 
5.2.2 Immunohistochemistry 
Paraffin-embedded SMG sections were deparaffinised, rehydrated and antigen 
retrieved by autoclaving with Trilogy™ as detailed in chapter 2, paragraph 2.3. 
After incubation with the specific primary antibodies (table 5-2), the detection was 
completed using the compatible host HRP-conjugated or fluorescent conjugated 
secondary antibodies. Nuclear and counterstaining was done with Mayer’s 
haematoxylin or Vectashield Antifade DAPI Mounting Medium (Vector 







Table 5-2 Primary Antibodies Used 
 
5.2.3 Western Blotting 
SMG protein extracts were electrophoresed on precast 4-2% SDS-PAGE gel and 
transferred to nitrocellulose membrane as detailed in chapter 2, Paragraph 2.4. 
Membranes were incubated with primary antibody (table 5-3), followed by 
application of anti-rabbit secondary antibody. Subsequently, signal development 
and exposure with Enhanced Chemioluminescence and ChemiDoc™ MP 
System were performed. 
 
Antibody 



















Na-K- CL-Cotransporter 1 (NKCC1) 
ABCAM, ab59791 Rabbit 1:6000 





Transmembrane member 16A (TMEM16A) 
ABCAM, ab53213 Rabbit RTU 1:1 





CD107a / LAMP-1 clone H4A3 Exbio, 10-671-C025 Mouse 1:1000 
Polyclonal Goat Anti-Rabbit 
Immunoglobulins-HRP 
Dako, P0448 Goat 1:200 
Polyclonal Goat Anti-Mouse 
Immunoglobulins- HRP 
Dako, P0447 Goat 1:100 
Polyclonal Rabbit Anti-Goat 
Immunoglobulins/HRP 
Dako, P0160 Rabbit 1:200 
Goat anti-Mouse IgG (H+L) Secondary 




Donkey anti-Rabbit IgG (H+L) Secondary 







Table 5-3 List of Antibodies Used in Western Blots 
 
5.2.4 RTqPCR  
Total RNAs isolated from SMG tissues (stored in RNAlater®) were extracted 
using RNeasy® Micro Kit (Qiagen) and 100 ng of extracted RNAs were reverse-
transcribed in a 20 μL reaction using the iScript™ cDNA Synthesis kit. 
Quantitative real time PCR (qRT-PCR) was carried out as detailed in chapter 2, 
Paragraph 2.5. All mouse primers were synthesized by PrimerDesign™, Ltd and 
are listed in Table 5-4. 
            Table 5-4 List of Primers used 
Gene Accession Number 
X-box binding protein 1 (Xbp1) NM_013842 
heat shock protein 5 (Hspa5) (BIP) (GRP 78) NM_001163434 
DNA-damage inducible transcript 3 (Ddit3) 
(CHOP) 
NM_007837 
actin, beta (Actb) NM_007393 
HPRT (Hypoxanthine guanine phosphoribosyl 
transferase) 
NM_013556 
Aquaporin 5 (AQP-5) 
NM_009701.4 
Na-K- CL-Cotransporter 1 (NKCC1) 
Solute carrier family 12, member 2 (Slc12a2) 
NM_009194.3 
Muscarinic 3 Receptor (M3R) 
NM_033269.4 
Transmembrane member 16A (TMEM16A) 
NM_178642.5 
 
Antibody Source & Catalogue Number Host 
Working 
Dilution 
3-Nitrotyrosine Millipore, 05-233 Mouse 1:1000 
Phospho-eIF2alpha (Ser51) Cell Signaling Technology, 9721 Rabbit 1:1000 
Β-actin Sigma, A2228 Mouse 1 μg/mL 
Polyclonal Goat Anti-Rabbit 
Immunoglobulins-HRP 
Dako, P0448 Goat 1:2000 
Polyclonal Goat Anti-Mouse 
Immunoglobulins- HRP 
Dako, P0447 Goat 1:1000 
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5.2.5 Microplate Intracellular Calcium Assays 
 We developed a novel protocol for assessment of Ca2+ signalling in the acinar 
units of the control and poly (I:C)-injected SMGs after their isolation from the 
C57/B6 mice, using the benchtop, multi-mode, FlexStation 3. The main outline of 




Figure 5.3 Illustrated summary of the novel protocol for measuring [Ca2+]i 
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• Reagents  
1. HEPES (Sigma-Aldrich, Cat. # H3375). 
2. NaCl (Sigma-Aldrich, Cat. # S7653). 
3. KCl (BDH, AnalaR, Cat. # 101984L). 
4. MgCl2 (Sigma-Aldrich, Cat. # M8266). 
5. CaCl2 (Sigma-Aldrich, Cat. # C-4901). 
6. Glucose (Sigma-Aldrich, Cat. # G8270). 
7. Glutamine (Sigma-Aldrich, Cat. # G7513). 
8. MEM Non-Essential Amino Acids Solution (100X) (Thermo Fisher 
Scientific (Life Technologies) Cat. # 11140050). 
9. Bovine serum albumin (BSA) (Sigma-Aldrich, Cat. # A2153). 
10. Collagenase from Clostridium histolyticum (Type-4 collagenase) (Sigma-
Aldrich, Cat. # C5138). 
11. Soybean Trypsin Inhibitor (Thermo Fisher Scientific (Life Technologies), 
Cat. # 17075029). 
12. Corning® Cell-Tak (Fisher Scientific Ltd, Cat. # 354240).  
13. NaHCO3 (Sigma-Aldrich, Cat. # S6014). 
14. Fura-2 AM (Molecular Probes™, Cat. # F-1201). 
15. Probenecid (Sigma-Aldrich, Cat. # P8761). 
16. Half-area, 96-well plates ((Fisher Scientific Ltd, Cat # 10717804). 
17. Carbachol (CCh) (Santa Cruz Biotechnology, Cat. # sc-202092).  
18. Ionomycin (IM) (Santa Cruz Biotechnology, Cat. # sc-3592). 
19. Culture grade dimethyl sulfoxide (DMSO) (Sigma-Aldrich, Cat. # 
276855). 




• Recipes  
1. HEPES incubation buffer:  A- Ca2+-containing buffer: 20 mM HEPES, 
95 mM NaCl, 4.7 mM KCl, 0.6 mM MgCl2, 1.3 mM CaCl2, 10 mM glucose, 
2 mM glutamine, and 1 × minimum Eagle's medium non-essential amino 
acids, pH 7.4. The buffer was oxygenated for 20 minutes before use. B: 
Ca2+-free buffer: prepared as previous, with the exception that 1M EGTA 
Ca2+ chelator was added and CaCl2 was omitted.  
2. BSA incubation buffer: BSA, 1% w/v final added to 25 ml of the HEPES 
buffer. 
3. Collagenase digestion buffer (CDB): 1.1 mg/ml type-4 collagenase and 
1 mg/ml soybean trypsin inhibitor added to 6 ml of BSA incubation buffer.  
4. Sodium bicarbonate (NaHCO3) neutral buffer solution: 0.1 M sodium 
bicarbonate, pH 8.0 was prepared by dissolving 420 mg NaHCO3 in 50 ml 
ultrapure distilled water. 
5. For coating of a half area 96-well plate: dilute 30 µl of Corning® Cell-
Tak in 2 ml of the neutral bicarbonate buffer. 
6. Fura-2 AM stock solution: Suspend 1 mg of lyophilized Fura-2 AM with 
DMSO to yield a 1 mM stock. Aliquot this stock and keep at all times in the 
dark at -20 oC. 
7. 1M probenecid: dissolve in 1 M NaOH (50 mg/ml), yielding a clear, 
colorless solution  
8. Fura-2 working solution: 4 µl Fura-2 AM stock, 4µl probenecid 1M and 
4 ml HEPES buffer. Caution: Buffer preparation and cell loading were 




• Assay plate preparation:  
To maintain acinar units in place throughout the FlexStation 3 measurements, 
Corning® Cell-Tak adhesive was used to coat the half-area, 96-well assay plates 
which were used in these experiments. Corning® Cell-Tak adhesive is a 
formulation of the "polyphenolic proteins" (Waite and Tanzer, 1981) extracted 
from the marine mussel, Mytilus edulis. This family of related proteins is the key 
component of the glue secreted by the mussel to anchor itself to solid structures 
in its natural environment (Waite, 1983).  
1. On the day preceding the experiment, the NaHCO3 neutral buffer solution 
was filter-sterilized.  
2. The amount of Corning® Cell-Tak required for each well in the assay plate 
was calculated according to the manufacturer’s recommendations: 0.56 
µg Corning® Cell-Tak/well.  
3. The correct amount of Corning® Cell-Tak was diluted into the neutral 
buffer, mixed thoroughly, and dispensed into the assay plate wells within 
10 minutes.  
4. The plate cover was placed and the coated assay plate was incubated 
overnight at room temperature. 
5. On the next day (the day of the experiment), the unevaporated Cell-Tak 
was poured off and each well was washed with 200µl filter-sterile distilled 
water to remove the bicarbonate.  
➢ Hint: it is of extreme importance not to place the Cell-Tak-coated assay plate 
in the CO2 incubator while preparing the compound plate, otherwise Cell-Tak 
will lose its activity and acinar units will be detached from the plate bottom 
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when the secretagogues are added and severe inconsistency in fluorescence 
recording will occur. 
• Isolation and preparation of the SMGs 
1. The SMGs were dissected out and rinsed with Hanks balanced salt 
solution  
2. Excised SMG was minced with scalpels or curved scissors in a labelled 
weighing boat, containing 1 ml of the CDB.  
3. The gland homogenate was transfered to a 50ml falcon tube and 
incubated in 4ml CDB, in a 37 °C water bath for 30 min.  
4. After the digestion was complete, the CDB was carefully pipetted-out and 
replaced with 6 ml of BSA incubation buffer.  
5. The tube was shaken vigorously by hand for 10 secs, in order to disperse 
the cells into smaller acinar units, figure 5.4.  
6. The physiologic units were allowed to settle, then the supernatant was 










Figure 5.4 Representative example of the physiologic acinar units obtained in the present protocol 




➢ Hint: care should be taken to remove the BSA buffer completely, followed by 
replacement with HEPES incubation buffer.  
• Dye loading 
1. To prevent leakage of the dye from the cells, add 1 mM probenecid; an 
organic anion transport blocker, to the dye buffer.  
2. The acinar units (in the falcon tube) were incubated in 4 ml Fura-2 working 
solution in a CO2 incubator at 37°C for 1 hour.  
3. During this period, the FlexStation 3 was switched on and the temperature 
was adjusted to 37°C.   
4. After one hour, the acinar units were washed with HEPES buffer once. 
5. The final HEPES buffer volume to be dispensed on the acinar units was 
calculated according to number of wells to be seeded, using the following 
formula: final HEPES buffer per gland= number of wells to be seeded x 75 
(final volume/well in the assay plate).  
6. After seeding the HEPES buffer/acinar units into the assay plate, it was 
covered and placed into its allocated position in the FlexStation, until 
preparation of the compound plate is complete. Caution: Do NOT do this 
step in the CO2 incubator. 
➢ Hint:  
It is essential to take into consideration the importance of having relatively equal 
density of acinar units per well. To achieve this: 
o Pipette the digested acinar units gently up and down frequently 
between each transfer of HEPES buffer/acinar units into the wells of 
the assay plate.  
164 
 
o We recommend performing this critical step near an inverted 
microscope to frequently check uniform density of the seeded acinar 
units. 
• Compound plate preparation:  
1. The stock solutions of the cholinergic receptor agonist; CCh and the 
calcium ionophore; IM were prepared in DMSO  
2. The intermediate and working solutions were prepare in DPBS, Table 5-5.  
 
Table 5-5 Carbachol and ionomycin preparation 
Carbachol stock solution (100mM): 100 mg CCh in 5.47 ml DMSO. 
Intermediate: 1:100 (in DPBS) 
Final conc. (µM) in assay plate Initial conc. (µM) in compound plate CCh (µl) Buffer (µl) 
50 200 40 160 
20 80 16 184 
10 40 8 192 
Ionomycin stock solution (3mM): 5 mg IM in 2.23 ml DMSO 
Intermediate: No intermediate is required 
Final conc. (µM) in 
assay plate 
Initial conc. (µM) in 
compound plate 
IM (µl) Buffer (µl) 
6 30 2 198 
 
Caution 1: The FlexStation will be set-up to transfer 25 µl CCh followed by 25 µl 
IM, from the compound plate columns to the 75 µl buffer/acinar units’ columns in 
the assay plate. Accordingly, it is very important to take into consideration that 
determination of the final concentrations in the compound plate, depends on the 
buffer volume in the corresponding well of the assay plate, before the compound 




Figure 5.5 Step-wise illustration of compound plate preparation 
                
 
Caution 2: It is very important to note that the compound concentration is subject 
to change after each compound addition (in experiments where multiple 
compounds are used). 
• Equipment 
FlexStation 3 (Molecular Devices, Inc.) benchtop scanning fluorometer is used to 
measure changes in fluorescence of the fura-2 stained acinar units upon 
agonists’ transfer from the compound plate to the pre-designated set of wells in 
the assay plate.  
1. The FlexStation 3 was set-up to record changes in calcium signals before 
(baseline) and after compound additions, as demonstrated in Table 5-6.  
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2. For baseline fluorescence reading, the settings were adjusted similar to 
that demonstrated in Table 2, except that:  
(i) An endpoint read type was selected 
(ii) The compound transfer option was not selected.  
3. The emission ratios with excitation wavelengths of 340 and 380 nm were 
recorded every 6 seconds after compound applications, for 3 minutes.  
4. Experimental data was processed directly using the SoftMax Pro software 
(otherwise it can be copied and pasted into any spreadsheet program, 



















Table 5-6 Flexstation setting 
• Read mode                      FL 
• Read type                        Flex  
• Category  
1. Wavelength [2 wave length pairs] 
• Excitation:  Lm1 340 nm                        Emission: Lm1 510 
                   Lm2 380 nm                                        Lm2 510 
Auto cut-off. 
2. Plate type 
• 96-well Corning half area flat clear bottom 
3. Read area settings 
• Select all (read the whole plate) 
4. PMT and optics settings 
• PMT Gain: Medium 
• Flashes per Read: 6 
5. Timing settings 
• Total run time: 3 mins 
• Interval: 6 secs. 
• Number of reads: 21 
6. Compound transfer 
• Number of transfers: 2 
Parameter Compound 1 (CCh) Compound 2 (IM) 
Initial volume (µl) 75 100 
Pipette height * 90 100 
Volume  25 25 
Rate (µl/sec) * 2 2 
Time point  20 120 
* The parameters for the integrated FlexStation pipettor require optimization for each assay. The 
dispensation height of the pipettor and the speed of dispensation should be adjusted to ensure 
optimal delivery of the compounds to the specific plates being used. Optimal delivery should not 
cause cell disruption but should allow adequate mixing of the compounds in the well. To assist 
adequate mixing of compounds, the volume of agonist added to the well is typically 25% of the 
final well volume. The optimal dispenser speed may vary according to how well cells adhere to 
the bottom of the well (Marshall et al., 2005). 
7. Compound plate type 
➢ Costar 96 opaque 3 ml 
8. Pipette tips and layout  
➢ Subject to experimental condition 
9. Compound and tips column  
➢ Subject to experimental condition 





5.3.1 Temporal iNOS Upregulation in the Acute Viral Mimic Model 
To examine the temporal acute induction of inducible nitric oxide synthase in 
response to SMG viral mimic inoculation, immunohistochemical analysis was 
performed on tissue sections from the poly (I:C) injected glands as early as 3 hrs 
post its retrograde infusion. It can be clearly seen from figure 5.6 the early intense 
acinar immunoexpression of the pro-inflammatory mediator in response to the 













6h P-PIC 9h P-PIC 24h P-PIC 
3h P-PIC 
Figure 5.6 iNOS immunoexpression in the SMGs.  
Photomicrographs showing the basal negative expression of iNOS, in the vehicle injected 
SMGs. 3hrs following poly (I:C) introduction: moderate acinar immunolabelling of the 
acute inflammatory mediator was seen. 6h post poly (I:C): increased acinar iNOS 
immunolabelling. 9hrs and 24 hrs after viral mimic injection: iNOS was intensely 
expressed in focal acinar areas beside its extensive mild expression in all acinar cells. 




5.3.2 Functional Recovery in Response to iNOS Inhibition 
It was important subsequently to substantiate the injurious role that may have 
been played by iNOS in the acute SMG dysfunction. Short and long term 
inhibition of iNOS using AG, protected the SMG functions significantly despite 
harbouring a potent viral mimic, figure 5.7.  


















To validate the inhibited production of nitric oxide in response to aminoguanidine 
treatment, tissue sections from AG-treated and non-treated SMGs were 
immunostained for peroxynitrite, using 3-Nitrotyrosine marker. Microscopic 
Unpaired t test (9h) 
P value 0.0088 
P value summary ** 
Paired t test (9h) 
P value 0.9221 
P value summary ns 
Unpaired t test (24h) 
P value <0.0001 
P value summary **** 
Paired t test (24h) 
P value 0.0597 
P value summary ns 
Figure 5.7 Functional analysis following the selective iNOS inhibitor; aminoguanidine. 
Enhancement of the SMGs’ secretory function from mice treated with aminoguanidine compared 
to the glands from the untreated animals which received the viral mimic only. Summary of 
statistical analysis for the mean flow rates of the vehicle and poly (I:C) injected glands in both 





























































































































* * * *
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examination of the stained sections showed that 3-nitrotyrosine is restricted to 
the SMG vasculature of the control groups. In the SMGs which received the viral 
mimic, 3-NT showed remarkable upregulation in the glandular parenchyma and 
stromal cells, in addition to the intense vascular immunoexpression. Conversely, 
AG reduced markedly the peroxynitrite marker to levels and profiles similar to the 
control glands, where 3-NT was seen exclusively in the abundant dilated blood 
vessels, which were not responsive to selective iNOS inhibition by AG, figure 5.8 
A. Immunolabelling the SMGs with DAB peroxidase allowed a clear preview of 
the acinar expression of 3-NT induced by poly (I:C) in the AG-primed and non-
primed SMGs. Importantly, the peroxynitrite marker intensely labelling acinar 
plasma membranes was markedly reduced in response to AG and limited only to 



























Figure 5.8 Immunohistochemical staining of 3-nitrotyrosine.  
A: In the upper panel, basal immunoprofile of the peroxynitrite marker in the control SMGs of the AG treated 
and non-treated mice. Note the restricted immunoexpression of the gland vasculature in both groups. In the 
lower immunofluorescent images, poly (I:C) induced an extensive expression of the peroxynitrite marker in the 
ducts (yellow arrow), stroma (green arrow) as well as the basal surfaces of acinar cells (blue arrow), all 
obviously declined with AG treatment. B: DAB-labelled SMGs, demonstrating the strong and specific 
membranous nitrotyrosine expression in the acinar cells following poly (I:C) exposure, which was limited to the 
gland vasculature (showing intense nitrotyrosine positivity) in the AG treated animals. Original magnification 
of upper panels=20x, insets=40x, DAB labelled glands=40x. 







































5.3.3 Characterizing the Potential Injurious Contributions of iNOS in The 
Acute SMG Dysfunction Model  
5.3.3.1 Peroxynitrite-Induced Nitration of Myriad of SMG Proteins. 
To investigate the extent of SMG proteins’ nitration with peroxynitrite, western 
blot analysis was conducted. Tissue extracts of glands injected with the vehicle 
and poly (I:C) in presence or absence of aminoguanidine were probed with 3-NT 
antibody. Figure 5.9 reveals the excessive nitration of the gland proteins upon 
single exposure to the viral mimic.  In contrast, AG suppressed the nitrosative 











Figure 5.9 Western blot representation of the peroxynitrite marker; 3-
Nitrotyrosine. 
Induction of "nitroxidative stress" in the SMGs following poly (I:C) introduction (P-
PIC), a plethora of SMG proteins exhibited tyrosine nitration which was markedly 













5.3.3.2 SERCA2 ATPase Co-localization with 3-Nitrotyrosine 
Western blot analysis of 3-Nitrotyrosine in the poly (I:C) injected SMGs revealed 
a noticeable band at the level of SERCA2 ATPase; 110 Kda, figure 5.9. To verify 
physical co-localization of 3-nitrotyrosine staining with SERCA2 ATPase, 
immunohistochemistry was performed to confirm the possibility of interaction 
between peroxynitrite and this key regulator of calcium transport (Periasamy and 
Kalyanasundaram, 2007).   
Figure 5.10 A shows the normal distribution of the calcium pump in the vehicle 
injected SMGs. The fluorescence signal observed was arranged in dense peri-
nuclear clusters in the cytosol of the acinar and duct cells coinciding with the 
normal ER distribution. Figure 5.10 B clearly displays co-localization between the 
3-NT and SERCA-ATPase proteins after poly (I:C) retrograde injection. Following 
AG treatment, the iNOS inhibitor succeeded in blocking peroxynitrite formation, 
hence the subsequent, potentially injurious, co-localization with the calcium 

























Figure 5. 5.10 Co-localization of 3-NT 
and SERCA2 ATPase.  
A:  immunofluorescence representation 
of the: negative NT expression in the 
normal SMGs. Note the clustered peri-











B:  Abundant co-localization of the 
upregulated 3-NT staining with SERCA2, 












C: AG-treated SMGs revealing the 
obvious decline of 3-NT expression and 




DAPI SERCA2 ATPase 3-NT Merged 
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5.3.3.3 Poly (I:C) Mediated-Disruption of Calcium Homeostasis 
Co-localization of 3-NT and SERCA2 pump raised the possibility that the viral 
mimic may have mediated calcium disruption in the SMGs. Accordingly, a novel 
protocol was optimized and implemented to study poly (I:C)-induced changes of 
Ca2+ release from the ER, using a mAChRs agonist; carbachol. Fura-2 ratio 
(340/380) versus time was monitored for 2 minutes using Flexstatio 3. The 
preliminary experiments conducted revealed that in general, addition of variable 
concentrations of carbachol [5µM to 100µM] to the vehicle-injected SMG acinar 
units resulted in prompt [Ca2+]i mobilization from intracellular ER stores, which 
was reflected as a sharp signal increase that peaked for 12 seconds after the 
secretagogue application. This peak was then followed by a plateau phase, 
whereby [Ca2+]i oscillated in the form of elevated and depressed repetitive cycles.  
In the poly (I:C) treated gland, we noticed an overall decrease in the amplitude of 
[Ca2+]i release from the ER upon carbachol addition, whereby drug 
concentrations [100µM-10µM] induced a minimally amplified [Ca2+]i response, but 
at an extremely significant lower level (p<0.0001) compared to the vehicle 
injected control glands. On the contrary, when the poly (I:C) injected gland was 
stimulated with low agonist concentration [5µM], a sharp decrease in [Ca2+]i 











The Flexstation 3 further 
permitted recording of the baseline calcium, prior to compound addition, which 
Two-way ANOVA 
Source of Variation P value 
Interaction <0.0001 **** 
Carbachol Conc. <0.0001 **** 
PIC Injection <0.0001 **** 
Sidak's multiple comparisons test 
VC vs PIC 
P Value 
100 uM <0.0001 **** 
50 uM <0.0001 **** 
20 uM <0.0001 **** 
10 uM <0.0001 **** 








































































































































Figure 5.11 Fura-2-detected fluorescent signals in SMGs.  
Differential changes in [Ca2+]i between Fura-2-loaded vehicle injected control glands (V-C) and 
those infused with poly (I:C) (P-PIC) after addition of different carbachol concentrations. 
Carbachol which was added after 20 seconds of baseline recording, induced a sharp increase in 
the fluorescence signal, which remained at an elevated level constantly up till 100 seconds 
following carbachol addition. Note the extremely significant reduction in calcium release in the 
poly (I:C)-treated group, in response to the high and low carbachol concentrations tested. All data 
is expressed as Δ340/380 (maximal [Ca2+]i increase after carbachol minus its basal expression 
prior to stimulation).  Bar chart represents the two-way ANOVA carried out to compare the mean 
± SEM Δ 340/380 of various carbachol concentrations on ER calcium release in both groups. 
Statistical analysis revealed an extremely significant reduction in [Ca2+]i in the glands which 
received poly (I:C) compared to the vehicle injected controls, a finding which was consistent with 
all carbachol concentrations tested, as shown by the Sidak’s pairwise analysis, ****p≤0.0001. P-
PIC: post poly (I:C). 
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surprisingly revealed an extremely significant increase in Fura-2 340/380 ratio, in 










Following these initial results, additional experiments were directed to detect the 
effect of AG treatment on the extremely disrupted calcium signalling. Acinar units 
from SMGs of AG treated and non-treated animals were prepared and for 
simplicity of analysis, these experiments were conducted using a single 
carbachol concentration (50µM). Figure 5.13 shows the extremely significant 
recovery conferred by AG treatment on the poly (I:C) injected glands and 
validates the detrimental consequences of extensive iNOS upregulation on acinar 
calcium homeostasis.   
Unpaired t test 
 
P value <0.0001 
P value summary **** 
Figure 5.12 The baseline 340/380 ratio recorded prior to 
compound application.  
Unpaired t-test revealed that the acinar cells from poly (I:C) 
injected SMG had an extremely significant high basal Ca2+ 












































To investigate whether iNOS mediated a reduced carbachol response via 
depleting ER stores, we assessed the amount of [Ca2+]ER using ionomycin (an 
ionophore that, in the absence of external Ca2+, releases Ca2+ from the 
intracellular stores in a receptor-independent manner (Albert and Tashjian, 
1986). We found that Ca2+ liberation from internal stores induced by ionomycin 
was significantly decreased in the poly (I:C) injected glands when incubated in a 
calcium free buffer, and that the AG-mediated recovery of the carbachol-
stimulated calcium release, demonstrated in figure 5.13, paralleled a relatively 
maintained [Ca2+]ER level, figure 5.14. 
ANOVA  
P value <0.0001 







V-C vs. P-PIC <0.0001 **** -91% 
AG-PIC vs. AG-VC 0.0052 ** -13% 
P-PIC vs. AG-PIC <0.0001 ****  























V-C P-PIC AG-PIC AG-VC
carbachol 50 µM
Figure 5.13 Fura-2-detected fluorescent signals in SMGs in response to 50 µM carbachol 
stimulation.  
SMGs from mice treated or not treated with AG as well as the appropriate vehicle injected controls 
were used and carbachol was added to detect the [Ca2+]i response in the acinar units. Stimulated 
Ca2+ response graph represents the Δ340/380 (maximal [Ca2+]i increase after carbachol 
application minus its basal expression prior to stimulation). Sidak’s pairwise comparison revealed 
the extremely significant recovery of the poly (I:C) injected glands when pre-treated with the 
selective iNOS inhibitor; AG. Data represents the mean ± SEM Δ 340/380 following carbachol 
















































To dually assess the impact of extracellular calcium and iNOS inhibition on 
resting calcium levels in the control and poly (I:C) injected glands, the physiologic 
units were incubated in calcium free and calcium containing buffers and 
stimulated with the calcium ionophore; ionomycin. Recording of baseline calcium 
using the Flexstation 3 revealed some interesting findings that can be 
summarized as follows: (i) removal of calcium from the buffer and addition of a 
chelator, did not change baseline calcium levels in the vehicle-injected control 
glands of the tested groups. In the AG non-treated group (ii) the extremely 
significant increase (53%) in baseline calcium of the poly (I:C) injected glands, 
compared to the control glands, was extremely reduced when calcium was 
removed from the incubation buffer. (iii) Even in the absence of extracellular 
calcium, the physiologic clusters of the poly (I:C) injected glands showed an 
extremely significant increase (13%) in basal calcium compared to the vehicle 
ANOVA summary 
P value <0.0001 
P value summary **** 
Sidak's multiple 
comparisons test 
P Value Summary % 
Change 
V-C vs. P-PIC <0.0001 **** -70% 
AG-VC vs. AG-PIC <0.0001 **** -36% 
P-PIC vs. AG-PIC <0.0001 **** 
 
V-C vs. AG-VC 0.011 * 
 
Figure 5.14 Ionomycin-induced Ca2+ release from the intracellular stores.  
Isolated acinar cells of vehicle and poly (I:C) injected SMGs from AG treated and non-treated 
animals were incubated in Ca-free medium. ANOVA followed by Sidak’s pairwise comparison 
revealed that the viral mimic induced an extremely significant reduction in mean±SEM ionomycin-
stimulated Ca2+ release from the internal stores and that AG mediated an extremely significant 































































injected control, suggesting interplay of more than one mechanism in disrupting 
resting [Ca2+]i. In the AG-treated group: (iv) poly (I:C) still induced 13% increase 
in basal calcium, and (v) it wasn’t until the physiologic clusters of this group were 
incubated in a calcium-free buffer, when the resting [Ca2+]i nearly paralleled the 
















ANOVA AG Non-Treated Group 
 
P value <0.0001 
P value summary **** 
 
Sidak's multiple comparisons test 
P Value Summary 
% 
Change 
V-C Ca vs. V-C nCa 0.9962 ns 
 
P-PIC Ca vs. P-PIC NCa <0.0001 **** 
 
V-C Ca vs. P-PIC Ca <0.0001 **** 52% 
V-C nCa vs. P-PIC NCa 0.0004 *** 13% 
ANOVA summary AG-Treated Group 
P value <0.0001 
P value summary **** 
Sidak's multiple comparisons test Summary P Value % Change 
AG+V-C Ca vs. AG+V-C NCa ns 0.9948 
 
AG+PIC Ca vs. AG+PIC NCa **** <0.0001 
 
AG+V-C Ca vs. AG+PIC Ca **** <0.0001 13% 
AG+V-C NCa vs. AG+PIC NCa ns 0.1361 -1.70% 
Figure 5.15 Baseline 340/380 ratio in the SMGs treated or not treated with AG.  
ANOVA followed by Sidak’s multiple comparison analysis revealed the differential change in 
baseline calcium among the tested physiologic units as explained in the text above. Ns: Non-
significant, ***p≤0.001, ****p≤0.0001. Ca: Calcium-containing buffer, NCa: Incubation buffer free 









































































































1 3 % -1 .7 %
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5.3.3.4 AG Inhibited Poly (I:C)-Induced Lysosomal Discharge  
The finding that poly (I:C)-injected glands maintained a significantly high resting 
Ca2+ despite calcium chelation from the extracellular medium, directed us 
towards assuming leakage of an intracellular Ca2+-rich organelle. Lysosomes 
contain up to 600 mM calcium (Christensen et al., 2002, Lloyd-Evans et al., 
2008), nearly matching the concentration described for the classic calcium 
storage organelle; the ER (Bygrave and Benedetti, 1996). To assess whether 
poly (I:C) has induced lysosomal membrane breach and sequential release of the 
organelle contents, we assessed the basal immunoexpression of the lysosomal 
protease; cathepsin-B, in the control SMGs and following poly (I:C) injection in 
the AG-treated and non-treated mice. In the control vehicle injected glands, 
cathepsin B was widely localized in the SMG duct cells. Six hrs post its intraductal 
infusion, poly (I:C) induced extra-lysosomal cathepsin B immunolocalization, its 
widespread tissue distribution and its depletion by 9 hrs of ductal infusion. 
Surprisingly, AG priming of the SMGs resulted in efficient interference with 
cathepsin B release from their characteristic perinuclear lysosomal localization 
up till 24 hrs post poly (I:C) injection, compared to its complete depletion in the 

























Figure 5.16 Cathepsin B immunoexpression in the SMGs. 
Photomicrographs showing: A the characteristic fine perinuclear granules of cathepsin B 
consistent with its lysosomal localization in the vehicle injected control glands. B: 6hrs post the 
viral mimic: cathepsin B was extensively seen in the SMG tissues and not only restricted to their 
peri-nuclear ductal localization. In addition, the fine granular cathepsin B immunoreactivity was 
replaced by enlarged granules or diffused cytoplasmic staining (arrows), suggesting the leakage 
of the cathepsin B from the lysosomes into the cytosol. C, E: 9hrs and 24 hrs respectively, 
sporadic cathepsin B was seen in the ducts. D, F: AG treated SMGs after 9 hrs and 24 hrs 
respectively, revealed the efficient retention of the peri-nuclear lysosomal protease in the ducts 
of these glands. Original magnification: V-C, 9h P-PIC, AG+24h P-PIC= 25x and 6h P-PIC, 







The cathepsin B extra-lysosomal discharge was further confirmed by its co-
localization with the lysosomal marker; Lamp-1. The vehicle injected SMGs 
revealed constant ductal co-expression of cathepsin B and Lamp-1, figure 5.17 
A.  Upon poly (I:C) exposure, co-localization of the lysosomal markers was 
markedly lost and cathepsin B was seen within acinar cells in addition to their 
normal duct localization, figure 5.17 B. Conversely, AG treatment relatively 
maintained the perinuclear ductal cathepsin B expression as marked by physical 

































DAPI CATH-B Merged Lamp1 
Figure 5.17 Co-localization of Lamp1 
and Cathepsin B.  
A:  Double immunofluorescent staining of 
cathepsin B and Lamp-1 in the vehicle 
injected control glands. Note the co-
localization of both lysosomal proteins in 








B: 9hrs post poly (I:C), some preserved 
ductal co-localization of the lysosomal 
markers in addition to the extra-lysosomal 
cathepsin B in the duct cytoplasm as well 










C: 9hrs post AG and poly (I:C), showing 
retention of peri-nuclear cathepsin B in 
lysosomes evidenced by the co-
localization of both lysosomal markers in 







5.3.3.5 AG Interfered with Induction of ER stress in the SMG Dysfunction 
Model 
Since Ca2+ is central to the regulation of processing and targeted dispatch of 
proteins in the ER, including crucial SG receptors, channels and transporters, we 
hypothesized that Ca2+ dysregulation in the current model has induced an ER 
stress condition which may have interrupted the ER Ca2+-dependent roles of 
protein synthesis and transport. ER-stress can induce the transcriptional 
activation of chaperones and protein folding-associated molecules to reduce the 
burden of protein synthesis in the ER (Zhang and Kaufman, 2006, Kimata and 
Kohno, 2011). Accordingly, to evaluate whether poly (I:C) has triggered ER 
stress, qRT-PCR analysis of ER-stress related genes; XBP1, GRP78 (Bip) and 
CHOP were performed. Poly (I:C)-injected SMGs displayed significant 
upregulation in the ER-stress related genes, an effect that was efficiently 






























ANOVA Bip CHOP XBP-1 
P value <0.0001 0.0001 <0.0001 
P value summary **** *** **** 








V-C vs. 9h P-PIC **** <0.0001 * 0.0301 **** <0.0001 
9h P-PIC vs. AG+9h P-PIC **** <0.0001 **** <0.0001 **** <0.0001 
AG+9h P-PIC vs. AG+V ns 0.4686 * 0.044 ns 0.8572 
Figure 5.18 mRNA expression of ER stress related genes; Bip, CHO and XBP-1.  
SMGs of mice treated or not-treated with AG were injected with the vehicle or poly (I:C). Tested 
genes were normalized to HPRT in both groups. A single aminoguanigine treatment restricted 
the significant acute upregulation of ER stress related genes, 9 hrs post poly (I:C) administration. 





































































































































































5.3.3.6 Downregulation of Water and Ion Transport Molecules 
Following the substantiation of ER stress induction in the acute viral mimic model, 
we aimed to substantiate the UPR-triggered mRNA decay (Grootjans et al., 2016) 
of key water driving molecules in the viral mimic model. qRT-PCR revealed an 
extremely significant downregulation (approximately 80% of the baseline level) in 
the mRNA expression levels of all tested genes. Importantly, retrieval of the 





































ANOVA   AQP-5 NKCC1 TMEM16A M3R 
P value <0.0001 <0.0001 <0.0001 <0.0001 
P value summary **** **** **** **** 










V-C vs. 24h P-PIC **** <0.0001 **** <0.0001 **** <0.0001 **** <0.0001 
24h P-PIC vs. AG+24h P-PIC *** 0.001 **** <0.0001 **** <0.0001 ** 0.0054 
AG+24h P-PIC vs. AG+V ns 0.3172 ns 0.9803 ns >0.9999 ns 0.1954 
Figure 5.19 mRNA expression of genes encoding water driving molecules; AQP5, NKCC1, 
TMEM16A and M3R.  
SMGs of mice treated or not-treated with AG were injected with the vehicle or poly (I:C). SMGs 
were harvested 24 hrs post the local injections, and tested genes were normalized to HPRT in 
AG non-treated glands and B-actin in AG-treated groups. Long term inhibition of iNOS, by 
incorporating aminoguanidine in drinking water for seven days prevented the extremely significant 
downregulation of the mRNA of key water driving molecules. Data represent means ± SEM (n=3). 
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5.3.3.7 Disrupted Subcellular Localization of Water and Ion Transport 
Proteins 
Next, we used antibodies against M3R, AQP-5, NKCC1 and TMEM16A, to 
confirm the reduced expression of these water driving molecules at the protein 
level and assess their immunolocalization. Immunoperoxidase labelling of SMGs 
from AG treated and non-treated mice revealed the following expression patterns 
for the control vehicle injected glands: (i) AQP-5 exhibited a strong, furrow-
shaped expression on the apical domains of acinar cells. Similarly, (ii) TMEM16A, 
showed intense, trough-like immunoexpression on luminal surfaces of acinar 
cells. Interestingly, TMEM16A was frequently seen as a thick branch-like 
connector linking multiple acinar and ductal lumena together. Moreover, (iii) 
NKCC1 revealed intense positive basolateral immunostaining of acinar cells as 
well as specific cells of all types of ducts. Finally, (iv) the muscarinic receptor; 
M3R, revealed a punctate basolateral membranous immunolabelling of acinar 
cells. 24 hrs following poly (I:C) retrograde infusion, a remarkable reduction was 
seen in all key water driving molecules. In addition, a markedly disrupted and 
altered immunolocalization of these molecules was displayed in the form of 
punctate, beaded and shrunken acinar cytoplasmic granules and thick patches. 
Predominantly, AG maintained the normal immunolocalization patterns of the 
tested proteins at a level comparable to that seen in the control vehicle injected 



























Figure 5.20 Immunohistochemistry of key water driving molecules; AQP5, NKCC1, 
TMEM16A and M3R.  
Control SMG showed A: positive furrow-like AQP-5 immunostaining on the luminal membranes 
of acinar cells. B: strong basolateral and apical NKCC1 as well as specific duct cell positivity 
(yellow arrows). C: TMEM16A immunolabelling of acinar apical domains as well as acinar-ductal 
interconnecting branches. D: M3R visualized using fluorescently labelled secondary antibody. 
M3R displayed a punctate expression pattern in the basal membrane of acini and in the 
cytoplasm and membrane of epithelial cells lining the intercalated and striated ducts. 24 hrs post 
poly (I:C) E: thickened membrane patches of AQP-5 (green arrows), basolateral staining (red 
arrows), as well as granular cytoplasmic immunostaining (black arrows). F: NKCC1 revealed an 
irregular intense, granular cytoplasmic expression. G: TMEM16A expression showing reduced 
and altered positive cytoplasmic granularity. H: M3R staining was remarkably reduced compared 
to the control glands. AG-treated glands; I, J, K and L: Obvious recovery of the expression level 
and subcellular localization of all tested water and ion transport proteins in response to AG 
treatment. Original magnification=40x 
  
 
Figure 5.20 Immunohistochemistry of key water driving molecules; AQP5, NKCC1, TMEM16A 
and M3R in Control SMGs and poly (I:C)-injected glands from AG-treated and non-treated mice.  
Control SMG showed A: positive furrow-like AQP-5 immunostaining on the luminal membranes 
of acinar cells. B: strong basolateral and apical NKCC1 as well as specific duct cell positivity 
(yellow arrows). C: TMEM16A immunolabelling of acinar apical domains as well as acinar-ductal 
interconnecting branches. D: M3R visualized using fluorescently labelled secondary antibody. 
M3R displayed a punctate expression pattern in the basal membrane of acini and in the 
cytoplasm and membrane of epithelial cells lining the intercalated and striated ducts. 24 hrs post 
poly (I:C) E: thickened membrane patches of AQP-5 (green arrows), basolateral staining (red 
arrows), as well as granular cytoplasmic immunostaining (black arrows). F: NKCC1 revealed an 
irregular intense, granular cytoplasmic expression. G: TMEM16A expression showing reduced 
and altered positive cytoplasmic granularity. H: M3R staining was remarkably reduced compared 























In the current chapter, we proposed an acute viral-mediated SG dysfunction 
mechanism, by which iNOS impaired saliva secretion via: dysregulating Ca2+ 
homeostasis, inducing ER stress and altering key water driving regulators at the 
gene and protein levels. Our results assigned iNOS upregulation as one of the 
earliest signals which takes place after acute infections of SGs. Moreover, we 
have shown the prompt parallel increase in peroxynitrite formation which 
culminated into nitrotyrosinilation of a plethora of SMG proteins.  
To investigate the contribution of iNOS to the viral hypofunction perceived, we 
used systemic and local administrations of a selective iNOS inhibitor; 
aminoguanidine hydrochloride (Waz et al., 1997, Viaro et al., 2000). Since pilot 
experiments revealed that a single i.p. dose of AG was only sufficient to inhibit 
iNOS up till 9 hrs post poly (I:C) retrograde injection, we employed a longer-term 
inhibition protocol to acquire sufficient iNOS retraction 24 hrs post poly (I:C) 
(MacFarlane et al., 1999). Functional analysis of the AG-treatment model 
revealed an extremely significant recovery of the poly (I:C) injected glands at 9hrs 
and 24 hrs post infection.  
Long-lasting and high levels of iNOS-derived NO has been hypothesized to 
directly nitrosylate functional proteins and disrupt essential cellular processes 
(Kimura-Shimmyo et al., 2002). In addition, peroxynitrite is believed to be 
responsible for the harmful effects of iNOS-derived NO during inflammation 
(Aydogan et al., 2006), via its rapid reaction with proteins to mediate radical 
tyrosine nitration and 3-nitrotyrosine production (Bigelow, 2009). In the present 
study, we were able to show that the AG-preserved saliva secretion paralleled 
decreased nitration of the SMG proteins and marked reduction of 3-nitrotyrosine 
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protein expression in the homogenates and tissue sections. Inhibition of the 
peroxynitrite marker in response to iNOS selective inhibition is in accordance with 
the previous demonstration that reactive nitrogen species production in mice is 
completely dependent upon the NO derived from iNOS (Koarai et al., 2002). Our 
results which verified the protective effects of AG on injured SGs, are in 
agreement with studies reporting the functional rescue afforded by: (i) selective 
iNOS inhibition in LPS-infected SMGs (Lomniczi et al., 2001) and (ii) peroxynitrite 
scavenging in irradiated SGs (Hanaue et al., 2007).  
Immunofluorescence staining of the SMG tissue sections treated with AG 
demonstrated that 3-NT positivity was predominantly perceived in blood vessels. 
A similar phenomenon was seen in AG-treated, irradiated SGs (Hanaue et al., 
2007), whereby AG, which extensively attenuated 3-NT, did not completely block 
its expression in the gland vasculature. These results may demonstrate that even 
though AG inhibited iNOS, which was the major source of NO-derived NT during 
the acute infection, eNOS which is responsible for most of the vascular NO 
produced and much less sensitive to AG (Alderton et al., 2001), may have given 
rise to the residual 3-NT in the AG treated glands.  
The current acute viral mimic SMG model demonstrated excessive, iNOS-driven 
co-localization of the peroxynitrite marker and SERCA2 ATPase pump. As a 
rational outcome from vicinity with a potent oxidant, we assumed inhibition of 
SERCA2 ATPase activity, and loss of its tight control on the ER as well as 
cytosolic calcium levels. To assess our hypothesis, we intended to measure the 
carbachol induced Ca2+ release from the ER as well as the basal cytosolic 
calcium levels in the AG-treated and non-treated SMGs.  
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The novel protocol developed for assessment of calcium responses utilizes small 
clusters (5-20 cells) of parenchymal cells and represents a powerful tool to study 
the physiological and pathophysiological features of calcium homeostasis in vivo. 
Fura-2, is by far the most commonly used ratiometric dye for imaging Ca2+ signals 
in intact cells. It exhibits excitation spectrum changes upon Ca2+ binding such that 
the Ca2+-free form is excited maximally at 380 nm while the Ca2+ bound form is 
excited maximally at 340 nm, figure 5.21. Both forms emit fluorescence with a 











Figure 5.21 FURA-2.  
A: Structural changes of Fura-2 by esterase activity and Ca2+ binding. Fura-2 AM ester is Ca2+ 
insensitive and nonpolar. Once inside the cell, esterase enzymes sequentially cleave the AM 
groups to leave Fura-2-free acid (Ca2+ sensitive, polar) trapped inside the cell, where it is able to 
bind Ca2+. B: carbachol is a muscarinic receptor agonist that initiates a signalling pathway, 
resulting in the release of Ca2+ within seconds. Fura-2 exhibits a calcium dependent excitation 
spectral shift to report the 340/380 ratio (adapted from (Wang et al., 2015)). C: Schematic 
illustration of intracellular calcium changes as recorded by Flexstation 3. The raw data depicts 
the typical signals obtained from a fura-2-loaded cell when it is excited at 340 and 380 nm. Agonist 
stimulation will cause an increase in the 340nm signal and a decrease in the 380nm signal. 
Addition of an ionophore (Ionomycin) in the presence of Ca 2+ will liberate Ca2+ from all intracellular 







Using a Flexstation 3 microplate fluorescent reader, baseline and variations of 
Fura-2 emission ratio were determined in the vehicle and poly (I:C) injected 
SMGs, from the AG treated and non-treated mice. We were able to record 
dramatic changes in Ca2+ homeostasis and signalling in the parenchymal clusters 
of mouse SMG, 24 hrs after poly (I:C) introduction. Disruption in stimulated [Ca2+]i 
responses was observed in the form of reduced liberation of Ca2+ from the ER 
(evoked by either carbachol in Ca2+-containing or ionomycin in Ca2+-free 
medium). In addition, elevated resting [Ca2+]i levels was recorded prior to 
compound applications. These results demonstrate the superimposition of 
several mechanisms implicated in the disruption of Ca2+ homeostasis.  
The reduction in magnitude of Ca2+ release from the intracellular stores 
independent of activation of IP3R; i.e. with ionomycin, suggested the diminished 
[Ca2+]ER content. This was expectedly reflected on the impairment of carbachol-
stimulated Ca2+ release. SERCA2 isoform of the sarco/endoplasmic reticulum 
Ca2+-ATPase is sensitive to cellular conditions of inflammation and oxidative 
stress as evidenced by the common appearance of 3-nitrotyrosine-modified 
forms of SERCA2 in diseases of human and rodent models (Bigelow, 2009). 
Since SERCA pump plays a major role in the rate-limiting replenishing of 
intracellular calcium stores after secretagouge-stimulated calcium release 
(Berridge et al., 2000, Bers, 2002, Vangheluwe et al., 2005, Homann et al., 2006), 
the physical co-localization of SERCA2 ATPase and peroxynitrite may explain 
the inability of the pump to replenish [Ca2+]ER, accounting for the reduced Ca2+ 




Importantly, AG which prevented ONOO- accumulation, induced an extremely 
significant recovery in the stimulated calcium response to carbachol and 
ionomycin, which further highlights the injurious contribution of the upregulated 
iNOS and it derivative; peroxynitrite in the impairment of salivary cells functioning 
following acute infections. Though, not comprehensively verified, it is worth noting 
that the extensively expressed acinar peroxynitrite may have similarly co-
localized and disrupted other critical cytosolic and organellar Ca2+ regulators in 
the current model of acute SG dysfunction.  
The novel protocol developed, further allowed the recording of resting [Ca2+]i, 
which showed extremely significant elevation in the poly (I:C) injected glands, 
prior to secretagogue additions. To investigate the basis of this finding, two 
buffers were formulated and used for preparation and incubations of the SMGs 
(Naftilan and Oparil, 1982, Pitelka et al., 1983). Our results demonstrated the 
overlap of more than one mechanism contributing to elevating baseline [Ca2+]i. 
Removal of calcium from the extracellular buffer as well as treatment of the mice 
with AG, remarkably retrieved the basal [Ca2+]i levels, which denoted the likely 
breach of the plasma membranes in the poly (I:C) injected SMGs, mediated by  
iNOS or its derivative; peroxynitrite. The sites of peroxynitrite formation are 
assumed to be spatially associated with the sources of superoxide (such as the 
plasma membrane NADPH oxidases) (Szabo et al., 2007). In addition, a major 
aspect of peroxynitrite-dependent cytotoxicity relies on its ability to trigger lipid 
peroxidation in membranes, resulting in degeneration of membrane lipids (Hogg 
and Kalyanaraman, 1999, Radi et al., 1991) and changes in membrane 
permeability and fluidity, with significant biological consequences (Richter, 1987).  
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In the current model, immunohistochemical staining revealed the preferential 
localization of 3-NT in the acinar cell membranes, which may account for the 
unrestrained efflux of Ca2+ from the extracellular buffer, facilitated by the likely 
peroxynitrite-damaged plasma membranes.  
Despite removal of Ca2+ from the prepared buffers, the baseline calcium level 
was not completely restored in the poly (I:C) injected glands, which indicated an 
intracellular leakage source, that may have contributed to the perceived increase 
in baseline Ca2+. Lysosomes contain up to 600 mM calcium (Christensen et al., 
2002, Lloyd-Evans et al., 2008), nearly matching the ER concentration (Bygrave 
and Benedetti, 1996). Immunostaining of the SMG tissue sections injected with 
the viral mimetic verified lysosomal membrane permeabilization (LMP) and the 
sequential release of the most abundant protease; cathepsin B (Rossi et al., 
2004). These results were further validated by immunofluorescent dissociation of 
cathepsin B from lysosomal Lamp-1. Interestingly, cathepsin B may constitute an 
amplifying feedback loop, in which a small amount of released cathepsin B 
triggers more extensive LMP from outside the lysosome (Johansson et al., 2010, 
Liu et al., 2003). Several mechanisms can disrupt the integrity of the lysosomal 
membranes (Serrano-Puebla and Boya, 2016). Although the exact trigger for 
disruption of lysosomes in the current model has not been comprehensively 
investigated, we were able to verify the involvement of iNOS-dependent 
mechanisms. In fact, iNOS expression has been shown to evoke an increase in 
ROS production (Zhao et al., 2010), which can penetrate lysosomes and produce 
highly toxic intermediates that damage lysosomal membrane proteins, such as 
Hsp70 (Serrano-Puebla and Boya, 2016).  
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The ER is involved in folding, processing and trafficking of newly synthesised 
secretory and membrane proteins (Chan et al., 2011). The resting free Ca2+ 
concentration in the ER is three to four orders of magnitude higher than cytosolic 
Ca2+. Disruption of ER homeostasis, as caused by alterations in [Ca2+]ER 
concentration, leads to the accumulation of unfolded proteins and activation of a 
specific stress response (Rutkowski and Kaufman, 2004). In the current research, 
disruption of calcium homeostasis justified our rationale that exposure to 
excessive iNOS may have likewise driven the gland into an acute stressful 
condition, warranting UPR activation. To verify this hypothesis, we analysed the 
upregulation of genes encoding key chaperones and folding sensors as markers 
of UPR activation in the AG treated and non-treated glands. In the current model, 
we found that a single poly (I:C) dose induced iNOS-dependent UPR activation, 
after 9 hrs of its introduction, manifested by the increased transcriptional 
expression of XBP1, GRP78 (Bip), CHOP. Our results are in harmony with 
studies showing that pro-inflammatory cytokines could induce ER stress in 
cultured cells, possibly via the generation of nitric oxide (Oyadomari et al., 2001, 
Kharroubi et al., 2004). These studies demonstrated the role played by nitric 
oxide in: i) downregulation Serca2b expression, ii) depletion of ER calcium stores, 
and iii) induction of the ER stress pathway. Similarly, pancreatic studies reported 
NO-mediated induction of ER stress in rat pancreatic islets, a finding which was 
prevented by the iNOS blocker; NG-methyl-L-arginine (LMA) (Cardozo et al., 
2005). In their study, they demonstrated that blocking NO production with LMA 
prevented cytokine-induced SERCA2b inhibition, ER Ca2+ depletion, xbp-1 
mRNA processing, CHOP expression, and β-cell death.  
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The high demand for protein synthesis in specialized secretory SG cells requires 
an evolved mechanism to properly fold, process, and release proteins. This 
renders the SGs particularly sensitive to ER stress evolution.  
With a conceptual identification of key mediators of the UPR in place, subsequent 
experiments turned towards investigating the relation between the verified SG 
stress, with its well documented negative impact on the mRNA and cellular 
protein realms and the compromised secretory machinery. Saliva secretion is 
predominantly initiated by the exciting effect of Acetylcholine on acinar M3 
receptors (Proctor, 2006), followed by a multistage process which is coordinated 
through several ion channels and transporters, water channels, as well as 
polarized calcium signalling events. Therefore, we examined the mRNA 
expression of key water driving molecules; M3R, AQP5 water channel, as well as 
NKCC1 and TMEM16A ion transporters, 24 hrs following poly (I:C) injection in 
the AG-treated and non-treated glands. Our results revealed the global 
downregulation of the tested genes in the mouse SMGs following poly (I:C) 
administration. In a process known as regulated IRE1 dependent decay (RIDD), 
pIRE-1α degrades ER associated mRNAs encoding mostly secretory proteins as 
well as cytosolic mRNAs, to reduce protein synthesis and allow the endoplasmic 
reticulum (ER) to recover from the accumulation of misfolded proteins (Hollien 
and Weissman, 2006, Hollien et al., 2009). Our results can possibly signify the 
role played by the non-specific nuclease activity which may have been perceived 





Owing to the pivotal role played by the ER in calcium-activated protein folding 
and targeted transport (Tsai and Weissman, 2010), we presumed that iNOS-
driven ER calcium depletion may have mediated defective protein folding as well 
















To substantiate our hypothesis, immunohistochemical staining of the 
membranous water driving molecules was performed in the control and 
experimental glands from AG-treated and non-treated mice.  
Figure 5.22 Illustrated representation of 
iNOS-mediated disruption of membrane 
trafficking.  
Dysregulation of [Ca2+]ER induced by iNOS or 
its oxidative derivative; peroxynitrite induced 
ER stress. Disruption of ER homeostasis may 
have caused misfolded proteins to be retained 














Immuno-analysis revealed that in the vehicle-injected control glands, AQP-5, 
TMEM16A were immunolocalized to the apical membranes of acinar cells. The 
furrow-shaped immunostaining pattern displayed by these molecules in normal 
glands represent the lateral intercellular canaliculi between neighbouring acinar 
cells, which are a specialized form of the lumen extending from the apical side 
towards the basal side between acinar cells (Pinkstaff, 1980, Segawa et al., 
1998). In addition, the TMEM16A interconnecting branches seen represent the 
acinar-intercalated duct segments, where the ion channel is more frequently 
expressed in the distal portions of these ducts toward the acini (Chenevert et al., 
2012). On the other hand, M3R and NKCC1 have predominantly immunolabelled 
the basolateral membranes of acinar cells and to a much lesser extent, NKCC1 
was seen in duct cells, which may account for a functional role of Cl- uptake in 
these ducts. These results are in agreement with Walcott et al., who 
demonstrated the presence of NKCC1 in the basolateral membranes of duct and 
acinar cells of mice (Walcott et al., 2005). Conversely, SMGs which received the 
viral mimic exhibited aberrant immunoexpression after 24 hrs, with all 
membranous proteins displaying a granular cytoplasmic pattern. Similar 
accumulation of proteins in intracellular inclusion bodies has been reported in 
neurodegenerative disease featuring intracellular Ca2+ dysregulation with 
consecutive endoplasmic reticulum Ca2+ depletion (Grosskreutz et al., 2010). The 
preserved membranous localization of these proteins in the AG treated glands 
suggest that iNOS and its derivatives may have directly interfered with the SMG 





Studies which deleted AQP5 (Ma et al., 1999, Krane et al., 2001), NKCC1 (Evans 
et al., 2000) and TMEM16A (Ousingsawat et al., 2009, Catalan et al., 2015) 
revealed vast reduction in saliva secretion. The present study demonstrates, for 
the first time, that loss of saliva secretion following acute SG infections and 
extensive iNOS upregulation, paralleled the ectopic cytoplasmic expression of 
membranous water and ion transport proteins.  
The current SG dysfunction model develops rapidly, with clearly defined initial 
triggering and pathogenic processes. Accordingly, we were able to 
comprehensively characterize the signals which sequentially prompted loss of 
function. The perceived iNOS-driven dysregulation of Ca2+ homeostasis and the 
resultant ER stress-induced aberrant expression of key membranous water 
driving proteins, projected the dysfunction mechanisms by which acute infections 

























Acute infections are often associated with SG pathology. To decipher the signal 
which triggers injury and dysfunction in the acutely infected SGs, it was essential 
to develop an in vivo model dually featuring functional compromise and innate 
immune exocrinopathy. Although viruses do not normally reach the SGs via a 
retrograde ductal route, we injected poly (I:C) locally into the SMGs to avoid 
systemic delivery, which is more likely to dilute the poly (I:C) and minimize the 
chance of its efficient exposure to the parenchymal cells. The cannulation 
technique established, allowed for the development of a reliable and reproducible 
mouse model, whereby intraductal conveyance of poly (I:C) pre-mixed with trypan 
blue fulfilled our aim in consistently ensuring successful infusion and delivering 
the same amount of the viral mimic into the SMGs (even when other drugs: 
TLR3/dsRNA inhibitor, RB6-8C5, z-VAD-fmk and AG, were systemically or locally 
used). In addition, this local innate immune activation protocol allowed us to rule 
out possible extraneous impacts that can arise from systemic delivery of the 
inflammagen. Another advantage of the current model was the possibility of 
temporally characterizing the innate immune events occurring in conjunction with 
the loss of function, this helped us during the quest for the signal which induced 
the early perceived dysfunction. For example, although it was completely 
surprising that the invasive MPO positive neutrophils/monocytes which infiltrated 
the gland 6hrs post poly (I:C) injection were bystanders in the current model 
(given their injurious roles during acute microbial infections), it became clear that 
extensive iNOS expression as early as 3hrs following delivery of the viral mimic 
has initialized the dysfunction signal even earlier than the immune cell infiltration. 
These results similarly, excluded any role played by potentially detrimental 
cytokines; like IL-1β, COX2 and IL-6, in the perceived loss of function.  
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To protect against viral infection, the host innate immune system has evolved 
sensors of nucleic acids. The same nucleic acid sensors that defend against 
viruses may also contribute to the SG pathogenesis (Holdgate and St Clair, 
2016). In the current model of SG dysfunction, we have shown the indispensable 
injurious role played by TLR3. TLR3 activation must be strictly regulated; one 
mechanism by which this is achieved is its compartmentalization to intracellular 
locations where it is unlikely to encounter its ligand unless infection or tissue 
damage occurs (Oshiumi et al., 2003). Moreover, therapeutic modulation of TLR3 
pathways has offered an attractive strategy to fight a variety of diseases. Cheng 
et al, successfully used specific small molecule agents to target the protein-RNA 
interface and disrupt dsRNA binding to TLR3 (Cheng et al., 2011). Interestingly, 
to evaluate the drug’s inhibitory activity, they monitored the NO level as an 
indicator of poly (I:C)-induced TLR3 activation. In the current study, we used a 
thiophenecarboxamidopropionate compound that acts as a direct, competitive 
and high affinity inhibitor of dsRNA binding to TLR3 and selectively antagonizes 
stimulated TLR3 by blocking signalling at the receptor level. We showed for the 
first time that in vivo inhibition of TLR3 effectively rescues viral-induced secretory 
hypofunction and ameliorates injury-inducing downstream signals. Thus, our 
findings suggest blockade of TLR3 as a new therapeutic strategy for the 
treatment of SG or oral diseases with viral implications. Previous studies have 
shown that the TLR3/dsRNA complex inhibitor can be highly protective against 
TLR3-mediated tissue injury, even when administered after exposure to the 




Accordingly, the TLR3 inhibition mouse model presented in this study may be 
promising for assessment of the functional and pathologic consequences of 
restricting this PRR in mice with well-established chronic inflammation or 
autoimmune diseases.  
One of the main and unexpected findings in the present study is the role played 
by the protease inhibitor; z-VAD-fmk in regulating the innate immune responses 
via controlling upregulation of TLR-3 and restricting its downstream signalling. 
The roles of endolysosomal proteases in innate immunity through the activation 
of TLRs has been previously highlighted. Endolysosomal TLRs are synthesized 
as quiescent pro-forms that have to be proteolytically activated to carry out their 
function (Bird et al., 2009). This has been shown for TLR9 (Ewald et al., 2008, 
Matsumoto et al., 2008, Park et al., 2008), TLR7 (Ewald et al., 2008) and TLR3 
(Garcia-Cattaneo et al., 2012, Toscano et al., 2013). Interestingly, analyses of 
several protease-deficient cells and of the effects of protease inhibitors have 
concluded that no single protease is responsible for TLR7 or TLR9 processing, 
indicating that there is redundancy in this reaction (Ewald et al., 2008, Matsumoto 
et al., 2008, Park et al., 2008).  
Previously, it has been shown that z-VAD-fmk inhibition of caspase 3 led to the 
down-regulation of JNK/SAPK and NF-kB, which were required for LPS-induced 
iNOS expression and NO production  (Chakravortty et al., 2001). In the current 
model, we showed efficient control of TLR3 upregulation and abrogation of a wide 
array of cytokines in response to z-VAD-fmk, rendering this pan caspase inhibitor 
a promising immune-modulating drug that can restrict the tissue damaging effects 




Previous studies designed to investigate the role played by innate immunity in 
SG injury, considered type-I IFNs to be the chief contributors to dysfunction 
(Nandula et al., 2013). The outcome of our study, showing iNOS as the innate 
immune damaging signal may not be contradictory with these studies, since type-
I interferons can promote upregulation of iNOS in various models (Zwaferink et 
al., 2008, Utaisincharoen et al., 2004, Bogdan et al., 2000). In addition, deletion 
of type-I IFN receptor; IFNAR-1, has substantially compromised iNOS induction 
(Huys et al., 2009).  
This is due to the multiple binding sites for factors modulated by type-I IFNs 
recognized in the promoter region of the iNOS gene, including IFN-stimulated 
response element (ISRE), and IFN-regulatory factor element (IRF-E) (Xie et al., 
1993). The scenario which may have taken place following introduction of poly 
(I:C) can be summarized in figure 6.1. TLR3 C-terminal which has been basally 
detected in the intercalated ducts may have initiated the entire response to poly 
(I:C) entry, inducing nuclear translocation of NF-κβ in these cells and upregulating 
IFN-β and IFN-γ. In turn, the released interferons may have signalled the 
neighbouring duct and acinar cells to: (i) enhance TLR3 mRNA synthesis 
(Miettinen et al., 2001), (ii) activate NF-κβ (Yang et al., 2005) and (iii) upregulate 
iNOS (Zwaferink et al., 2008, Utaisincharoen et al., 2004), which prompted the 


















Different studies have shown that acinar cells are able to activate signalling 
pathways involved in the expression of inflammatory mediators (Gukovsky et al., 
1998, Ramudo et al., 2009, Ramnath et al., 2009, Dios, 2010). This changed the 
classically recognised theory that glandular injury would trigger a local and 
systemic inflammatory response, in which the immune cells play the central role. 
In addition, the exocrine acinar cells have displayed efficient ability to produce: 
(i) cytokines such as TNF-α, IL-6 and IL-1β (Gukovskaya et al., 1997, Blinman et 
al., 2000, Kim et al., 2000), (ii) chemokines such as CXCL1 (KC), monocyte 
chemoattractant protein-1 (MCP-1) or CCL2 and macrophage inflammatory 
protein 2 (MIP-2) or CXCL2 (Blinman et al., 2000) and (iii) adhesion molecules 
example intercellular adhesion molecule 1 (ICAM-1) (Zaninovic et al., 2000, 
Ramudo et al., 2007).  
Figure 6.1 Summary illustration depicting propagation 
of the immune signal initialized in TLR3 positive 
intercalated ducts to the neighbouring acinar and duct 
cells.  

















One of the interesting findings in the present study is the demonstrated ability of 
SG epithelial cells to overexpress different types of inflammatory mediators in 
response to innate immune activation. We have shown that during acute 
infection: (i) NF-κB was translocated to both ductal and acinar nuclei, (ii) SMG 
ducts displayed enhanced production of IFN-β, IFN-γ and Cox2 and (iii) acinar 
cells intensively expressed IFN-β, and iNOS. By showing that the exocrine 
parenchyma expresses these cytokines as early as 6 hrs after injection of an 
inflammagen, we clearly demonstrate the dominant role of these cells in releasing 
the first inflammatory signals in response to the injury initiated within them, 
independent of the bystander role assigned to the infiltrating immune cells.  
The most important finding in the current study is the pattern of [Ca2+]i disruption 
which was detected very early in the acinar cells upon their exposure to the viral 
mimic, TLR3 stimulation and iNOS overproduction. We have shown that this 
trilogy can trigger: (i) Ca2+ depletion from intracellular endoplasmic reticulum 
stores, (ii) increase Ca2+ entry through the plasma membrane, (iii) release Ca2+ 
from membrane-perturbed lysosomes and (iv) potentially affect Ca2+ pumps. 
Previous studies have allocated responses that can prevent Ca2+ mobilization as 
candidates for pathogenesis of SS (Caulfield et al., 2009) and radiation-induced 
SG damage (Coppes et al., 2005). In fact, these studies were based on earlier 
reports relating the pathological inhibition of salivary secretion to NO release 
(Konttinen et al., 1997). Alternatively, due to the increased occurrence of 
glandular destruction in SS (Duffy and O’Reilly, 2016) and following irradiation 
(Marino et al., 2014), release of DAMPs can represent a sustained endogenous 
source of  TLR3 ligation, which can amplify the cycle of iNOS overexpression, 
NO production and Ca2+ signal disruption.  
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The present study may not only relate to the combination of events that drive 
glands from SS or irradiated patients to stop secretion but also outline the early 
time course of possible interaction between the immune system and interference 
with stimulus-secretion coupling.  
In the final part of this study, it was revealed, for the first time, that one of the 
early acute events following exposure to a viral mimic and/or TLR3 stimulation is 
the activation of ER stress. In the current model, ER stress can be simply related 
to [Ca2+]ER depletion, which may have culminated into loss of function by 
downregulating the mRNA machinery, protein translation or disrupted trafficking 
of key membranous water-driving molecules.  
Interestingly, a mouse model of acute pancreatitis revealed that induction of ER 
stress provides acini an opportunity to suppress their secretory function and 
regenerate damaged cells, as evidenced by the acinar and centroacinar 
regenerative response which followed the exocrine disease (Hess et al., 2011). 
Indeed, ER stress is implicated in various inflammatory pathological conditions 
(Grootjans et al., 2016) and investigations have revealed a reciprocal regulation 
between ER stress and inflammation.  ER stress can directly initiate inflammatory 
pathways and, in turn, pro-inflammatory stimuli such as ROS, TLR ligands and 
cytokines can trigger ER stress — such that the resulting UPR activation can 
further amplify inflammatory responses (Zhang et al., 2006). To what extent our 
results reproduce the chronic state that occurs in SG inflammation is an open 
question and ER stress may provide the link between chronic SG inflammation 
and loss of function. The scenario of acute viral SG injury and dysfunction 
















Figure 6.2 Summary illustration depicting the main TLR-3 mediated signalling events that 
induced SMG injury and loss of secretion and the drugs used to counteract the poly (I:C) 



























The results presented in the current study have demonstrated clearly the 
mechanisms underlying loss of saliva secretion following exposure to primary 
viral infections. However, the mouse model developed herein outlines further 
aspects of research worthy of investigation. 
➢ Development of an SS Model Based Solely on Multiple Poly (I:C) 
Injections 
Initial independent experiments (not shown) provisionally showed that a total of 
four intraductal infusions of poly (I:C) (single injection/week for four consecutive 
weeks), resulted in loss of function, 24 hrs after the last injection received and 
infiltration of all SMG lobules with 1-3 peri-vascular immune cell clusters. 
Nevertheless, auto-antibody formation has not been verified, it may be promising 
to follow up with this protocol, towards: (i) possible development of an SS model, 
based uniquely on dynamic cycles of acute viral infections and (ii) verifying if the 
injurious mechanisms operating in the presented acute model are comparable to 
those perceived in the chronic autoimmune state.     
➢ Role Played by Cathepsins in SMG Injury and Dysfunction 
Primary experiments (two mice) utilizing the cathepsin B inhibitor; CA-074, 
revealed recovery of the poly (I:C) injected glands. Further reproducibility of these 
experiments added to the broadly verified z-VAD-fmk results provide a 
comprehensive foundation upon which further work can be executed to entirely 
confirm the beneficial role of cathepsin B inhibition in diseases featuring 
uncontrolled innate immune activation by endosomal TLRs (TLR3, 7, 8, 9 and 13 






➢ Identification of the Mechanisms Involved in LMP 
In the present SMG mouse model, a single injection of poly (I:C) rapidly triggered 
global disruption of lysosomal membranes and release of the organelle contents, 
as early as 9 hrs post infection. Lysosomes form an ‘‘Achilles heel’’ for cancer 
cells by sensitizing them to death pathways through LMP, providing a potential 
new anti-cancer target. Through appropriate stimuli, the lysosome membrane is 
permeated to release lysosomal enzymes, especially cathepsin B, into the 
cytosol (Gao et al., 2014). Release of cathepsin B activates caspase-dependent 
death pathways, promoting cancer cell death even if those cancer cells are 
resistant to normal apoptotic pathways (Boya and Kroemer, 2008). Thus, many 
approaches have been developed to induce LMP, such as oxidation (Denamur 
et al., 2011) and cytotoxic cytokines (Erdal et al., 2005). Among these, reactive 
oxygen species (ROS)-associated oxidation has attracted much attention 
because it can cause rapid lysosomal leakage and dysfunction, causing cells to 
undergo apoptosis with high efficacy at low dose (Lin et al., 2010). However, ROS 
is generally cytotoxic and not cell specific, therefore, new strategies to selectively 
induce ROS-triggered LMP in cancer cells are needed for current anticancer 
therapy so as to prevent  harmful side effects and increase treatment efficacy 
(Gao et al., 2014).  The viral mimic provoked local LMP and cathepsin B release 
in the present mouse model. Thorough investigation of the mechanisms 
underlying poly (I:C)-triggered LMP may offer promising opportunities to limit this 
phenomenon to cancer cells, via driving them to express or signal in the same 
way which prompted the SMG duct cell lysosomes to disrupt and release their 




➢ TLR3 Modulation in Chronic Mucosal Inflammation and 
Autoimmunity  
The current study unravelled two mechanisms which efficiently controlled TLR3 
upregulated expression and downstream inflammatory mediators in the SMGs, 
despite the presence of a potent stimulant; poly (I:C). The use of protease 
inhibitors in oral mucosal and SG diseases featuring chronically stimulated TLR3 
receptors may act as brakes that can regulate and fine-tune the repeated cycles 
of mucosal damage by cytokines and apoptotic signals.  
➢ Regeneration of the mouse SMGs Following Activation of the Innate 
Immunity 
Stimulation of TLR3 causes rapid and global changes in the expression of 
epigenetic modifiers to enhance chromatin remodeling and nuclear 
reprogramming (Lee et al., 2012a). In the context of regenerative medicine, 
epigenetics is becoming a pivotal area of interest (Consalvi et al., 2016). The 
current model may be insightful for the study of regeneration following acute viral 
infections and the epigenetic events in SGs following injury, supported by the 
synchronized innate immune activation and TLR3 ligation. Moreover, owing to 
the resident stem or progenitor cell population harbored by SGs, which is capable 
of regenerating the parenchyme (Denny et al., 1993),  stem cell-derived 
extracellular vesicles appear to be naturally equipped to mediate tissue 
regeneration (Ono et al., 2015) and recent evidence suggests their therapeutic 
potential for targeted delivery of exogenous miRNAs (Vlassov et al., 2012). 
Isolating and characterizing the exosomes secreted in the regeneration phase of 
this rapid-developing model can provide valuable information on the extracellular 
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